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Abstract 
Protein synthesis is an essential process for all living organisms and is an effective major 
target for current antibiotics. Elongation factor Tu (EF-Tu) is a highly conserved and 
essential protein that functions during protein synthesis. EF-Ts interacts with EF-Tu to 
help maintain a functionally active state of EF-Tu required for cell growth. Although 
EF-Ts is essential for Escherichia coli, its sequence is poorly conserved. LepA is a highly 
conserved protein within bacteria and has a similar structure to EF-Tu. In spite of this, 
LepA has been shown to be non-essential under ideal conditions and the function of 
LepA still remains elusive. An analysis on the structurally unique aspects of LepA, 
EF-Tu and EF-Ts was performed here in an effort to gain an understanding on the 
functions of these proteins. This knowledge, in combination with their unique structural 
components will provide important tools in developing new and effective antibiotics.  
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Chapter 1 
 
Translation  
The process of gene expression is the process in which genetic information is utilized 
towards the synthesis of a functional cellular product, such as an essential protein. In all 
living organisms gene expression is a highly complex and regulated process. It involves a 
large number of intermediate steps and many molecular interaction partners that facilitate 
the necessary speed and accuracy of this process. In bacteria, gene expression can be 
simplified into two main stages which are the processes of transcription and translation. 
During the process of transcription, DNA is used as a template for the synthesis of 
messenger RNA (mRNA). Messenger RNA is subsequently utilized during translation to 
direct the synthesis of proteins (1). In bacteria the transcribed mRNA is used directly as a 
message for protein synthesis. This process utilizes triplet nucleotide codons, encoded 
within the mRNA, which specify the sequence of amino acids needed to build a specific 
polypeptide chain.  
Proteins are ubiquitous macromolecules as they are found in all domains of life and fulfill 
diverse roles such as cellular signalling, transporting molecules and catalyzing metabolic 
processes (2). As proteins are essential to all forms of life, it is not surprising that protein 
synthesis occurs in all domains of life.  
 
1.1a The Bacterial Ribosome 
The process of protein synthesis takes place on the ribosome, which is a 
ribocucleoprotein (RNP) comprised of a large and a small subunit (Figure 1.1). Each 
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ribosomal subunit is made up of approximately two-thirds ribosomal RNA (rRNA) and 
one-third protein. The ribosome encompasses 30% of the cellular mass of a bacterial cell 
and approximately 5% of a eukaryotic cell (3). In Escherichia coli, the ribosome has a 
mass of 2.5 MDa and a sedimentation coefficient of 70S.  
 
 
 
 
 
 
 
 
Figure 1.1. The bacterial ribosome with three tRNA binding sites occupied. Structure of the 70S 
ribosome from Thermus Thermophilus represented in ribbon, in complex with mRNA (spacefill and 
coloured in green), A- P- and E-site bound tRNA (shown in licorice and coloured blue, orange and red, 
respectively). The 50S is coloured in black and the 30S is coloured in grey. Structure was obtained by 
X-ray crystallography to 3.6 Å resolution (PDB ID 2WDK, 2WDL (4)). 
 
In bacteria, the large ribosomal subunit, or the 50S subunit, contains a 2904 nucleotide 
23S rRNA and a 115 nucleotide 5S rRNA and 34 (L1-L34) ribosomal proteins (5), while 
the small ribosomal subunit, the 30S subunit, consists of a 1542 nucleotide 16S rRNA 
and 21 (S1-S21) ribosomal proteins (6). The ribosome contains 3 tRNA binding sites 
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(Figure 1.1), the aminoacyl (A) site, the peptidyl (P) site and the exit (E) site (7), which 
straddle both the 50S and 30S subunits.  
Prior to ribosome assembly 16S and 23S rRNA are processed by RNase III (8), RNase E, 
RNase G (9) and RNase T (10), to form a mature 16S and 23S rRNA. Following 
maturation of the 16S and 23S rRNA, all rRNA and ribosomal proteins must assemble in 
the correct manner to form an active ribosomal complex (11). Self-assembly has been 
shown to occur in the absence of co-factors in vitro (12). However, the conditions utilized 
to observe self-assembly are not physiologically relevant and the rate observed for self-
assembly is too slow to sustain life. Further evidence suggests that several additional 
ribosomal biogenesis factors monitor the assembly of the ribosome, which are required 
for the fast and efficient assembly observed in vivo.  
Numerous biochemical and structural studies on the ribosome have facilitated the overall 
understanding of what parts within the ribosome contribute to its overall function. 
Electron microscopic studies on the structure of the ribosome have been available since 
the 1970s; however, it was not until 1999 that high resolution X-Ray crystallographic 
structures of the ribosome became available. The overall structure of the small ribosomal 
subunit is largely determined by the 16S rRNA. There are three main domains within the 
30S (5’ domain, central domain and 3’ major domain) which form the body, platform and 
head of the 30S subunit (13). The 30S subunit harbours the site of decoding (the decoding 
centre), which is involved in the selection of the correct aminoacylated-tRNA (aa-tRNA) 
corresponding to the mRNA codon presented in the A site of the translating ribosome 
(14). Nucleotides A1492, A1493 and G530 of the 16S rRNA interact with the codon-
anticodon helix in the ribosomal A site (14). Cognate Watson-Crick base pairing results 
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in a short double helix which is stabilized by the conserved nucleotides A1492, A1493 
and G530 (14). Stabilization of a cognate Watson-Crick base pair is critical during the 
decoding process, as this is utilized to discriminate cognate codon-anticodon interactions 
against near-cognate and non-cognate interactions.  
Similar to the small ribosomal subunit, the large subunit structure is mainly determined 
by its large rRNA (23S rRNA). The 50S ribosomal subunit contains the peptidyl 
transferase centre (PTC), which catalyzes peptide-bond formation (15). In addition, the 
50S subunit also contains the so called L7/L12 stalk, which has been shown to stimulate 
the activity of guanine nucleotide triphosphatases (GTPases) such as EF-Tu and EF-G 
interacting with the ribosomal A site (16,17).  
 
1.1b GTPases 
GTPases are molecular switches that function in a variety of cellular processes and are 
regulated by guanine nucleotide binding (Figure 1.2). When bound to GTP, these proteins 
are active, which means that they can efficiently interact with their downstream effectors 
in this state. This interaction is maintained until GTP hydrolysis occurs. Typically, the 
intrinsic rate of GTP hydrolysis by GTPases is slow and occurs with rates on the order of 
10
-4
s
-1
 (18). This slow rate of GTP hydrolysis by the GTPase is likely to maintain an 
active state of the protein until its function is carried out. However, GTPases which are 
constantly in an active state have been shown to have toxic effects on a cell (19). 
Therefore, GTPase activating proteins or factors (GAP/GAF) are utilized within a cell to 
stimulate the rate of GTP hydrolysis. For GTPases EF-G and EF-Tu, the ribosome acts as 
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a GAF and has been shown to stimulate the intrinsic rate of GTP hydrolysis by 10
6
-fold 
(20). Following GTP hydrolysis, the protein is bound to GDP in an inactive state, such 
that it cannot interact efficiently with its downstream effector (21). GDP must dissociate 
from the protein before GTP can bind so that the protein can return to an active state. 
Guanine nucleotide exchange factors (GEFs) are utilized to catalyze the dissociation of 
GDP from the protein if dissociation is slower than the rate needed to regenerate an 
active state of the protein for further function. In this way GEFs promote the regeneration 
of an active GTP-bound GTPase.  
 
Figure 1.2. General cycle of a GTPase. A GTPase bound to GTP adopts an active state that may interact 
with a downstream effector for further function until GTP hydrolysis occurs. This is often stimulated by a 
GTPase activating protein/factor (GAP/GAF). The GTPase, now bound to GDP, is in an inactive state. 
GDP dissociation can be catalyzed by a guanine nucleotide exchange factor (GEF). GTP can subsequently 
bind and the process may continue.  
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1.1c Protein Synthesis  
The process of mRNA directed protein synthesis is catalyzed by the ribosome and can be 
divided into four distinct steps, initiation, elongation, termination and recycling (Figure 
1.3).  
Initiation involves the assembly of a pre-initiation complex containing mRNA, as well as 
an initiator tRNA onto the small ribosomal subunit, followed by the subsequent 
association of the large subunit to form an initiation complex that can be used in the 
process of elongation (22). Initiation in bacteria is catalyzed by three initiation factors 
IF1, IF2 and IF3 (22), which promote the correct positioning of the start codon as well as 
the initiator tRNA. In eukaryotes and archaea the process of initiation is far more 
complex than in bacteria as several other initiation factors are required. In eukaryotes, 
proper positioning of the mRNA initiation codon in the P site of the ribosome is 
facilitated by initiation factors in combination with scanning of the mRNA (23). Binding 
of the mRNA to the small subunit in bacteria does not require initiation factors to assist in 
recruitment or scanning for positioning of the mRNA. Correct positioning of the mRNA 
in bacteria is facilitated by the interaction of the Shine-Dalgarno sequence in the mRNA 
with the complementary anti-Shine-Dalgarno sequence on the 16S rRNA (24). Initiator 
tRNA in eukaryotes is delivered to the small subunit with the help of initiation factors. 
Although binding of initiator tRNA in bacteria can be accelerated by the presence of 
initiation factors, it is not delivered to the small subunit by initiation factors (25).  
Following initiation, elongation of the polypeptide chain encoded by the mRNA can 
occur. Elongation is the only process in translation that is universally conserved and 
consists of three main steps (i) decoding of the mRNA, (ii) peptide-bond formation and 
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(iii) translocation (26). This process is catalyzed by the universally conserved elongation 
factors (EF), EF-Tu, EF-Ts and EF-G in bacteria and eEF1A, eEF1B and eEF2 in 
eukaryotes (21).  
Once a stop-codon is encountered in the A site of the ribosome, release factors (RF1 and 
RF2) in bacteria recognize and bind to the ribosome and catalyze peptide release (27). 
RF1 and RF3 contain a conserved GGQ motif that is essential for peptide release through 
positioning of the hydrolytic water (28). Although RF3 accelerates the dissociation of 
RF1 and RF2 from the ribosome, it is not essential in bacteria (29). Similar to bacteria, 
eukaryotes contain a release factor (eRF1) which recognizes termination codons (26). 
However, eRF1 is able to recognize all the termination codons and binds to release factor 
3 (eRF3) before binding to the ribosome (30). Furthermore, unlike RF3, eRF3 is essential 
for peptide release (31).  
Following termination the ribosome is recycled to prepare for catalysis of a new round of 
protein synthesis. In this process ribosome recycling factor (RRF) and EF-G catalyze the 
dissociation of the 70S ribosome into the 50S and 30S ribosomal subunits (32). IF3 binds 
to the 30S subunit still containing mRNA and tRNA and promotes their dissociation (26). 
With the ribosomal subunits now separated, initiation can occur once again and the 
process of protein synthesis can restart. Interestingly, no RRF homologue is found in 
eukaryotes, and this process is poorly understood in eukaryotes. Recently, it has been 
shown that ABCE1 in eukaryotes can promote ribosome recycling (33). Although 
recycling in eukaryotes is not well understood, it is clear that it is different than the 
prokaryote process.  
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Figure 1.3. The cyclic process of translation in bacteria. Protein synthesis in bacteria occurs by four 
main steps, initiation, elongation, termination and recycling. The factors involved in each process, as well 
as a snapshot of the end product for each step is represented. 
 
1.1d Translation Elongation in Bacteria 
The process of elongation can be broken down into three main steps, decoding of the 
mRNA, peptide-bond formation and translocation (26).  
Decoding of the mRNA codon occurs by the cognate aa-tRNA (1). Transfer RNA 
(tRNA) is an adaptor molecule that bridges the gap between the mRNA and the growing 
polypeptide chain. Through mRNA codon – tRNA anticodon interactions, aa-tRNA is 
able to recognize mRNA codons that correspond to a specific amino acid attached to the 
tRNA (1). In turn, this amino acid can be utilized in building a polypeptide chain on the 
ribosome (34). There are approximately 30 different tRNAs within prokaryotes (35) 
which are amino acid specific and have been studied extensively over the last 50 years in 
terms of processing, dynamics and structure.  
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Each tRNA contains between 75 to 90 RNA nucleotides and forms a cloverleaf 
secondary structure (36) (Figure 1.4). While diverse in sequence, all tRNAs share a 
similar secondary and tertiary structure (Figure 1.4). All tRNAs consist of a 
phosphorylated 5’ end, a dihydro uracil loop (D-loop) which contains a modified 
dihydrouridine base, an anticodon loop that can base pair with the mRNA triplet codon, a 
variable loop which differs in length between tRNAs, a TΨC loop (T-loop) that contains 
a pseudouridine and an acceptor stem comprised of the 3’ end for amino acid attachment 
(36). The elements of the secondary structure fold into an L-shaped tertiary conformation 
(36), where the anticodon loop and the acceptor stem are at opposite ends and 
approximately 76 Å apart. The D and T-loops of the tRNA form the elbow region in the 
tertiary structure (Figure 1.4). This L-shape formed by all tRNAs facilitates the contacts 
made during protein synthesis. For example, the anticodon loop of the tRNA can interact 
with the mRNA, while the amino acid on the acceptor stem can make contacts near the 
polypeptide chain. 
Even though all aa-tRNAs are very similar with respect to their general structure, each 
tRNA is charged with a specific amino acid. This specificity is critical for maintaining 
the genetic code. To help maintain specificity there are discriminator bases within tRNAs 
which are utilized in distinguishing them from each other during aminoacylation (37). 
Aa-tRNA synthetases use a double-sieve mechanism to help prevent errors which may 
propagate into the synthesis of errant proteins. The strategy of the double-sieve 
mechanism is to combine the use of a restricted binding pocket for the specific amino 
acid with proofreading. Following the aminoacylation of tRNA, EF-Tu binds to the 
formed aa-tRNA and facilitates its delivery to the translating ribosome (38). 
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Figure 1.4. Structure of tRNA. (A) Secondary structure of the cloverleaf tRNA showing the acceptor 
stem coloured in blue, the TΨC loop coloured in pink, the anticodon loop coloured in green, the D loop 
coloured in purple and the variable loop coloured in yellow. (B) The crystal structure of yeast tRNA is 
coloured as in A. (PDB ID 6TNA was used (36)). 
 
EF-Tu in E. coli is a 43 kilodalton (kDa) (39) GTPase involved in the delivery of 
aa-tRNA to the A site of an actively translating ribosome (40). In the active GTP-bound 
state of EF-Tu, a ternary complex (EF-Tu•GTP•aa-tRNA) is formed and rapidly binds to 
the ribosome (Figure 1.5). The laboratory of Dr. Marina Rodnina has performed a 
detailed analysis of the many steps during EF-Tu facilitated delivery of aa-tRNA to the 
translating ribosome (41). Following initial binding and correct codon-anticodon 
recognition, GTPase activation of EF-Tu occurs (42). This stimulation by the ribosome 
results in a 10
6
-fold increase in the GTPase activity of EF-Tu (20). Furthermore, this 
stimulation is required to maintain the rapid and accurate rate of protein synthesis.  
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Figure 1.5. EF-Tu-dependent A site binding. During initial binding, the ternary complex binds to the 
ribosome, followed by codon recognition, triggering GTPase activation of EF-Tu (light blue). Subsequently 
GTP hydrolysis and Pi release occur, inducing a conformational change in EF-Tu leading to the release and 
accommodation of the aa-tRNA and peptidyl transfer. EF-Tu•GDP can dissociate before, during or after 
accommodation of aa-tRNA. 
 
Following GTP hydrolysis and Pi release (43), EF-Tu undergoes a large conformational 
change (44) which results in the inactive EF-Tu•GDP complex. As EF-Tu•GDP has a 
2-fold decreased affinity for aa-tRNA compared to EF-Tu•GTP, aa-tRNA is subsequently 
released from EF-Tu•GDP (41). EF-Tu•GDP dissociates from the ribosome, however the 
exact timing - whether it occurs before, during, or after tRNA accomodation into the 
ribosomal A site is not known. EF-Tu•GDP must be recycled to EF-Tu•GTP to enable 
efficient protein synthesis in vivo. EF-Tu has a higher binding affinity for GDP than for 
GTP (45) and the rate of GDP dissociation from EF-Tu is extremely slow, therefore 
nucleotide exchange is catalyzed by the guanine nucleotide exchange factor (GEF) EF-Ts 
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(Figure 1.6) (46,47). The high cellular concentration of GTP (10 mM) relative to GDP 
(1 mM) (48) allows EF-Tu to be recycled to its active GTP-bound form, enabling binding 
of a new aa-tRNA to continue the cycle of elongation.  
 
 
 
 
 
 
 
 
 
Figure 1.6. The functional cycle of EF-Tu. The cyclic process of EF-Tu catalyzing the delivery of 
aa-tRNA to the ribosome starts with the formation of the EF-Tu•GTP•aa-tRNA complex. Following 
accommodation of aa-tRNA, EF-Tu bound to GDP dissociates from the ribosome. EF-Ts facilitates the 
recycling of EF-Tu•GDP to EF-Tu•GTP complex. 
 
Following aa-tRNA accommodation into the ribosomal A site, peptide-bond formation 
occurs between the incoming aa-tRNA and the peptidyl-tRNA in the P site (49). The PTC 
is composed of highly conserved rRNA and the mechanism of peptide-bond formation is 
conserved between eukaryotes and prokaryotes (26). The A and P-site tRNAs are 
positioned by interactions made with the 23S rRNA. Nucleotides of the 23S rRNA within 
the peptidyl-transferase center seem to have a role in positioning peptidyl-tRNA rather 
than in catalyzing peptide-bond formation. Proper positioning allows the α-amino group 
of the A-site bound aa-tRNA to attack the carbonyl carbon of the ester in the 
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peptidyl-tRNA in the P site. Although the ribosome is not involved in chemical catalysis 
it can modulate peptide-bond formation by conformational changes in the PTC (50).  
In order for elongation to continue, the P and A-site tRNAs, along with the mRNA, must 
move to the E and P sites respectively. The translational GTPase EF-G, binds to the Pre-
translocation ribosome complex in its GTP-bound active state and catalyzes translocation 
of the tRNAs and the mRNA (Figure 1.7) (51). Structural studies have revealed that EFG 
binding to the ribosome induces a so-called ratcheted state of the ribosome (52), which is 
critical to promote translocation. Furthermore, domain IV of EF-G protrudes into the 
ribosomal A site and prevents the backwards movement of the tRNAs into their original 
P and A site positions respectively (52). Following tRNA movement and Pi release, the 
ribosome can return to a non-ratcheted state (51). EF-G, now bound to GDP, dissociates 
from the ribosome, and the deacyl-tRNA occupying the E site quickly dissociates from 
the ribosome (51). The P site is occupied with the now one amino acid longer 
peptidyl-tRNA and the A site is empty, exposing the next codon specifying the next 
aa-tRNA to be incorporated into the growing polypeptide chain. 
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Figure 1.7. Translocation in the presence of EF-G. EF-G•GTP catalyzes translocation of A- and P-site 
tRNAs to the P and E sites of the ribosome by binding to the ribosome in a GTP-bound state and inducing 
an unlocked state of the ribosome (yellow) following GTP hydrolysis. Following translocation, EF-G•GDP 
and deacyl-tRNA dissociate from the ribosome. An empty A site with a new mRNA codon is left for the 
next round of elongation. 
 
Forward translocation of tRNA and mRNA can occur intrinsically as peptidyl-tRNA has 
a higher affinity for the P site than for the A site of the ribosome (53). Therefore, peptide-
bond formation promotes the movement of the A-site peptidyl-tRNA to the P site as this 
is thermodynamically favoured. Furthermore, in the absence of EF-G, the process of 
translocation can be facilitated by thiol-reactive reagents or by the omission of ribosomal 
proteins S12 and S13 (54).  
Interestingly, it has been shown that back-translocation can occur spontaneously within 
the ribosome just as forward translocation can (55). Deacyl-tRNA has a higher affinity 
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for the P site than the E site (53). Therefore, the movement of the deacyl-tRNA, 
occupying the P-site, towards the ribosomal E site is not favoured. It has been shown that 
in the absence of all factors all tRNAs have the highest affinity for the ribosomal P site 
over any of other site. However, depending on the tRNAs occupying the E, P and or 
A-sites of the ribosome, the rate and extent of spontaneous tRNA movement within the 
ribosome is dependent upon the affinity of the peptidyl-tRNA and tRNA for the 
respective ribosomal sites (55). Movement of the tRNAs within the ribosome will reflect 
their most thermodynamically favoured state (55). This supports the idea that interactions 
made within the ribosome modulate the process and speed of translation. Translational 
GTPases, such as EF-G, have evolved to interact with the ribosome in such a way that the 
forward movement of translation is supported.  
EF-G not only promotes forward translocation but prevents back-translocation by 
inserting its domain IV into the ribosomal A site. A translational GTPase in bacteria, 
LepA, has been shown to have a similar structure to EF-G, however, it has been 
demonstrated to catalyze back-translocation (56). Although back-translocation can occur 
spontaneously and can be catalyzed by LepA, the functional importance of this process is 
currently not understood.  
 
1.1e Objectives  
The process of elongation in protein synthesis is the only universally conserved step in 
translation. Therefore, knowledge obtained of this process within bacteria can be 
transferred to other domains of life. Elongation in protein synthesis is an essential process 
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and is an effective antibiotic target (57). Currently, there are several biochemical studies 
and structures that have elucidated the overall process of elongation and how antibiotics 
inhibit it. However, there are still some questions regarding events that occur during this 
process that need to be addressed. Knowledge obtained on the mechanism of elongation 
and interaction between elongation related translational GTPases and the ribosome can be 
utilized in the development of novel antibiotics. 
Objective 1: LepA is a translational GTPase found in bacteria and eukaryotic 
mitochondria and chloroplasts. LepA is poorly understood in terms of its cellular and 
mechanistic function. It has a structure similar to EF-G and the EF-TuGTPaa-tRNA 
ternary complex (58), however, its role or function in vivo is not understood. Although 
LepA is highly conserved throughout bacteria, it has been shown to be dispensable to the 
cell under optimal (culture) conditions (59). 
Despite its similarity in structure to EF-G and EF-TuGTPaa-tRNA, LepA contains a 
unique C-terminal domain (CTD) which resembles a truncated version of domain IV in 
EF-G (58). This domain has been demonstrated to contact the ribosome (60) and may be 
important for the function of LepA, as domain IV is important for the function of EF-G. 
It has been shown that the contacts made between the ribosome and translational 
GTPases EF-G and EF-Tu modulate the interaction of these proteins with guanine 
nucleotides as well as their GTPase activity. Information obtained on whether LepAs 
CTD is important for the interaction between LepA, guanine nucleotides and the 
ribosome may give insight into the function of this protein. The emphasis of the first 
objective will be to address the role of the unique CTD in LepA. Analysis on the role of 
this domain and the interaction between LepA and the ribosome, which may affect its 
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function as a translational GTPase, will be performed. Furthermore, a comparison of the 
interaction between LepA, guanine nucleotides and the ribosome to other known 
GTPases, such as EF-G, may give insight into the function of this protein and its role in 
the cell. 
Objective2: EF-Tu is an essential GTPase in all living cells. In order to maintain the 
speed of translation observed in vivo, EF-Ts binds to EF-Tu and catalyzes the 
dissociation of GDP from EF-Tu, which allows GTP to bind. In spite of this, EF-Ts is 
highly divergent in sequence among bacterial species. The majority of residues involved 
in forming contacts with EF-Tu are conserved within EF-Ts, however, contacts made 
with the C-terminus of EF-Ts are poorly conserved. Furthermore, the interaction between 
the EF-Tu and EF-Ts homologues in eukaryotes are different than those seen in bacteria. 
Given the divergence of EF-Ts, it is questionable whether the contacts made between 
EF-Tu and EF-Ts need to be conserved to maintain function or whether this divergence 
results in differences in the catalytic ability of EF-Ts to act as a GEF. Understanding the 
variability and structural requirements within EF-Ts in bacteria might be an important 
tool in the design of antibiotics.  
E. coli and P. aeruginosa are two gram-negative bacterial species which share 55% 
sequence identity in EF-Ts. In spite of this relatively high sequence identity within 
EF-Ts, these two species are extremely divergent in the sequence of the C-terminal 
module within EF-Ts which contacts the G-domain of EF-Tu. The emphasis of the 
second objective will be to compare the ability of EF-Ts from these two organisms to 
catalyze the dissociation of guanine nucleotides from EF-Tu and to determine if the 
18 
 
divergence observed in their C-terminal module causes any differences in their catalytic 
ability.  
Objective 3: Comparisons of GTP and GDP-bound states of EF-Tu have revealed major 
domain rearrangements within EF-Tu (44). Little is known however about the 
mechanisms underlying these conformational changes. Furthermore, it is not understood 
when EF-Tu dissociates from the ribosome relative to the accommodation of aa-tRNA. 
Currently, the means of directly measuring these events has not been developed. By 
developing a real-time fluorescence-based assay for measuring the conformational 
dynamics of EF-Tu on and off the ribosome, the above can be investigated. 
The thiol group of cysteine is often used to attach a fluorescent dye to a protein. 
However, cysteine residues are not always located in positions optimal for the analysis of 
interactions or conformational changes. The emphasis of the third objective will be on 
the construction of a cysteine-free (Cys-less) EF-Tu that can be used for the subsequent 
site-specific integration of cysteines located in optimal positions for fluorescent labelling 
and analysis. This will be a powerful tool for further understanding the dynamic 
movement of EF-Tu on and off the ribosome.  
 
Significance 
Analysis of all three objectives will not only help gain a better understanding of how 
these proteins function individually, but will also assist in understanding elongation 
during translation as a whole. GTPases that function during elongation have evolved to 
facilitate the speed and accuracy of this process through interactions with the ribosome 
that help ensure the directionality of translation and in this way they are essential for the 
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cell. A lot is known about this process, however, there are still details in this process that 
is not understood and will be addressed in the objectives listed above. Furthermore, given 
that elongation is a current target for antibiotics, addressing the above objectives may 
inform the development of new and unique targets.  
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Chapter 2. 
Identification of Two Structural Elements in LepA Important for its Ribosome 
Stimulated GTPase Activity. 
2.1 Introduction 
2.1a Identification and Initial Characterisation of LepA 
Deletion studies of regions flanking the gene encoding for leader (signal) peptidase I 
(lep) in Escherichia coli revealed that a stretch of 2 kilobases (kb) upstream of the lep 
gene is required for signal peptidase expression (61). Further studies by the lab of 
Masayori Inouye on the DNA sequence surrounding the lep gene demonstrated that the 
lep promoter is located 2 kb upstream of the gene (62). Interestingly, an open reading 
frame (ORF) located between the lep promoter and the lep gene was identified to encode 
for a 598 amino acid polypeptide and annotated as lepA.  
The primary sequence of LepA indicates that there are no long stretches of hydrophobic 
regions in LepA, however localization studies of the LepA protein identified that it was 
mainly found in the membrane and the periplasm (62). Additionally, the mitochondrial 
counterpart of LepA, Guf1, was also found in the mitochondrial matrix and associated 
with the inner mitochondrial membrane (63). Given that LepA localizes in the 
cytoplasmic membrane of E. coli, it was originally proposed that like signal peptidase I, 
LepA may be involved in catalyzing the passage of proteins across the membrane (62). 
However, initial knockout studies of the lepA gene in E. coli under optimal growth 
conditions did not affect cell growth (59) indicating that, unlike signal peptidase I, LepA 
is not essential for the growth of E. coli and that LepA is not involved in protein export 
(59).  
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Further analysis by the lab of Masayori Inouye demonstrated that the amino-terminus of 
LepA has homology to EF-G and EF-Tu as well as IF2 (64). The sequence of the lepA 
gene revealed that LepA contains all four G motifs: G1 (P-loop; consensus 
GX4GK(S/T)), G2 (effector loop, or switch I; DXnT), G3 (switch II; DX2G), and G4 
(NKXD) which are responsible for interacting with a guanine nucleotide (21). GTP 
binding studies performed by Masayori Inouye and coworkers confirmed the presence of 
a guanine nucleotide binding domain and that LepA is indeed a GTP-binding protein like 
EF-G, EF-Tu and IF2 (64). Structural prediction tools support the idea that LepA likely 
has a similar secondary structure to these proteins (56). However the cellular function of 
LepA remains elusive. 
 
2.1b Analysis of LepA Under Stress Conditions 
In order to identify the cellular function of LepA, the effect of deleting the lepA gene was 
analyzed under various cellular growth conditions in E. coli (59). Although no effect of 
the lepA knockout was observed in E. coli, a later study in Helicobacter pylori, where 
over 1000 random gene knockouts were tested with respect to effects on growth at pH 4.8 
revealed lepA as one of ten genes essential for growth under these conditions (65). 
Studies on the mitochondrial homologue of LepA (Guf1) in yeast, show that Guf1 is 
dispensable under optimal growth conditions in rich media (63). However, at low 
temperatures (15C), in vivo protein synthesis in the mitochondria of cells lacking guf1 is 
significantly lower than in wild type cells (63). This study also revealed that Guf1 is 
upregulated in mitochondria at low temperatures (15C) as well as higher temperatures 
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(37C) (63). A recent study of the chloroplast LepA homolog (CpLepA) showed that 
growth of Arabidopsis thaliana is reduced in the absence of cplepa (66). These studies 
indicate that although LepA may not be essential under ideal conditions, it may be 
required for cellular growth under stress conditions.  
Growth of cells under different magnesium concentrations in the absence and presence of 
lepA revealed a significant reduction in cellular growth under high magnesium 
concentrations (100 mM) in the absence of lepA (67). In addition, work showed that at 
14 mM Mg
2+
, LepA is able to increase the rate of poly(Phe) synthesis in vitro (67). 
However, how LepA is activated in the cell and what the mechanism or function of LepA 
is remains unknown.  
 
2.1c Histidine as a Catalytic Residue 
In Ras-like G-proteins, a glutamine typically acts as a base by abstracting a proton from 
water, activating it for a nucleophilic attack on the gamma-phosphate of GTP ultimately 
triggering the efficient hydrolysis of the bound GTP (18). Interestingly, EF-Tu contains a 
histidine residue (His 84) in the switch II region, which has been shown to be important 
for GTPase activity of EF-Tu (68). Using mutagenesis in combination with rapid kinetics 
it was shown that substitution of His 84 in EF-Tu with an alanine residue significantly 
reduces the rate of ribosome stimulated GTP hydrolysis by EF-Tu, indicating that His 84 
is important for catalysis of GTP hydrolysis (68). Structures of EF-Tu bound to GTP and 
GDP (44,69) illustrate that a conformational change occurs within the switch II region 
following GTP hydrolysis. A structure of EF-Tu bound to a non-hydrolyzable analogue 
of GTP (GMPPNP) revealed that there is a hydrophobic gate formed by Val 20 and Ile 60 
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within the G-domain of EF-Tu that prevents His 84 from activating a water molecule for 
GTP hydrolysis. Structural studies of EF-Tu on the ribosome demonstrate that the 
hydrophobic gate within EF-Tu opens following ribosome binding (70,71). This allows 
His 84, which interacts with A2662 of the 23S rRNA, to reposition and potentially 
activate water for GTP hydrolysis. Other translational GTPases, such as EF-G and LepA, 
contain a histidine that is 100% conserved in a similar location as found in EF-Tu, 
suggesting a similar catalytic role for this residue in all translational GTPases.  
 
2.1d Structural Analysis of LepA 
In 2008 the structure of LepA from E. coli was determined using X-ray crystallography 
(58) and confirmed that LepA is similar in structure to EF-G (Figure 2.1). LepA contains 
5 domains with domains I, II, III and V of LepA corresponding closely to domains I, II, 
III and V of EF-G. However, LepA does not contain a domain that corresponds to 
domain IV of EF-G, but does contain a unique C-terminal domain (CTD) that occupies a 
similar position as domain IV in EF-G (Figure 2.1).  
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Figure 2.1. Structural comparison of LepA and EF-G. The domain arrangement is represented on the 
left, the corresponding residues within the domain are indicated above the respective domain. Cartoon 
representations of EF-G from Thermus thermophilus (PDB ID 1FNM (72)) and LepA from Escherichia 
coli (PDB ID 3CB4 (58)) are shown on the right. Domains are coloured according to the domain 
arrangement with the G-domain coloured pink, G’ domain coloured purple, domain II coloured blue, 
domain III coloured red, domain IV coloured green and domain V coloured yellow. Residues 556 – 599 of 
LepA were not resolved in the structure and their position in the CTD is indicated by white lines in the 
alignment. 
 
Domain I of LepA is a guanine nucleotide-binding domain (G-domain) with a Rossmann 
fold typical for G-proteins. Domain II in LepA has a 6-stranded -barrel structure and 
domains III and V consist of a -- fold, which is similar to domains III and V in EF-G. 
Although domains III and V in LepA have a similar fold as these domains in EF-G, they 
are oriented differently than in EF-G. In LepA, domain V is rotated and shifted upwards 
relative to domain I, allowing for a larger interface between domains I and V. The CTD 
of LepA is composed of a long -helix between 4 -sheets and is very basic giving it a 
net positive charge. However, as only part of the CTD is resolved in the available X-ray 
crystal structure of LepA (58), it is not clear what the entire structure of this domain is. 
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Interestingly, LepA is not the only GTP-binding protein in the prokaryotic cell with a 
three dimensional structure similar to that of EF-G. GTPases BipA and Tet(M)/Tet(O) 
also have a structure similar to that of EF-G (73-75). BipA is a 65 kDa protein that is 
encoded by the gene bipA and similar to LepA, BipA has been shown to be essential 
under stress conditions such as low temperature and low pH (76). However, unlike LepA, 
BipA has been shown to function as a virulence regulator (73). No full-length structure of 
BipA is currently available. However, a crystal structure of the C-terminal half (domains 
III, V and the CTD) of BipA from Vibrio parahaemolyticus (77) has been determined and 
shows structural similarity to domains III and V of EF-G. Furthermore, like EF-G and 
LepA, BipA has five domains, where the N-terminal G-domain and domains II, III and V 
are predicted to be similar in structure to EF-G and LepA. Also similar to LepA, BipA 
contains a unique CTD that has been shown, through deletion studies, to be required for 
BipA-ribosome interaction (78).  
Tet(M) and Tet(O) are two bacterial ribosome protection proteins which have GTPase 
activity and mediate tetracycline resistance. They are both approximately 68 kDa in size 
and have been shown to be similar in structure to EF-G (74,75). Structural alignment of 
Tet(M) and Tet(O) reveals a high level of structural conservation with all five domains of 
EF-G (74). 
It is interesting that the cell has evolved proteins with extremely similar structures but 
different functions. In spite of their functions being different, they all engage with the 
70S ribosome in a similar fashion. This raises the questions as to how these interactions 
are regulated and timed in order to facilitate (or not inhibit) efficient protein synthesis.  
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2.1e LepA Interaction with the Ribosome 
Structures of EF-G, LepA, Tet(O) and Tet(M) bound to the ribosome have been 
determined (52,60,79,80). All proteins bind to the ribosome below the L7/L12 stalk base. 
This binding site is shared with other translational GTPases that bind to the ribosome, 
such as EF-Tu (70). The available structures of factors on the ribosome have revealed 
that domains I, II, III and V of all three proteins contact the ribosome in a very similar 
fashion. Domain I, or the G-domain, contacts helix 95 of the 23S rRNA, domain II 
interacts with helix 5 of the 16S rRNA, domain III interacts with S12 of the 30S subunit 
and domain V interacts with helices 43, 44 and L11 of the 50S subunit. The largest 
difference in the interactions between LepA, EF-G, Tet(O) and Tet(M) and the ribosome 
is between the contacts made between the ribosome and domain IV of 
EF-G/Tet(O)/Tet(M) and the CTD of LepA. Domain IV of EF-G has been shown to be 
essential for EF-G’s multiple turnover GTPase activity and the catalysis of translocation 
(81,82). Domain IV of EF-G also inserts into the A site of the ribosome and contacts 
P-site tRNA and mRNA. Domain IV of Tet(O) and Tet(M) extends into the ribosome in 
the same direction as domain IV in EF-G, however, it does not extend as far into the 
ribosome as EF-G and contacts helices 18 and 34 of the 16S rRNA (79,80).  
Considering that the CTD of LepA is unique, it is not surprising that it makes contacts 
with the ribosome which are different from that of domain IV in EF-G (60). The cryo-EM 
structure of LepA bound to the 70S ribosome shows that the CTD of LepA makes 
contacts with A-site tRNA as well as helix 89 of the 23S rRNA. However, since not all of 
LepAs CTD is resolved in this structure, it is unknown what contacts are made between 
LepAs last 50 residues and the ribosome.  
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A recently resolved structure of the ribosome with EF-G bound, solved using X-ray 
crystallography, showed that the ribosome induces a conformational change in EF-G 
(52). The most prominent conformational change exhibited by EF-G upon binding to the 
ribosome is within domain IV. Not only can conformational changes within EF-G be 
observed upon ribosome binding, but EF-G also causes conformational changes within 
the ribosome itself, such as ratcheting of the two subunits and movement of the ribosomal 
stalk (52). A cryo-EM structure of Tet(O) bound to the ribosome revealed that similar to 
EF-G, Tet(O) binding leads to a movement in the ribosomal stalk (83). However, no 
movement between the ribosomal subunits can be observed upon Tet(O) binding. 
Interestingly, recent footprinting studies with LepA on the 70S ribosome indicate that 
LepA binds and stabilizes a ratcheted conformation of the 70S ribosome (84). However, 
given the lack of X-ray crystallographic structures and the poor resolution of available 
cryo-EM three-dimensional reconstructions for Tet(O), Tet(M), LepA and BipA bound to 
the ribosome, it is difficult to compare the conformational changes that may occur within 
the ribosome upon protein binding.  
 
2.1f Cellular Function of LepA 
LepA is a highly conserved protein within bacteria, where EF-Tu is the only translational 
GTPase more conserved than LepA (56). In spite of this, LepA is expressed in low 
amounts in the cell (85) whereas EF-Tu is a highly abundant protein.  
In 2006, it was shown by Knud Nierhaus and colleagues that LepA is capable of 
catalyzing back-translocation, the movement of the E and P-site mRNA and tRNAs back 
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to the P and A sites respectively (56). However, the same study also demonstrated that 
back-translocation cannot reverse antibiotic induced misincorporations within translation 
and therefore the purpose of LepA catalyzed back-translocation in the cell is still unclear.   
Given the structural similarity between LepA and EF-G, the ability of LepA to catalyze 
forward translocation was analyzed, as well as its ability to compete with EF-G for 
binding to the ribosome (86). Not only is LepA able to compete with EF-G for ribosome 
binding, but it is also able to catalyze forward translocation. Given the cellular 
concentration of LepA (10-fold less than EF-G (85)), it is unlikely that LepA competes or 
inhibits the ability of EF-G to function in the cell. Therefore a particular functional state 
of the ribosome must exist that is specific for LepA and not EF-G. 
LepA is the only protein similar in structure to EF-G that has been shown to promote 
forward translocation (86). Preliminary antibiotic studies have shown that thiostrepton, 
which prevents stable binding of EF-G to the ribosome, also inhibits LepA with a similar 
inhibitory concentration (84). These data suggest that LepA could function as EF-G in the 
cell, however, the lack of domain IV in LepA prevents it from inhibiting spontaneous 
back-translocation of the tRNAs and mRNA. LepA does contain a CTD which contacts 
the ribosome in a different manner than domain IV of EF-G. These contacts may be 
important for the overall function of LepA or may give insight into the function of LepA. 
The fact that the entire CTD has not been fully resolved indicates that it is a highly 
flexible domain. The flexibility of this domain may contribute to contacts made between 
LepA and the ribosome, which in turn could regulate or contribute to the function of 
LepA. To gain an understanding of the function of LepA, the CTD in LepA has been 
analyzed here in terms of its effect on known interaction partners of LepA.  
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2.2 Materials and Methods 
2.2a Molecular Biology 
The ORF for lepA was PCR-amplified from E. coli genomic DNA in a reaction catalyzed 
by Pfu DNA polymerase (Fermentas) using primers obtained from Invitrogen 
(5’-AATCATACCATATGAAGAATATACG-3’ and 
5’-CTCCTAAGCTTTATTTGTTGTCTT-3’; underlined nucleotides denote the 
restriction sites for NdeI and HindIII enzymes. All restriction enzymes were purchased 
from Fermentas and PCR reactions were carried out in a TGradient thermocycler 
(Biometra): 25 μL of the reaction mixture contains 0.2 ng of template DNA, 1 μM of 
primer pair, 0.3 μM of each dNTP and 7.5 units of DNA polymerase. The reaction was 
carried out by pre-heating the reaction mixture to 95C for 3 min followed by 30 cycles 
of 95C for 1 min, 65C for 1 min and 72C for 14 min. This was followed by a final 
elongation step at 72C for 15 min. PCR products were evaluated by 1% agarose gel 
electrophoresis at 80 V for 80 min. The resulting 3.1 kb PCR product was ligated (T4 
DNA ligase, Invitrogen) into SmaI digested pUC19. 1.5 L of the resulting product was 
transformed into 15 L of E. coli DH5α competent cells (New England Biolabs) grown 
on Luria-Bertani (LB) agar plates supplemented with 100 µg/mL of ampicillin. Plasmids 
were isolated from selected colonies using a mini-prep purification kit (EZ-10 spin 
column plasmid DNA kit, BioBasic). Ligated plasmids were identified by restriction 
digestion with NdeI and HindIII. The lepA ORF was excised from pUC19-lepA with 
HindIII and NdeI and ligated into similarly digested pET28a. Sequence and orientation 
was confirmed by sequencing (Macrogen DNA Sequencing Services).  
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2.2b Mutagenesis 
CTD truncation variants were generated based on a secondary structure prediction using 
Jpred (87). Truncated variants of LepA (ΔA494, ΔP520, ΔG555) were constructed via 
PCR using pET28a-lepA as a template. A single primer 
(5’-TAAGGCTTGCGGCCGCACTCGA-3’ (Invitrogen)) was used for the construction 
of all three CTD truncation variants. The forward primers were obtained from Invitrogen 
and were used in construction of the truncation variants ΔA494, ΔP520 and ΔG555, 
respectively.  
ΔA494-f 5’-CGCATCAACACGTTCACCGTTGATTA-3’ 
ΔP520-f 5’-TGGGATCAGATCTTTCATCTTCTCCA-3’ 
ΔG555-f 5’-GCCATAACATTTAGCCAGTACGTTTT-3’ 
The bold region of the primers corresponds to the codon encoding the terminal amino 
acid in the resulting truncation variant. 
Reactions were carried out under the following conditions: 25 μL of the reaction mixture 
contained 80 ng of template, 13 pM of each primer, 200 μM of each dNTP and 0.4 units 
of DNA polymerase (Phusion, New England Biolabs). The reactions were carried out by 
pre-heating the reaction mixture to 98C for 3 min followed by 35 cycles of 98C for 
1 min, 60C for 45 sec and 72C for 5 min followed by a final incubation at 72C for 
5 min. The PCR-amplification products were evaluated by a 1% agarose gel as described 
above. Blunt-end ligations of the products produced circular plasmids encoding LepA 
truncation variants in pET28a vectors. Products were ligated with T4 ligase (Fermentas) 
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and transformed into E. coli DH5α (New England Biolabs) competent cells for 
propagation and E. coli BL21-DE3 (New England Biolabs) competent cells for 
expression. 
LepA H81A was constructed via site-directed mutagenesis carried out on the pET28a-
lepA template using the Quickchange™ method (Stratagene). Primers (forward primer 
5’-TATCGACACCCCAGGCGCCGTAGACTTCTCCTATG-3’ and reverse primer 
5’-CATAGGAGAAGTCTACGGCGCCTGGGGTGTCGATA-3’) were obtained from 
Invitrogen. The position of mutagenesis is denoted in bold; underlined nucleotides denote 
the SmaI restriction site (5’-CCCGGG-3’) which was removed via a silent mutation. 
Reactions were carried out under the following conditions: 25 μL of the reaction mixture 
contained 80 ng of template, 1 μM of primer pair, 0.3 μM of each dNTP and 0.4 units of 
DNA polymerase (Pfu, Fermentas). The reaction was initiated by pre-heating the reaction 
mixture to 95C for 3 min followed by 18 cycles of 95C for 45 s, 65C for 1 min, 72C 
for 12 min and subsequent incubation at 72C for 20 min. The PCR-amplified products 
were analyzed on a 1% agarose gel as described above. Products were ligated with T4 
ligase (Fermentas) and transformed into E. coli DH5α (New England Biolabs) competent 
cells for propagation and E. coli BL21-DE3 (New England Biolabs) for expression. The 
mutation was confirmed by sequencing as described above.  
 
2.2c Expression and Purification of LepA Proteins   
All buffers were filtered through 0.45 µm Whatman nitrocellulose membranes and 
degassed prior to use. E. coli BL21-DE3 competent cells were grown in LB media 
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supplemented with 50 g/mL kanamycin. For protein overexpression of LepA wild type 
and H81A, cells were grown at 37C to mid-log phase (OD600 = ~ 0.6) and induced with 
isopropyl--D-thiogalactopyranoside (IPTG, BioBasic) to a final concentration of 1 mM. 
Cells were grown for an additional 3 hrs at 37C, harvested by centrifugation (5000 x g 
for 10 min at 4C), flash frozen and stored at -80C. For protein overexpression of the 
LepA CTD truncation variants, cells were grown at 37C to mid-log phase 
(OD600 = ~ 0.6) and induced with IPTG to a final concentration of 0.5 mM. Cells were 
grown for an additional 16 hrs at 16C, harvested by centrifugation (5000 x g for 10 min 
at 4C), flash frozen and stored at -80C. To analyze LepA expression, samples of equal 
amounts of cells were taken every 30 min, lysed with 8 M urea in buffer 2.1 (50 mM 
Tris-Cl pH 7.5 (20 °C), 70 mM NH4Cl, 30 mM KCl and 7 mM MgCl2) and analyzed by 
10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 80 V for 
20 min followed by 180 V for 60 min (BioRad Mini Protean 3 System). Gels were 
stained with Coomassie Brilliant blue; all other SDS-PAGEs were performed in a similar 
manner.  
For purification of all LepA proteins, cell pellets (approximately 8 g) were resuspended 
in 7 mL of buffer 2.2 (50 mM Tris-Cl pH 8.0 (4 °C), 60 mM NH4Cl, 7 mM MgCl2, 
300 mM KCl, 7 mM β-mercaptoethanol (BME), 1 mM phenylmethanesulfonylfluoride 
(PMSF), 10 mM imidazole and 15% glycerol) per gram of cells and lysed with 
0.1 mg/mL lysozyme. Cellular debris were removed through centrifugation at 30 000 x g 
for 45 min using a JA-16 rotor (Beckman) yielding a S30 extract. LepA was purified 
from the S30 extract using affinity chromatography (7 mL Ni
2+
-Sepharose resin (GE 
Healthcare)) equilibrated with buffer 2.2. The resin was washed three times with 50 mL 
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of buffer 2.2 and four times with 50 mL of buffer 2.3 (buffer 2.2 with 20 mM imidazole). 
The protein was eluted in 10 washes of 7 mL buffer 2.4 (buffer 2.2 with 250 mM 
imidazole). His6-tagged LepA protein was concentrated to 60-100 µM via ultrafiltration 
(Vivaspin 20, 30000 MWCO (Sartorius)) and further purified using size exclusion 
chromatography (SEC) (XK26/100 column; Superdex 75 prep grade (GE healthcare)) 
equilibrated in buffer 2.5 (50 mM Tris-Cl pH 7.5 (4°C), 70 mM NH4Cl, 300 mM KCl, 
7 mM MgCl2 and 15% glycerol). Fractions were analyzed by SDS-PAGE, and those 
containing LepA (of >90% pure) were pooled and concentrated via ultrafiltration (vide 
supra) and stored at -80C. The final protein concentration was determined 
spectrophotometrically at 280 nm using a molar extinction coefficient (39 935 M
-1
 cm
-1 
for wild type, LepA H81A and LepA ΔG555, 38 320 M-1 cm-1 for LepA ΔP520 and LepA 
ΔA494; calculated using ProtParam (88)) and confirmed using the Bradford Protein 
Assay (BioRad). Final protein preparation purity is shown by SDS-PAGE (Appendix 
Figure A.1).  
 
2.2d Purification of E. coli Ribosomes  
Vacant ribosomes were purified as previously described (89) from 50g of E. coli 
MRE600 cells. Alumina was used to open the cells with a mortar and pestle for 30 min at 
4C. DNase I was added and the mixture was ground for an additional 30 min. Buffer 2.6 
(20 mM Tris-Cl pH 7.6 (4°C), 100 mM NH4Cl, 10.5 mM MgCl2, 0.5 mM 
ethylenediaminetetraacetic acid (EDTA) and 3 mM BME) was added and the mixture 
was centrifuged at 1 000 x g for 10 min followed by 10 000 x g for 30 min in a Beckman 
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JA-14 rotor. The supernatant was filtered and centrifuged at 30 000 x g in a Beckman 
Ti-45 rotor for 30 min. This resulting supernatant (S30, approximately 40 mL) was 
overlayed on 20 mL of buffer 2.7 (20 mM Tris-Cl pH 7.6 (4°C), 500 mM NH4Cl, 
10.5 mM MgCl2, 0.5 mM EDTA, 1.1 M sucrose, 3 mM BME) and spun at 200 000 x g 
for 17 hrs in a Ti-45 rotor. Pellets were dissolved in buffer 2.8 (20 mM Tris-Cl pH 7.6 
(4°C), 500 mM NH4Cl, 10.5 mM MgCl2, 0.5 mM EDTA and 7 mM BME) with the help 
of a glass rod to a final volume of 100 mL. This solution was overlayed on 4 mL of 
buffer 2.7 and spun in a Ti-45 rotor at 200 000 x g for 16 hrs at 4°C. The above pellets 
were dissolved in buffer 2.8 as described above to a final volume of 60 mL. The solution 
was overlayed on 1.5 mL of buffer 2.7 and centrifuged in a Beckman SW28 at 
140 000 x g for 13 hrs at 4°C. The resulting pellets were dissolved in 10 mL of buffer 2.9 
(20 mM Tris-Cl pH 7.6 (4°C), 60 mM NH4Cl, 5.25 mM Mg acetate, 0.25 mM EDTA, 
and 3 mM BME) supplemented with 5% sucrose. The concentration of ribosomes was 
determined by the absorbance at 260 nm, flash frozen and stored at -80°C.  
70S, 50S and 30S ribosomal subunits were separated using zonal centrifugation. 400 mL 
of buffer 2.9 was loaded into a Beckman Ti-15 at a flow rate 8 mL/min spinning at 
2000 rpm. Approximately 12 500 OD of ribosome solution (approximately 20 mL) was 
loaded into the spinning rotor followed by a 10-40% sucrose gradient (approximately 
1370 mL) (20 mM Tris-Cl pH7.6 (4°C), 60 mM NH4Cl, 5.25 mM Mg acetate, 0.25 mM 
EDTA, 3 mM BME and the corresponding percent of sucrose). Subsequently, 150 mL of 
50% sucrose was loaded into the spinning rotor. This was centrifuged for 19 hrs at 
28 000 rpm at 4°C. The rotor was slowed down to 2000 rpm and unloaded in 50 mL 
fractions with 50% sucrose at a flow rate of ~8 mL/min. The absorbance of the fractions 
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was monitored at a wavelength of 260 nm and fractions containing 30S, 50S subunits and 
70S ribosomes were pooled and centrifuged for 48 hrs at 200 000 x g in a Ti-45 rotor at 
4°C. Pellets were dissolved in buffer 2.10 (20 mM Tris-Cl pH 7.6 (4°C), 50 mM NH4Cl 
and 5 mM MgCl2) to a final concentration of approximately 10 μM, flash frozen and 
stored at -80°C for further use.  
 
2.2e Fluorescence Titrations  
To determine guanine nucleotide binding affinities of LepA and its variants, fluorescence 
measurements were performed using a Photon Technology International (PTI) 
QuantaMaster Spectrofluorometer. Intrinsic tryptophan fluorescence of LepA was excited 
at 280 nm in a 0.3 x 0.3 cm quartz cuvette (Starna) at room temperature. Förster 
resonance energy transfer (FRET) between the tryptophans in LepA and 2’-/3’-O-N’-
Methylanthraniloyl (mant) modified guanine nucleotides was utilized to determine the 
equilibrium dissociation constants (KD) for mant-GTP/GDP/GDPNP to LepA. The 
resulting fluorescence emission was monitored from 300 nm to 500 nm, with a slit width 
of 3 nm. The background fluorescence signals due to the presence of protein and 
nucleotide were subtracted from the overall fluorescence of the system. Measurements 
were carried out using 2 µM LepA in buffer 2.1 and adding increasing amounts of the 
respective mant-guanine nucleotide (Invitrogen). Fluorescence changes (F) in the 
corrected tryptophan fluorescence emission at 325 nm and mant at 440 nm were plotted 
as a function of nucleotide concentration and subsequently fit with a hyperbolic function 
(Equation 2.1), where Bmax is the final fluorescence and X is the guanine nucleotide 
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concentration. From this, the dissociation constant (KD) for each nucleotide derivative 
was obtained.  
 
F = Bmax  X / (KD + X)       (Equation 2.1) 
 
2.2f Stopped-Flow Fluorescence  
Fluorescence stopped-flow measurements were performed using a KinTek SF-2004 
stopped-flow apparatus (KinTek Corporation). Measurements were performed in a 
manner similar to that previously described (90). In brief, mant-nucleotides were excited 
via FRET from the tryptophan residues (ex = 280 nm) present in LepA and the resulting 
fluorescent emission was detected after passing through LG-400-F cut off filters 
(NewPort).  
Dissociation rate constants were determined by pre-incubating 200 µM mant-GDP with 
2 µM LepA in buffer 2.1 at 37°C for 15 min, or 200 µM mant-GTP / 100 µM 
mant-GDPNP with 2 µM LepA, 3 mM phosphoenolpyruvate (PEP) and 0.1 mg/mL 
pyruvate kinase (PK) in buffer 2.1 at 37°C for 15 min. These mixtures were rapidly 
mixed with 2 mM of corresponding guanine nucleotide in similar buffer conditions. 
Dissociation time courses were fit with a one-exponential function (Equation 2.2):  
 
F = F + A  exp(-k-1  t)       (Equation 2.2) 
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where F is the fluorescence at time t, F is the fluorescence at equilibrium, and k-1 is the 
dissociation rate constant. 
The apparent rate for the bimolecular association of mant-nucleotides to LepA was 
determined by rapidly mixing 25 μL of LepA (1 μM after mixing) with 25 μL of varying 
concentrations of mant-nucleotides (ranging from 3 to 50 μM after mixing) at 20°C in 
buffer 2.1. Mant-GTP association experiments were supplemented with 3 mM PEP and 
0.1 mg/mL PK. Fluorescence time courses were best fit with a two exponential equation 
(Equation 2.3):  
 
F = F + A  exp(-kapp1  t) + B  exp(-kapp2  t)    (Equation 2.3) 
 
where F is the fluorescence at time t, F is the fluorescence at equilibrium, kapp1 is the 
first apparent rate constant and kapp2 is the second apparent rate constant. The apparent 
rate constants were plotted as a function of nucleotide concentration. kapp1 was linearly 
dependent on nucleotide concentration and the slope of this plot represents an association 
rate constant (k1(LepA•GTP) for GTP and k1(LepA•GDP) for GDP). kapp2 was not dependent on 
nucleotide concentration. Calculations were performed using TableCurve (Jandel 
Scientific) and Prism (GraphPad Software).  
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2.2g LepA Proteins Binding to the Ribosome  
Binding of LepA to the ribosome was assessed using ultracentrifugation in a TLA-100.3 
rotor (Beckman Coulter). Reactions containing 2 µM LepA were added to either 0.1 µM 
70S, 50S or 30S ribosomal particles in the presence of 0.1 mM guanine nucleotides in a 
total volume of 400 µL in buffer 2.1. Reactions were incubated for 15 min at 37°C and 
layered onto 1700 µL of buffer 2.11 (20 mM Tris-HCl pH7.6 (4°C), 60 mM NH4Cl, 
5.25 mM Mg acetate, 0.25 mM EDTA, 10% sucrose, 3 mM BME) and centrifuged at 
65 000 x g for 18 hrs. Pellets were resuspended in 40 μL of buffer 2.1, and 20 pmol of 
each sample was loaded into an immunoblot (slot-blot apparatus, BioRad Biodot SF). 
The presence of LepA in the pellet was detected through the use of the N-terminal 
His6-tag on LepA using a monoclonal anti-polyhistidine antibody from mouse (Sigma) 
and anti-mouse IgG (Fab specific) peroxidase conjugate from goat (Sigma). 
Chemiluminescence was used for detection where 50 mL of 200 μM p-coumeric acid 
(Sigma) and 2.5 μM luminol (Sigma) in 0.1 M Tris-Cl pH 8.5 was added to 0.06% H2O2 
in 10 mL of 0.1M Tris-Cl pH 8.5. Chemiluminescence was detected using a Typhoon 
9400 imager from GE healthcare. 
 
2.2h GTP Hydrolysis  
To measure the intrinsic GTPase activity of LepA and its variants, liberation of 
32
Pi from 
[γ32P]-GTP (Perkin Elmer) was utilized. Guanine nucleotide charging solution 
(radioactive nucleotide at 100 dpm/pmol, 3 mM PEP, 0.1 mg/mL PK) was incubated at 
37C for 15 min to catalyze nucleotide triphosphate formation from the diphosphate form 
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to prevent inhibition of the GTPase by diphosphates in multiple turnover experiments. 
Hydrolysis assays were carried out in buffer 2.1. Reaction mixtures contained 5 μM 
LepA protein and 0 to 350 μM [γ32P]-GTP. 10 µL samples were removed at 40 min and 
quenched in 50 L buffer 2.12 (1 M HClO4 with 3 mM potassium phosphate). The 
inorganic phosphate was extracted using 300 µL of 20 mM Na2Mo4 and 750 µL of 
isopropyl acetate. Samples were vortexed for 10 min (Eppendorf MixMate) and 
centrifuged at 15 800 x g for 5 min (Labnet Hermle Z180M Micro Centrifuge). The 
extracted 
32
Pi phosphate-molybdate complex in the organic phase was added to 2 mL of 
EcoLite scintillation cocktail (EcoLite, MP Biomedicals), and counted in a Perkin-Elmer 
Tri-Carb 2800TR liquid scintillation analyzer. Background radioactivity was subtracted 
and the amount of GTP hydrolyzed as a function of time was calculated and plotted 
against increasing GTP concentration. Data was fit with equation 2.4.  
 
Y = vmax  X/ (KM + X)       (Equation 2.4) 
 
where Y is equal to the concentration of GTP hydrolyzed over time, vmax is the maximum 
rate of GTP hydrolyzed over time, KM is the substrate concentration needed to achieve a 
half-maximum enzyme velocity and X is the substrate (GTP) concentration. 
To measure ribosome stimulated GTP hydrolysis of LepA, liberation of 
32
Pi from 
[γ32P]-GTP (Perkin Elmer) in the presence of LepA and 70S ribosomes was assessed. 
Guanine nucleotide charging solution was incubated as described above. Hydrolysis 
assays were carried out in buffer 2.1. Reaction mixtures contained 0.01 μM protein, 
40 
 
100 μM [γ32P]-GTP and 0 to 8 µM 70S ribosomes. 10 µL samples were removed at 
various time points (10 to 40 min) and quenched, then 
32
Pi was extracted and analysed as 
described above. Background radioactivity was subtracted and the concentration of GTP 
hydrolyzed was calculated as a function of time and plotted against increasing 70S 
ribosome concentration and fit with equation 2.4 where X is equal to 70S ribosome 
concentration. 
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2.3 Results 
2.3a Structure Prediction of the C-Terminal Domain of LepA 
Many proteins and complexes that interact with the A site of the bacterial ribosome have 
similar structures. The most recent structure of E. coli LepA illustrates how similar in 
structure LepA is to EF-G (Figure 2.1) (58); however, the complete structure of LepA is 
still unknown. To gain insight into the function of the unresolved part of the CTD of 
LepA, a secondary structure prediction was performed (Figure 2.2) using Jpred (87). This 
prediction is in good agreement with the secondary structure elements found in the 
structure derived from X-ray crystallography. The unresolved C-terminal amino acids 
(43) are predicted to form two alpha helices (Figure 2.2).  
 
 
Figure 2.2. Structure prediction of the CTD of LepA. The structure of LepAs CTD was predicted using 
Jpred. Beta-sheets are represented as arrows and alpha-helices as cylinders. Solid green shapes are 
predicted structural components that are also found in the structure of LepA determined by X-ray 
crystallography. 
 
From this, three CTD truncation variants were designed (Figure 2.3) in which this 
domain was sequentially truncated from the CTD of LepA.  
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Figure 2.3. CTD truncation variants constructed. LepA ΔG555, ΔP520 and ΔA494 are illustrated 
respectively. The corresponding protein designation is written above the domain representation and the 
amino acids corresponding to these domains are written above the respective domain. All structures are 
represented in cartoon on the right and coloured as in figure 2.1. 
 
2.3b LepA Interaction with Guanine Nucleotides (GDP/GDPNP/GTP). 
The interaction of LepA with guanine nucleotides has not been determined so far, 
preventing an understanding of the cellular state of the protein. Most GTPases, such as 
EF-Tu and EF-G, cycle between their active GTP-bound form and their inactive 
GDP-bound form. To elucidate the binding affinities of LepA for guanine nucleotides, 
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the interaction between purified E. coli LepA and guanine nucleotides has been analyzed 
using equilibrium fluorescence spectroscopy measurements (Materials and Methods). A 
potential effect of the CTD on the interaction between LepA and the respective guanine 
nucleotides was also analyzed to elucidate a role of this unique domain within LepA. To 
this end, FRET between the intrinsic tryptophan residues in LepA as a donor fluorophore 
and the mant group on mant-labelled guanine nucleotides as an acceptor fluorophore was 
utilized. Upon excitation of the tryptophan residues in LepA, a decrease in tryptophan 
fluorescence (emission max  325nm) as well as an increase in mant fluorescence 
(emission max  440nm) was observed (Figure 2.4). Changes in the relative fluorescence 
were fit with a hyperbolic function (Eq. 2.1) and reveal a comparable affinity for 
mant-GDP and mant-GDPNP (a non-hydrolysable analogue of GTP) for wild type LepA 
(KD(LepAGDP) = 110 ± 50 μM and KD(LepAGDPNP) = 30 ± 10 μM) and the LepA CTD 
truncation variants A494 (KD(A494GDP) = 90 ± 45 µM and 
KD(A494GDPNP) = 60 ± 40 µM), P520 (KD(P520GDP) = 90 ± 70 µM and 
KD(P520GDPNP) = 55 ± 20 µM) and G555 (KD(G555GDP = 130 ± 120 µM and 
KD(G555GDPNP) = 50 ± 16 µM) (Table 2.1 and 2.2). These data show that LepA has a 
micro-molar affinity for guanine nucleotides, which is consistent with results shown for 
EF-G (KD(EF-GGDP) 17 µM and KD(EF-GGTP)  7 µM ) (91). Furthermore, these results 
indicate that the CTD truncation variants constructed bind to guanine nucleotides with a 
similar affinity as wild type LepA. 
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Figure 2.4. Equilibrium fluorescence titration of LepA with guanine nucleotides. (A) LepA titrated 
with increasing concentrations of guanine nucleotide from 0 (black) to 150 µM (pink). Fluorescence 
emission was monitored from 300 to 500 nm. (B ) Mant-GDP or (D) Mant-GDPNP emission at 440nm and 
(C and E) LepA Trp emission at 325 nm was plotted as a function of increasing Mant-GDP/GDPNP 
concentration. Nucleotide concentration dependence of the fluorescence emission was used to determine 
KD values for LepA wild type (filled circles), LepA ΔA494 (squares), LepA ΔP520 (triangles), LepA 
ΔG555 (diamonds) and LepA H81A (open circles). 
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Table 2.1. Dissociation Constants (KD) Governing the Interaction Between LepA 
Variants and Mant-GDP. 
LepA KD μM 
(Trp decay)  
KD μM  
(Mant Increase)  
KD μM 
average  
Wild Type 140 ± 50 75 ± 20 110 ± 50 
ΔA494 110 ± 60 60 ± 10   90 ± 45 
ΔP520 140 ± 110 50 ± 10   90 ± 70 
ΔG555 200 ± 175 70 ± 15 130 ± 120 
H81A   80 ± 10 20 ± 5   50 ± 10 
 
 
Table 2.2. Dissociation Constants (KD) Governing the Interaction Between LepA 
Variants and Mant-GDPNP. 
LepA KD μM 
(Trp decay)  
KD μM  
(Mant Increase)  
KD μM  
average  
Wild Type   50 ± 10 10 ± 5 30 ± 10 
ΔA494   90 ± 10 16 ± 20 60 ± 40 
ΔP520 110 ± 10 15 ± 5 55 ± 20 
ΔG555   80 ± 10 30 ± 10 50 ± 16 
H81A   20 ± 6 30 ± 20 20 ± 10 
 
 
All translational GTPases contain a conserved histidine residue that may be essential for 
efficient GTP hydrolysis. Based on LepAs structural similarity to EF-Tu, a sequence 
alignment revealed that His 81 of LepA is found in a similar position as His 84 in EF-Tu, 
which has been shown to be essential for GTP hydrolysis in EF-Tu (68). To confirm that 
substitution of His 81 in LepA provides a GTPase inactive variant of LepA which can be 
subsequently used as a tool for further studies on the role of GTP hydrolysis by LepA, a 
H81A substitution of LepA was constructed. LepA-guanine nucleotide equilibrium 
binding studies reveal that the final fluorescence emission of mant-GDPNP/GDP plateaus 
at a lower level than in the presence of the other LepA proteins. However, guanine 
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nucleotide binding is not affected by this substitution (Table 2.1 and 2.2) as the calculated 
KD for mant-GDP and mant-GDPNP are 50 ± 13 µM and 20 ± 10 µM, respectively.  
To further analyze the interaction of LepA with guanine nucleotides, rate constants for 
nucleotide association (k1(LepA•GDP/GTP)) and dissociation (k-1(LepA•GDP/GTP/GDPNP)) were 
determined using the stopped-flow technique based on the FRET system described above, 
but only monitoring the fluorescence of mant-guanine nucleotides. To measure the rate of 
mant-guanine nucleotide dissociation, LepA was incubated with 50 to 100-fold excess of 
mant-guanine nucleotide (Materials and Methods) and rapidly mixed with a 1000-fold 
excess of non-fluorescent guanine nucleotide to prevent rebinding of the labelled 
nucleotide. A rapid decrease in fluorescence was observed upon mixing, representing 
mant-guanine nucleotide dissociation from LepA (Figure 2.5). The k-1 was determined for 
mant-GDP, mant-GTP and mant-GDPNP from LepA proteins by fitting the obtained time 
courses with a one-exponential function (Eq. 2.2). The obtained values for the respective 
rate constants show that dissociation of mant-guanine nucleotides from all LepA proteins 
are similar to each other (Table 2.3). Interestingly, the rate of mant-GTP dissociation is 
almost 10-fold faster than mant-GDP dissociation from LepA. Furthermore, 
mant-GDPNP dissociation is approximately 100-fold faster than mant-GDP dissociation 
from LepA.  
 
 
47 
 
 
Figure 2.5. Dissociation of guanine nucleotides from LepA. (A) Time course of (A) mant-GDP 
(200 µM) (B) mant-GTP (200 µM) (C) mant-GDPNP (40 µM) dissociation from LepA (2 µM) measured 
by FRET excitation of mant-GDP/GTP/GDPNP. 
 
Table 2.3. Rate of Mant-Guanine Nucleotide Dissociation from LepA Variants. 
Protein k-1(LepA•GDP) (s
-1
) k-1(LepA•GTP) (s
-1
) k-1(LepA•GDPNP) (s
-1
) 
LepA 4.2 ± 0.3 21 ± 4 127 ± 9 
ΔA494 2.9 ± 0.5 28 ± 5 229 ± 14 
ΔP520 3.4 ± 0.1 34 ± 12 417 ± 23 
ΔG555 4.9 ± 0.9 14 ± 4 371 ± 76 
H81A 2.8 ± 0.3 29 ± 1 185 ± 25 
EF-G* 300* 7* 200* 
*Data previously published (91) 
 
In order to determine the association rate constants between LepA and guanine 
nucleotides, LepA was rapidly mixed with increasing concentrations of the respective 
mant-guanine nucleotide (Figure 2.6). All time courses showed a biphasic behaviour 
where the first phase was dependent on the concentration of guanine nucleotides and the 
second slower phase was independent of the guanine nucleotide concentration present. 
This is indicative of a binding event that is followed by a conformational change within 
LepA. Data were fit with a two-exponential equation (Eq. 2.3) to determine the apparent 
rates for each nucleotide concentration which were subsequently plotted as a function of 
the nucleotide concentration. The resulting slope of the linear concentration dependent 
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rate gave similar k1(LepA•GDP) values for mant-GDP association to all LepA proteins 
(Table 2.4). Similar results were observed for the k1(LepA•GTP) values for mant-GTP. The 
previously determined value of k1 for mant-GTP and EF-G (0.58 ± 0.04 µM
-1
s
-1
) (91) is 
similar to that obtained here for LepA and mant-GTP (0.43 ± 0.04 µM
-1
s
-1
) (Table 2.4). 
Y-intercepts obtained from the k1(LepA•GDP/GTP) plots are in agreement with k-1(LepA•GDP/GTP) 
values determined in the above described dissociation experiments (Table 2.4) where the 
rate of mant-GTP dissociation is almost 10-fold faster than mant-GDP dissociation. 
Furthermore, KD values obtained from k-1 / k1 for mant-GTP and mant-GDP give 
micro-molar values (Table 2.5). However, the KD values obtained for LepA proteins and 
mant-GDP is an order of magnitude lower than values for LepA and mant-GTP 
(Table 2.5). This is in disagreement with the equilibrium values obtained for LepA 
proteins and mant-GDP. In spite of this, results demonstrate that the LepA CTD 
truncation variants bind to guanine nucleotides with a similar affinity as wild type LepA.  
The values obtained for k2 were not dependent on guanine nucleotide concentration and 
were similar for all LepA proteins (Table 2.4). Furthermore, k2 values were similar for 
LepA interacting with mant-GDP and mant-GTP.  
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Figure 2.6. Association kinetics for guanine nucleotides and LepA. (A) Time course of mant-GDP 
(100 µM) association to LepA (2 µM) measured by FRET excitation of mant-GDP. (B) Time course of 
mant-GTP (100 µM) association to LepA (2 µM) measured by FRET excitation of mant-GTP. (C) 
Concentration dependence of kapp for mant-GDP and (D) mant-GTP calculated from the association time 
courses. LepA wild type (circles), ΔA494 (squares), ΔP520 (upright triangles), ΔG555 (diamonds) and 
H81A (downward triangles). Filled shapes represent kapp1 and open are kapp2. 
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Table 2.4. Rate of Association Between LepA Variants and Mant-Guanine 
Nucleotides. 
Protein k1 
(LepA•GDP) 
(µM
-1
s
-1
) 
k-1 
(LepA•GDP) 
y-int (s
-1
) 
k2 
(LepA•GDP) 
(s
-1
) 
k1 
(LepA•GTP) 
(µM
-1
s
-1
) 
k-1 
(LepA•GTP) 
y-int (s
-1
) 
k2 
(LepA•GTP) 
(s
-1
) 
LepA 1.0±0.1 11±2 6.4±0.6 0.4±0.1 32±3 5.5±1.4 
ΔA494 0.8±0.1   8±3 5.1±0.2 0.3±0.1 39±3 5.4±0.5 
ΔP520 0.9±0.1 13±1 7.4±0.4 0.3±0.1 51±3 9.6±1.0 
ΔG555 1.0±0.1   9±2 3.3±0.4 0.4±0.1 76±6 7.9±0.8 
H81A 0.7±0.1   8±2 2.3±0.3 0.2±0.1 46±6 4.7±1.1 
EF-G* NA NA NA 0.6±0.1 NA NA 
*Data previously published (91) 
 
Table 2.5. Dissociation Constants (KD) of LepA Variants and Mant-GDP/GTP 
Determined by Pre-Steady State Kinetics. 
Protein KD  
Mant-GDP 
(μM)  
KD  
Mant-GTP 
(μM)  
LepA 4.1 ± 0.3   50 ± 10 
ΔA494 3.5 ± 0.6   85 ± 20 
ΔP520 3.7 ± 0.1 100 ± 40 
ΔG555 4.8 ± 0.9   40 ± 10 
H81A 4.3 ± 0.5 130 ± 60 
 
2.3c LepA Interaction with the Ribosome 
The structure of LepA on the ribosome has revealed that LepAs CTD contacts the 23S 
rRNA (60). However, only approximately two thirds of the CTD (residues 480 – 545) 
have been resolved in the cryo-EM map of LepA bound to the ribosome (60). The contact 
between the CTD of LepA and the ribosome suggests that this domain may be involved 
in LepA binding to the ribosome. However, given that LepA interacts with the ribosome 
through other domains, the CTD may be dispensable for LepA-ribosome interaction. 
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Here an ultracentrifugation assay was utilized to assess whether truncating the CTD 
inhibits LepAs ability to bind to the 70S ribosome as well as to the individual 50S and 
30S ribosomal subunits (Materials and Methods). To this end, a sucrose cushion was used 
to separate the ribosome/ribosome-bound LepA from the free LepA protein. Following 
ultracentrifugation, the presence of LepA in the ribosome pellet was assessed via 
immunoblotting (Materials and Methods).  
The presence of all LepA proteins were detected in the 70S ribosomal pellet as well as 
the 50S and 30S ribosome subunit pellet, regardless of guanine nucleotide present, 
indicating that all CTD truncation variants of LepA are able to stably associate with the 
ribosome (Figure 2.7). Surprisingly, the association of LepA ΔG555 (shortest truncation) 
seems to be weaker than the other variants as a 5-fold higher protein concentration was 
needed to detect LepA ΔG555 in the ribosome pellet with comparable band intensity to 
the full length protein and the other truncated LepA variants (Figure 2.7d). Detection of 
LepA proteins in the pellet was not due to protein aggregation as LepA proteins could not 
be detected in the absence of the 70S ribosome or 50S or 30S ribosomal subunits. This 
suggests that binding of LepA to the ribosome is mainly achieved through the remaining 
domains of LepA interacting with the ribosome. Interestingly, a nucleotide dependence of 
this interaction is revealed in the differential intensity of the band corresponding to wild 
type LepA. Following ultracentrifugation with the 70S ribosome or 50S ribosomal 
subunit the LepA signal, indicative of the fraction of LepA bound, is lower in the 
presence of GDPNP than in the apo or GDP-bound states. This behaviour is not observed 
in the presence of the 30S ribosomal subunits. A similar nucleotide dependence is not 
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observed for the LepA variants including LepA H81A (Figure 2.7), suggesting a role for 
the CTD in nucleotide-dependent regulation of ribosome binding. 
 
 
Figure 2.7. Immunodetection of LepA bound to the ribosome following ultracentrifugation. (A) LepA 
proteins (2 µM) (indicated on top) bound to the 70S (0.1 µM) ribosome in the presence of various guanine 
nucleotides (GTP, GDPNP, GDP (0.1 mM)) or apo indicated on the left. Pellet following 
ultracentrifugation of LepA proteins bound to GDPNP in the absence of ribosome is shown (No Rb). 
Intensity of each band compared to a standard (no fill) is represented as a bar graph below the 
corresponding immunoblot. LepA wild type (filled), ΔA494 (chequered), ΔP520 (striped) in the presence 
of (1) 70S, (2) 70S + GDP, (3) 70S + GDPNP and (4) 70S + GTP is represented. (B) LepA proteins (2 µM) 
bound to the 50S (0.1 µM) subunit in the presence of various guanine nucleotides (GDPNP, GDP 
(0.1 mM)) or apo. Intensity of each band compared to a standard (no fill) is represented as a bar graph 
below the corresponding immunoblot. LepA wild type (filled), ΔA494 (chequered), ΔP520 (striped) in the 
presence of (1) 50S, (2) 50S + GDP and (3) 50S + GDPNP is represented.  (C) LepA proteins (2 µM) 
bound to the 30S (0.1 µM) subunit in the presence of various guanine nucleotides (GDPNP, GDP 
(0.1 mM)) or apo. Intensity of each band compared to a standard (no fill) is represented as a bar graph 
below the corresponding immunoblot. LepA wild type (filled), ΔA494 (chequered), ΔP520 (striped) in the 
presence of (1) 30S, (2) 30S + GDP and (3) 30S + GDPNP is represented. (D) LepA ΔG555 protein 
(10 µM) bound to the 70S, 50S and 30S (0.1 µM) in the presence of GDPNP (0.1 mM). (E) LepA H81A 
(2 µM) bound to the 70S (0.1 µM) in the presence of various guanine nucleotides (GDPNP, GDP, GTP 
(0.1 mM)) or apo indicated on top. 
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2.3d GTPase Activity of LepA 
LepA is classified as a translational GTPase, however its intrinsic GTPase activity has 
not been characterised so far. Here the characterisation of the intrinsic GTPase activity of 
LepA and the CTD variants were examined (Figure 2.8). Michaelis-Menten kinetics were 
used to describe the intrinsic GTPase activity of LepA by determining the Michaelis 
constant (KM), vmax and the kcat for LepA and the respective variants. Consistent with a 
putative role of His 81 in the catalysis of GTP hydrolysis, no hydrolysis of GTP was 
observed over time in the presence of LepA H81A. Therefore, Michaelis-Menten 
parameters could not be determined for this variant. The KM obtained for all LepA CTD 
truncation variants are consistently in the high micro-molar range 
(wild type LepA = 270 ± 90 µM, LepA ΔA494 = 370 ± 35 µM, LepA 
ΔP520 = 900 ± 200 µM and LepA ΔG555 = 700 ± 100 µM (Table 2.6)) and are 
significantly higher than the equilibrium binding constants (KD) determined here for 
LepA and GTP. In addition, the KM values are higher for the LepA CTD truncation 
variants than for wild type LepA. However, the obtained vmax and in turn the determined 
kcat for LepA (0.003 ± 0.001 s
-1
) and LepA variants (LepA ΔA494 = 0.005 ± 0.001 s-1, 
LepA ΔP520 = 0.007 ± 0.001 s-1, LepA ΔG555 = 0.003 ± 0.001 s-1) are similar to each 
other, indicating that the CTD truncation variants are not impaired in their ability to 
hydrolyze GTP.   
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Figure 2.8. Michaelis-Menten titration of the intrinsic GTPase activity of LepA. Initial rates of GTP 
hydrolysis are plotted as a function of increasing GTP concentration in the presence of (5 µM) wild type 
(circles), ΔA494 (squares), ΔP520 (triangles), ΔG555 (diamonds). 
 
Table 2.6. Intrinsic GTPase Activity of LepA Variants. 
LepA KM (µM) vmax (µM s
-1
) kcat (s
-1
) 
Wild Type 270 ± 90 0.016 ± 0.003 0.003 ± 0.001 
ΔA494 370 ± 35 0.023 ± 0.001 0.005 ± 0.001 
ΔP520 900 ± 200 0.034 ± 0.006 0.007 ± 0.001 
ΔG555 700 ± 100 0.017 ± 0.002 0.003 ± 0.001 
 
 
The GTPase activity of LepA has previously been shown to be stimulated by the 70S 
ribosome to a similar extent as EF-G (56). However, no detailed kinetic parameters 
describing this interaction were reported, preventing the mechanistic interpretation of this 
interaction. The first detailed analysis of the ribosome-stimulated GTPase activity of 
LepA (Figure 2.9) performing a Michaelis-Menten analysis of wild type LepA and the 
CTD truncation variants is presented here. KM and kcat values obtained for full length 
LepA (0.32 ± 0.08 µM, 2.3 ± 0.3 s
-1
) are similar to EF-G values (0.4 ± 0.1 µM, 
2.7 ± 0.3 s
-1
) (Table 2.7), which is consistent with the finding from the study by Knud 
Nierhaus and co-workers (56) and previous studies on EF-G (92). Interestingly, the KM 
values obtained here for LepA CTD truncation variants are at least an order of magnitude 
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larger than values for the full length protein (LepA ΔA494 = 36 ± 26 µM, 
LepA ΔP520 = 10 ± 5 µM, LepA ΔG555 = 7 ± 3 µM). However, even though all CTD 
truncations variants exhibit a similar 10 to 100-fold effect on the KM, the kcat values 
obtained for the two larger deletions ΔA494 (5.2 ± 3.3 s-1) and ΔP520 (5.3 ± 1.8 s-1) are 
within error of those obtained for wild type LepA and EF-G. Surprisingly, the kcat value 
obtained for the shortest deletion LepA ΔG555 (0.6 ± 0.2 s-1) is 10-fold lower, reducing 
the stimulatory effect of the 70S ribosome from approximately 1000-fold to 100-fold.  
 
 
 
 
Figure 2.9. Michaelis-Menten titration of the ribosome stimulated GTPase activity of LepA. Initial 
rates of GTP hydrolysis are plotted as a function of increasing 70S ribosome concentration in the presence 
of (0.01 µM) LepA wild type (filled circles), EF-G (downward triangles), LepA ΔA494 (squares), LepA 
ΔP520 (upright triangles), LepA ΔG555 (diamonds), LepA H81A (open circles). 
 
Table 2.7. 70S Stimulated GTPase Activity of LepA Variants. 
Protein KM (µM) vmax (µM s
-1
) kcat (s
-1
) 
LepA 0.32±0.08 0.023±0.001 2.3±0.3 
ΔA494    36±26 0.052±0.033 5.2±3.3 
ΔP520    10±5 0.053±0.017 5.3±1.8 
ΔG555      7±3 0.006±0.002 0.6±0.2 
EF-G 0.40±0.10 0.027±0.002 2.7±0.3 
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2.3e Catalytic Histidine in LepA 
Consistent with the observation that LepA contains a histidine residue (His 81) in a 
similar position as the catalytic His 84 of EF-Tu (68,70,71), substitution of His 81 in 
LepA resulted in the decrease of LepAs GTPase activity to background levels which 
could not be stimulated by the 70S ribosome (Figure 2.9). Therefore, like His 84 in 
EF-Tu, His 81 of E. coli LepA likely plays a key role in the mechanism of GTP 
hydrolysis by LepA. 
57 
 
2.4 Discussion 
Many proteins and complexes that bind to the A site of the bacterial ribosome have very 
similar structures. For example, the structure of EF-G and the ternary complex of 
EF-Tu•GTP•aa-tRNA are extremely similar, a fact that has been termed molecular 
mimicry (93). Although LepA has a similar structure to EF-G (58), it does not contain a 
domain resembling domain (IV) of EF-G. Instead LepA contains a unique C-terminal 
domain that assumes a structure resembling a shorter version of EF-Gs domain IV. In this 
study, the role of LepAs unique CTD was examined with respect to binding guanine 
nucleotides, GTP hydrolysis and ribosome binding.  
 
2.4a LepA and Guanine Nucleotides 
Although LepA has been shown to be a highly conserved translational GTPase (56), its 
nucleotide binding properties have not been studied so far. Here it is shown that LepA 
has a micro-molar affinity for guanine nucleotides, which is similar to the structurally 
related translational GTPase EF-G (91).  
Association and dissociation rate constants governing the interaction between LepA and 
mant-GDP/GTP have been reported here using a pre-steady-state kinetic analysis. The 
equilibrium binding constants (KD) obtained from these values provide an estimate for 
the affinities and reveal that LepA has an approximately 10-fold higher affinity for 
mant-GDP than for mant-GTP. This is consistent with data obtained for EF-Tu, which 
also has a 10-fold higher affinity for GDP than for GTP (45). The difference in affinity 
between LepA and mant-GDP/GTP does not arise from differences in the association rate 
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constants, as mant-GTP and mant-GDP binding rates are similar to each other. However, 
a 10-fold faster dissociation of mant-GTP was observed, thus raising the KD value 
10-fold over that between LepA and mant-GDP. It was shown for EF-G that dissociation 
of mant-GDPNP is extremely fast (91) and approximately 10-fold faster than the 
dissociation of mant-GTP, which is similar to what is observed here for LepA. However, 
dissociation of mant-GDP from EF-G was also shown to be extremely fast and, unlike 
LepA, is faster than the dissociation of mant-GTP. The difference in the rate of 
mant-GDP dissociation from LepA and EF-G may be due to the presence of the G’ 
domain within EF-G or its absence in LepA. The G’ domain of EF-G has been shown to 
make contacts with its core G-domain (94) similar to contacts made between the GEF 
EF-Ts and EF-Tu. The two β-hairpins of the G’ domain insert into the G-domain of 
EF-G. Furthermore, there are hydrogen bonds between residues in the G’ domain of 
EF-G and residues involved in interacting with the guanine nucleotide in the G-domain. 
These contacts indicate that the presence of the G’ domain in EF-G may act as a 
modulator for guanine nucleotide binding in EF-G as a GEF would. Both EF-Tu and 
LepA lack a G’ domain. It has previously been observed for EF-Tu that GTP dissociation 
is 10-fold faster than GDP dissociation (45), which is similar to what is observed here for 
LepA. However, dissociation of guanine nucleotides from LepA occurs within seconds 
and is approximately 1000-fold faster than dissociation of guanine nucleotides from 
EF-Tu. This gives rise to a 1000-fold lower affinity between LepA and guanine 
nucleotides compared to EF-Tu and guanine nucleotides. The rapid dissociation of 
guanine nucleotides observed from LepA, will likely ensure the rapid turnover of the 
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bound nucleotide. Therefore, similar to EF-G, LepA most likely does not require a GEF 
to facilitate the rapid exchange of GDP for GTP.  
Interestingly, time courses for the association kinetics revealed a two-step binding 
mechanism, a fast concentration dependent step and a slower step that was independent 
of guanine nucleotide concentration. This suggests a nucleotide binding mechanism that 
involves a first rapid binding event, likely followed by a conformational change (Figure 
2.10). However, only one phase was observed for any guanine nucleotide dissociation 
which indicates that the reverse of the second conformational change is likely to rapid to 
detect (> 300 s
-1
). Furthermore, the amplitudes for the two phases of association for either 
mant-GDP or mant-GTP are not equal. The fast phase has greater amplitude (9-fold 
higher with mant-GTP and 3-fold higher with mant-GDP) than the slower phase. This 
suggests that the majority of the LepA•guanine nucleotide complex exists in the initial 
binding complex. However, more of the LepAGDP complex may exist than the 
LepAGTP complex. This may also explain the discrepancy between the KD values 
obtained from the pre-steady state data and the steady state data. Values determined for 
LepA and mant-GTP interaction are comparable due to the majority of the complex being 
in the LepAGTP state. However values obtained for the interaction between LepA and 
mant-GDP may not correspond due to a mixture of the LepAGDP and LepAGDP 
complex.  
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Figure 2.10. Model of LepA interacting with guanine nucleotides. Based on the available pre-steady 
state kinetic analysis a two-step binding mechanism is proposed. GTP or GDP binds to LepA rapidly, 
followed by a conformational change in LepA (represented by the italic font).  
 
2.4b The C-Terminal Domain of LepA is Involved in GTPase Activation on the 
Ribosome 
In order to understand the molecular mechanism of LepA in terms of its function as a 
translational GTPase, it is important to unravel the specific roles of its individual 
domains. Given that the CTD of LepA is unique, it is of particular interest to understand 
the role of this domain within LepA, in particular with its role in binding to the ribosome. 
The CTD of LepA is not fully resolved in the structure obtained by X-ray crystallography 
and indicates that it is likely a flexible domain, which may contribute to its function (95). 
Three variants of E. coli LepA were constructed here that were sequentially truncated 
from the C-terminal end, and analyzed in their ability to interact with guanine nucleotides 
and the ribosome compared to wild type LepA.  
The CTD does not affect the ability of LepA to interact with guanine nucleotides as the 
LepA CTD truncation variants (ΔA494, ΔP520 and ΔG555) bind to guanine nucleotides 
with similar affinities as wild type LepA. Furthermore, deletion of the CTD of LepA does 
not abolish binding to the ribosome as LepA•ribosome complexes are observed for all 
LepA variants and 70S, 50S and 30S ribosomal particles. This was somewhat surprising 
given that structural data on LepA shows that the part of the CTD that is resolved 
contacts the 23S rRNA (60). It was shown that BipA, which is structurally similar to 
61 
 
LepA and also contains a unique CTD, needs this unique CTD for ribosome binding (78). 
However, removal of domain IV in EF-G does not abolish binding between EF-G and the 
ribosome (81). This finding indicates that similar to EF-G, LepA utilizes contacts 
between all other domains and the ribosome to bind. However, the CTD seems to be 
needed for guanine nucleotide dependant binding of LepA to the ribosome. Furthermore, 
removal of the CTD seems to increase the amount of LepA bound to the ribosome 
compared to wild type. Given that the CTD contacts the ribosome, its fold or contacts 
with the ribosome may influence the fold or contacts between the rest of LepA and the 
ribosome. Therefore, the presence of the CTD may restrict or direct the overall contacts 
between LepA and the ribosome. This in turn may facilitate nucleotide dependant binding 
of LepA to the ribosome. 
The CTD is not required for LepA to intrinsically hydrolyze GTP as all the CTD 
truncation variants of LepA can hydrolyze GTP with similar kcat values as wild type 
LepA. The KM values determined here are significantly higher than the KD values 
obtained. Given that two phases are observed in guanine nucleotide binding, it is likely 
that there is at least another step involved, which may be a conformational change 
following guanine nucleotide binding, which could be required before GTP hydrolysis 
can occur. In addition, other translational GTPases have been shown to first hydrolyze 
GTP, release Pi and then release GDP, breaking product release into more than one step 
(43,96). Control of Pi release has been shown to be important for the downstream 
function of EF-G (96) and may be important for the function of LepA.  
Although truncation of the CTD of LepA does not strongly impede ribosome binding or 
guanine nucleotide binding, it is required for efficient multiple turnover of GTP 
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hydrolysis on the ribosome. The LepA CTD truncation variants have a 10-fold higher KM 
value than wild type LepA and EF-G. This indicates that the LepA variants can form a 
complex with the 70S ribosomes, but likely have a lower affinity for the ribosome than 
wild type. Although the CTD may not be essential for binding to the ribosome like the 
unique CTD domain in BipA (78), it may be important or contribute to tight interactions 
made between the ribosome and LepA. Also, given that the KM values for all the CTD 
truncation variants are similar indicates that only the last 44 residues of LepA are 
important for LepA interaction with the ribosome as further truncation of the CTD does 
not additionally increase the KM determined here.  
Interestingly, the kcat determined for ribosome stimulated GTPase activity of LepA 
ΔA494 and ΔP520 are similar to that of wild type LepA and EF-G values obtained here 
and elsewhere (91). However, the kcat determined for ribosome stimulated GTPase 
activity of LepA ΔG555 was approximately a quarter that of wild type LepA and the 
other LepA variants. These results were surprising given that LepA ΔG555 has the least 
amount of the CTD removed. The residues deleted with this variant have not been 
resolved in the crystal structure (58) and are likely to be highly flexible. These results 
indicate that the last 44 residues of LepA are required for efficient ribosome-stimulated 
GTPase activity of LepA. However, when more of the CTD of LepA is removed, the 
turnover of GTP hydrolyzed in the presence of the ribosome is restored to that of wild 
type. This indicates that the presence of the last 44 residues within LepA may stabilize 
the rest of the CTD and promote proper folding of this domain. Removal of this flexible 
region in LepA may lead to an unstructured CTD or a fold which is different than that of 
full length and may inhibit the interaction between LepA and the ribosome. Interestingly, 
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the last 50 amino acids in the C-terminus of E. coli LepA are highly conserved (>80% 
similar) in sequence between the bacterial species aligned here. Therefore, removal of 
this conserved region may lead to different contacts made between the CTD and the 
ribosome, which in turn may inhibit ribosome stimulated GTPase activity of LepA. 
However, when more of the CTD is removed, there is no longer any CTD to inhibit the 
turnover of GTP. Domain IV of EF-G has been shown to be important, not only for rapid 
turnover of GTP hydrolysis by EF-G on the ribosome (81), but for the function of EF-G, 
which is to promote translocation (52). Therefore, the CTD may regulate the GTPase 
activity of LepA on the ribosome, which in turn may be important for the function of 
LepA. 
These results in combination with the pelleting and immunoblotting results suggest that 
the CTD of LepA may act to regulate ribosome interaction with LepA and ribosome- 
stimulated GTPase activity of LepA. Based on the pelleting and immunoblotting results, 
there seems to be a difference in the amount of wild type LepA bound to the 70S whether 
GTP/GDPNP or GDP or no nucleotide is bound. Furthermore, there does not seem to be 
this distinction with the CTD truncation variants. This may indicate that the CTD needs 
to be present in order for the 70S ribosome to discriminate against the various guanine 
nucleotide-bound states of LepA. These results were surprising as the CTD is more than 
20 Å away from the guanine nucleotide-binding domain. Comparison of the structure of 
LepA with that of the aa-tRNA•EF-Tu•GTP ternary complex indicates that there may be 
a role for the CTD of LepA in signalling GTPase activation (70). The signal pathway 
which leads to stimulation of EF-Tu GTPase activity is not fully understood, however, a 
communication pathway between the decoding center of the ribosome and the guanosine 
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triphosphate center of EF-Tu has been suggested (70). The contacts made between the 
CTD of LepA and the ribosome may be needed to communicate from the decoding center 
of the ribosome to the G-domain of LepA.  
 
2.4c H81 is the Catalytic Histidine in LepA 
It has been shown that histidine 84 within switch II of EF-Tu is important for the 
translational GTPase EF-Tu (68); however, this has not been confirmed in LepA. LepA 
contains a histidine (His 81) that is in a similar position as the catalytic histidine in 
EF-Tu. Furthermore, this histidine is 100% conserved in identity within the 43 bacterial 
species aligned here (Appendix Figure A.3). Substitution of His 81 to Ala did not 
significantly affect LepAs ability to bind to the ribosome or guanine nucleotides. 
Interestingly, this substitution did eliminate the differential binding between wild type 
LepA and the 70S ribosome in the presence of GTP/GDPNP or GDP/apo. This indicates 
that this substitution may also cause a conformational change in the G-domain of LepA 
which is needed for nucleotide dependant binding to the ribosome.  
It has been assumed that a histidine located in switch II of translational GTPases is 
essential for GTPase activity. Data obtained here on the GTPase activity of LepA on and 
off the ribosome demonstrated that substitution of His 81 severely affects the GTPase 
activity of LepA, suggesting that His 81 in LepA plays a key role during GTP hydrolysis. 
Structural studies of EF-Tu bound to the ribosome show that His 84 interacts with A2662 
of the 23S rRNA (70,97). This contact may be important, not only in the positioning of 
the nucleophilic water, but in the overall interaction made with the ribosome.  
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2.5 Future Directions 
Here, effects of LepAs unique CTD and histidine 81 in LepA have been analyzed in 
terms of their effect on LepAs interaction with guanine nucleotides and the ribosome.  
The function of LepA in vivo is still not understood. Although LepA is only found in low 
amounts in bacterial cells and eukaryotic cell organelles (mitochondria and chloroplasts), 
it is highly conserved (56). It has been shown that the presence of LepA is beneficial 
under certain stress conditions. However, the functional mechanism of how LepA 
functions as a GTPase in the cell is unknown. Furthermore, it is unknown whether the 
ability of LepA to hydrolyze GTP is necessary for the results observed in vivo under 
stress. The functional importance of GTP hydrolysis by LepA can be analyzed by 
utilizing the LepA H81A variant in knockout lepA strains. This will demonstrate whether 
GTPase activity of LepA is important for its cellular function in the cell during stress 
conditions. 
While it has previously been shown that LepA can catalyze back-translocation (56) as 
well as forward translocation (67), it is not clear how or when this is carried out in the 
cell. Given that LepA is a translational GTPase that binds to the A site of the ribosome, it 
is possible that under stress conditions LepA increases in abundance and targets specific 
ribosome complexes in an effort to rescue the cell. Given that the only LepA-ribosome 
contacts that are different than the EF-G-ribosome contacts are between LepA and its 
unique CTD, it is likely that this domain is utilized in ribosome differentiation between 
LepA and other proteins which bind to the A site. In vivo experiments comparing wild 
type LepA to these CTD truncation variants and their ability to rescue cells under stress 
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would give further insight into the functional importance of this unique domain. In 
addition, the unique CTD in LepA may be used to assist LepA in differentiating between 
various ribosomal complexes in order to target a specific complex. In an effort to 
understand if LepA only targets specific ribosomal complexes, it would be interesting to 
analyze complex formation between various ribosomal complexes, such as Pre and Post-
translocated ribosomal complexes, and how the deletion of the CTD of LepA affects this 
interaction. 
Interestingly, 16% of the residues in E. coli LepA are cysteine (Appendix Figure A.2). 
This percentage is significantly higher than for E. coli EF-G, which is comprised of only 
4% cysteine residues. An alignment of bacterial LepA primary sequences (Appendix 
Figure A.3 and Table A.2) shows that most bacterial LepA sequences contain 10-20% 
cysteine residues. It is known that cysteine residues may stabilize the structure of proteins 
through disulfide bridges (98). Based on the crystal structure of LepA, all cysteine 
residues are too far apart from each other to form any disulfide bonds. However, some 
are surface exposed and may form a disulfide bond with another LepA protein, forming a 
dimer. This may indicate that LepA exists as a dimer until it interacts elsewhere for 
function or that it may function as a dimer. 
Cysteine residues are also involved in enzyme catalysis (99). Four of the 10 cysteine 
residues in E. coli LepA are found to be more than 80% conserved in identity in the 
alignment of bacterial species performed here (Appendix Table A.2). It is possible that 
one or all of these cysteines play a role in the functional mechanism of LepA.  
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Mutagenesis on each cysteine residue in E. coli LepA has been performed (Appendix 
Table A.2). Given that LepA has a high abundance of cysteine residues, it would be 
interesting to analyze whether these have a role on the ability of LepA to function. 
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Chapter 3  
A Tail of Two Proteins; The C-terminal Module of EF-Ts Alters Nucleotide 
Exchange in EF-Tu.  
3.1 Introduction 
3.1a The Function of EF-Tu 
Elongation Factors are essential proteins found in all kingdoms of life, and these factors 
are among the most abundant proteins in any given cell (85). EF-Tu represents up to 5% 
of the total cellular protein in E. coli (85). It is a 43 kDa protein consisting of three 
domains (Figure 3.1). Domain 1 is the guanine nucleotide binding domain (G-domain) 
with a consensus Rossmann fold, while domains 2 and 3 each consist of anti-parallel 
β-barrels (44,69). The G-domain contains five regions of high sequence conservation on 
the amino acid level that are present in all GTPases (GTPase sequence motifs) (21). 
These five elements (G1 to G5 sequence motifs) mediate interactions with the guanine 
nucleotide; G1 is the P-loop which coordinates phosphates of the bound nucleotide, while 
G2 and G3 form switch I and part of the switch II region, respectively. Switch regions are 
aptly named as they undergo conformational changes when the protein changes from the 
GTP to the GDP-bound form. The G4 and G5 motifs coordinate the guanine moiety of 
the nucleotide.  
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Figure 3.1. Structures of EF-Tu bound to GTP and GDP. Structure of (A) Thermus aquaticus EF-Tu 
with a bound GTP (PDB ID 1EFT (69)) and (B) E. coli EF-Tu with a bound GDP (PDB ID 1EFC (44)) 
determined by X-ray crystallography. The guanine nucleotide is shown in stick representation. EF-Tu is 
represented in cartoon with domain I coloured in blue, domain II coloured in red and domain III shown in 
grey. Switch I and switch II regions within domain I are highlighted in yellow and green respectively. 
 
When bound to GTP, EF-Tu has a high affinity for aa-tRNA (KD ≈ 1 x 10
-8 
M (100)) and 
forms a ternary complex (TC) (EF-Tu•GTP•aa-tRNA) (Figure 3.2) that can interact with 
the ribosome (initial binding of the TC to the ribosome has a KD ≈ 6 x 10
-7
 M (41)). The 
structure of EF-Tu bound to Phe-tRNA
Phe
 has been determined by X-ray crystallography 
and shows that all domains of EF-Tu interact with aa-tRNA (101). Domains 1 and 2 
interact with the CCA-aa end of the aa-tRNA which protects the aa-ester bond from 
hydrolysis. The 5’-end of the aa-tRNA binds to the 3-domain-junction of EF-Tu, while 
the T-stem of the aa-tRNA makes contacts with domain 3 of EF-Tu. 
70 
 
 
Figure 3.2. Structure of EF-Tu bound to aa-tRNA. Structure of T. aquaticus EF-Tu bound to GTP and to 
yeast Phe-tRNA
Phe
 (PDB ID 1TTT (101)) determined by X-ray crystallography. EF-Tu and GTP are 
represented as in figure 3.1, while Phe-tRNA
Phe
 is shown in black and by ribbon representation. 
 
Codon dependent delivery of aa-tRNA to the 70S ribosome by EF-Tu is comprised of 
several steps that have been previously studied (42). X-ray crystallographic structures of 
the TC bound to the ribosome reveal that EF-Tu binds to the ribosome near the sarcin-
ricin loop on the large (50S) ribosomal subunit (70). Initial binding of the TC to the 
ribosome is followed by codon recognition between the mRNA codon located in the 30S 
ribosomal A site and the aa-tRNA anticodon. Correct codon-anticodon recognition 
greatly stabilizes the TC on the ribosome and activates a signal that is transmitted to the 
G-domain of EF-Tu through a poorly understood mechanism. Structural and biochemical 
studies of EF-Tu indicate that the phosphate of A2662, which is located in the sarcin-
ricin loop of the 23S rRNA, positions histidine 84 of EF-Tu towards the attacking water 
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(97). In this “active” conformation, the catalytic His 84 can act as a general base in 
catalyzing a nucleophilic water attack on the gamma-phosphate of the EF-Tu-bound 
nucleotide (97).  
Following GTP hydrolysis and Pi release (42,43), EF-Tu undergoes a large 
conformational change (44,69) where domain 1 rotates approximately 90° relative to 
domains 2 and 3, resulting in an open conformation. Rotation of the domains within 
EF-Tu causes all the aa-tRNA binding sites to move apart (44). The affinity of 
EF-Tu•GDP for aa-tRNA is thus lowered by two orders of magnitude compared to 
EF-Tu•GTP (KD(EF-Tu•GDP) ≈ 1 x 10
-6
M, KD(EF-Tu•GTP) ≈ 1 x 10
-8 
M (100)). This decrease in 
affinity leads to the release of aa-tRNA from EF-Tu and the subsequent accommodation 
of aa-tRNA into the 50S ribosomal A site. 
The intrinsic rate of GDP release from EF-Tu is extremely slow (45). In order to 
accelerate GDP dissociation from EF-Tu, a guanine nucleotide exchange factor (GEF) is 
needed (46). The GEF for EF-Tu is EF-Ts, facilitating rapid conversion of EF-Tu to its 
active GTP-bound state required for the rates of protein synthesis (~ 12 amino acids/s 
(102)) observed in vivo.  
The three dimensional structure of E. coli EF-Tu bound to EF-Ts (47) revealed the 
contacts between these two proteins (Figure 3.3). Domain 3 of EF-Tu interacts with 
subdomain C of EF-Ts, while domain 1 (G-domain) of EF-Tu interacts with subdomain 
N, the N-terminal domain and the C-terminal module of EF-Ts. The interaction with 
EF-Ts induces movement of EF-Tus helix D away from the nucleotide-binding site so 
that the ribose and guanine base are no longer stabilized by residues in this helix. EF-Ts 
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binding to EF-Tu further disrupts the phosphate-binding loop and induces movement of 
helix B. This disruption breaks the interactions between residues in helix B of EF-Tu and 
water molecules coordinating the Mg
2+
 ion that is needed to stabilize the bound 
nucleotide. Structural and biochemical studies have shown that these interactions enhance 
the rate of GDP dissociation from EF-Tu by a factor of 60 000 (45,103). In this manner 
EF-Ts enables the rapid turnover of active EF-Tu. The intracellular concentration of GTP 
is ten times higher than that of GDP (48) and GTP binding to EF-Tu•EF-Ts disrupts this 
interaction, giving rise to an EF-Tu•GTP complex, allowing another aa-tRNA to bind, 
forming a new ternary complex able to participate in the elongation cycle. 
 
Figure 3.3. Structure of EF-Tu bound to EF-Ts. Structure of E. coli EF-Tu bound to EF-Ts (PDB ID 
1EFU (47)) determined by X-ray crystallography. EF-Tu is represented as in figure 3.1. EF-Ts is 
represented in cartoon with the N-terminal domain coloured orange, subdomain N coloured brown, 
subdomain C coloured yellow, the dimerization domain (coiled-coil) coloured tan and the C-terminal 
module coloured black. 
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3.1b Nucleotide Exchange in EF-Tu 
The kinetic mechanism of EF-Ts catalyzed nucleotide exchange in EF-Tu has been 
analyzed in great detail in the model systems of E. coli and S. cerevisiae (45,104). The 
homologue of EF-Tu in eukaryotes, eEF1A, has been shown to bind GDP and GTP with 
an affinity that is 100-fold lower than that of E. coli EF-Tu (104). However, even though 
the rate of GDP dissociation from eEF1A is 100-fold faster than in E. coli EF-Tu, it is 
still not fast enough to maintain the required in vivo protein synthesis rates (~ 10 amino 
acids/s (105)). 
The structures of the two nucleotide exchange factor complexes have been determined 
previously for the eukaryotic (with the C-terminal catalytically active domain of 
eEF1B) and the prokaryotic system (47,106). Although both GEFs disturb the Mg2+ to 
lower the affinity for the guanine nucleotide, these structures reveal two different modes 
of interaction for the exchange factors in the prokaryotic and eukaryotic system. The 
C-terminal region of eEF1B docks onto domain I of eEF1A and accelerates the rate of 
GDP dissociation from eEF1A 60-fold (104), which is significantly less than the 
prokaryotic system, but enough to facilitate in vivo rates of protein synthesis. 
Furthermore, the contacts made between eEF1A and its exchange factor differ between 
the prokaryotic and eukaryotic factor. eEF1B interacts with the opposite side of eEF1A 
than EF-Ts with EF-Tu (Figure 3.4). As a result, there is no contact made between 
domain III of eEF1A and eEF1Bα. The N-terminal half of eEF1B interacts with domain 
II of eEF1A, whereas there are no contacts made between EF-Ts and domain II in the 
prokaryotic EF-Tu. A similar system for nucleotide exchange also exists in mitochondria 
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where the respective mitochondria specific EF-Tsmt is also required to assist in the rapid 
dissociation of GDP from mitochondrial EF-Tumt. The structure of the bovine 
EF-Tumt•EF-Tsmt complex (107) determined by X-ray crystallography revealed a three 
dimensional arrangement very similar to the bacterial complex (Figure 3.4). Even though 
the amino-terminus of EF-Tsmt makes similar contacts with EF-Tumt as in the bacterial 
system, EF-Ts in mitochondria lacks the coiled-coil motif present in bacteria. It was 
previously shown that deletion of the coiled-coil motif in EF-Ts from E. coli reduces the 
ability of EF-Ts to catalyze the dissociation of guanine nucleotides (108) as well as 
decrease the stability of the EF-Tu•EF-Ts complex. The lack of a coiled-coil domain in 
mitochondrial EF-Tsmt indicates that it uses other parts to function, such as its amino-
terminus. In addition, EF-Tumt has a lower affinity for guanine nucleotides (109), which 
may have abolished the need for the coiled-coil domain in EF-Tsmt.  
 
Figure 3.4. Structures of the eEF1A•eEF1Bα and the EF-Tumt•EF-Tsmt complex. Crystal structure of 
(A) Yeast eEF1A bound to the C-terminal domain of eEF1Bα represented in cartoon (PDB ID 1F60 (110)). 
eEF1A is coloured as EF-Tu in figure 3.1 and eEF1Bα is coloured in black. (B) Mitochondrial EF-Tu 
bound to EF-Ts is represented in cartoon (PDB ID 1XB2 (107)). EF-Tu is coloured as in figure 3.1 and 
EF-Ts is coloured as in figure 3.3. 
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3.1c Divergence of EF-Ts 
EF-Ts is essential for maintaining protein synthesis rates in vivo in E. coli (111). In spite 
of this, EF-Ts is highly divergent in sequence among different species. The question then 
is if the divergence in the primary sequence of EF-Ts affects the function of EF-Ts to act 
as a GEF. 
Similar to E. coli, Pseudomonas aeruginosa is a gram-negative bacteria. P. aeruginosa is 
an opportunistic pathogen and is a current concern for public health. EF-Ts from these 
two bacterial species share 55% sequence identity, which is high in comparison to other 
species. A comparative analysis on the ability of EF-Ts to catalyze guanine nucleotide 
dissociation from EF-Tu was performed here between E. coli and P. aeruginosa. Both 
species of EF-Ts can stimulate the rate of guanine nucleotide dissociation from the 
species-specific EF-Tu to a similar extent, however EF-Ts from P. aeruginosa seems to 
catalyze the exchange of guanine nucleotides in EF-Tu more efficiently than EF-Ts from 
E. coli. Analysis of the differences in the interactions between EF-Tu and EF-Ts show an 
extension of the C-terminal module of EF-Ts from P. aeruginosa compared to EF-Ts 
from E. coli. Examination of the C-terminal module of EF-Ts suggests that it can 
modulate the rate of guanine nucleotide dissociation from EF-Tu, revealing a novel 
regulatory element present in EF-Ts. 
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3.2 Materials and Methods 
3.2a Molecular Biology 
The ORF for tufA from P. aeruginosa genomic DNA was PCR amplified in a reaction 
catalyzed by Phusion polymerase (Finnzymes) using primers 5’-AGA GGA TCC CTG 
TCG TGG CTA AAG GA-3’ and 5’- ATG GCA GGA GCT CCG ATT ACT CGA-3’. 
The underlined nucleotides denote BamHI and SacI restriction sites engineered into the 
primers. All restriction enzymes used were purchased from Fermentas. The ORF for tsf 
from P. aeruginosa genomic DNA was similarly amplified, using primers 5’- TTC CAT 
ATG GCA GAA ATT ACT GCA GC-3’ and 5’- CAG TCG AAT TCG TCT TTG TTA 
CTG-3’, with engineered NdeI and EcoRI restriction sites respectively. The resulting 
PCR products were ligated into SmaI digested pUC19 (New England BioLabs) using T4 
DNA ligase (Invitrogen). The ligation mixture was transformed into subcloning 
efficiency E. coli DH5α cells (New England BioLabs), which were grown at 37°C on 
LB-agar plates supplemented with 100 µg/mL ampicillin and 50 µg/mL 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-gal, Rose Scientific). Blue-white selection 
and restriction analysis were utilized to isolate cells containing recombinant plasmids 
(designated pUCPatufA and pUCPatsf), which were further propagated for plasmid 
isolation. ORFs were excised using the respective restriction endonucleases and ligated 
into similarly digested pET28a for PatufA and Patsf, creating plasmids pETPatufA and 
pETPatsf. Plasmids were transformed into E. coli DH5α competent cells and grown in 
LB media, supplemented with 50 µg/mL kanamycin, for plasmid propagation. Sequence 
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and orientation was confirmed by DNA sequencing (Macrogen DNA Sequencing 
Services).  
pET21a (pKECAHIS) (112) containing the full-length sequence coding for a C-terminal 
His6-tagged EF-Tu from E. coli was utilized. A construct for EF-Ts from E. coli 
(pHK1Ts) was expressed as a fusion protein with an intein self-splicing element on the 
C-terminus and chitin binding domain as in (45). The plasmid (pCA24N) containing the 
tsf gene from E. coli encoding for EF-Ts with an N-terminal His6-tag was obtained from 
the ASKA library of clones (113).  
 
3.2b Mutagenesis  
Substitution of Gln 283 to a Met was introduced via site-directed mutagenesis carried out 
on the pET28a-Patsf template using the Quickchange™ method (Stratagene). Primers 
(forward primer 5’-GCT GCT GAA GTT GCC GCT ATG GTA GCC GCC ACC AAG 
C-3’ and reverse primer 5’-GCT TGG TGG CGG CTA CCA TAG CGG CAA CTT 
CAG CAG C-3’) were obtained from Integrated DNA Technologies (IDT). The position 
of mutagenesis is denoted in bold; underlined nucleotides denote the Acu1 restriction site 
(5’-CTGAAG-3’) which was inserted via a silent mutation. Reactions were carried out 
under the following conditions: 25 μL of the reaction mixture contained 1000 ng of 
template, 0.4 μM of primer pair, 0.4 mM of each dNTP and 3 units of DNA polymerase 
(TruPfu, Truin Science Ltd.). The reaction was initiated by pre-heating the reaction 
mixture to 95C for 5 min followed by 18 cycles of 95C for 45 s, 55C for 1 min and 
68C for 15 min followed by a final extension at 68°C for 15 min.  
78 
 
The C-terminal deletion in EF-TsP.a. was constructed by inserting a stop codon via site-
directed mutagenesis as described above. Primers (forward primer 5’-GCC GCT CAA 
TAA GCT TCC ACC AAG C-3’ and reverse primer 5’-GCT TGG TGG AAG CTT ATT 
GAG CGG C-3’) were obtained from Integrated DNA Technologies (IDT). The position 
of mutagenesis is denoted in bold; underlined nucleotides denote the HindIII restriction 
site (5’-AAGCTT-3’) which was inserted via a silent mutation. Reactions were carried 
out under the following conditions: 25 μL of the reaction mixture contained 1000 ng of 
template, 0.4 μM of primer pair, 0.4 mM of each dNTP and 3 units of DNA polymerase 
(TruPfu, Truin Science Ltd.). The reaction was initiated by pre-heating the reaction 
mixture to 95C for 5 min followed by 18 cycles of 95C for 45 s, 50C for 1 min and 
68C for 25 min followed by a final extension at 68°C for 25 min.  
EF-TsE.c.P.a. C-terminal chimera was constructed via site-directed mutagenesis carried out 
on the pHk1Ts via site-directed mutagenesis as above. Primers (forward primer 5’-GTT 
GCT GCC ATG GTA GCC GCC ACC AAG CAG TGC TTT GCC AAG G-3’ and 
reverse primer 5’-CCT TGG CAA AGC ACT GCT TGG TGG CGG CTA CCA TGG 
CAG CAA C -3’) were obtained from Integrated DNA Technologies (IDT). The position 
of mutagenesis is denoted in bold; underlined nucleotides denote the NcoI restriction site 
(5’-CCATGG-3’) which was inserted via a silent mutation. Reactions were carried out 
under the following conditions: 25 μL of the reaction mixture contained 1000 ng of 
template, 0.4 μM of primer pair, 0.4 mM of each dNTP and 3 units of DNA polymerase 
(TruPfu, Truin Science Ltd.). The reaction was initiated by pre-heating the reaction 
mixture to 95C for 5 min followed by 18 cycles of 95C for 45 s, 55C for 1 min, 68C 
for 20 min followed by a final extension at 68°C for 20 min.  
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The PCR-amplification products were analyzed on a 1% agarose gel at 80V for 80 min. 
Products were transformed into E. coli DH5α (New England Biolabs) competent cells for 
propagation and E. coli BL21-DE3 (New England Biolabs) for expression. The mutations 
were confirmed by sequencing (GeneWiz Inc). 
 
3.2c Protein Expression and Purification 
EF-Tu and all EF-Ts variants derived from P. aeruginosa were expressed in E. coli 
(strain BL21-DE3 (Novagen)) containing the respective plasmid. Cells were grown at 
37C in LB medium supplemented with 50 g/mL kanamycin to mid-log phase 
(OD600 = 0.6) and induced with 1 mM IPTG (BioBasic). Cells were grown for an 
additional 3 hrs at 37C, harvested by centrifugation (5000  g for 10 min at 4C) and 
stored at -80C. 
EF-Tu from E. coli was expressed in LB supplemented with 100 g/mL ampicillin and 
EF-Ts from E. coli (obtained from the ASKA collection) expressed in LB supplemented 
with 30 g/mL of chloramphenicol. EF-Ts variants derived from E. coli (pHK1Ts) were 
grown at 37C in LB medium supplemented with 100 g/mL ampicillin. Cells containing 
the respective plasmid were grown to mid-log phase (OD600 = 0.6) and induced with 
1 mM IPTG. Following induction the temperature was reduced to 25°C for 2 hrs, then to 
16°C overnight. Cells were harvested by centrifugation as described above. 
To analyze protein expression, one OD600 samples were taken every 30 min, lysed with 
8 M urea in buffer 3.1 (50 mM Tris-Cl pH 7.5 (20°C), 70 mM NH4Cl, 30 mM KCl and 
7 mM MgCl2) and analyzed by 12% SDS-PAGE at 80 V for 30 min, then 200 V for 
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60 min (BioRad Mini Protean 3 System). Gels were stained with Coomassie Brilliant 
blue; all other SDS-PAGEs were performed in a similar manner.  
Similar purification procedures were followed for EF-Tu from E. coli (pKECAHIS) and 
P. aeruginosa (pETPatufA) as well as EF-Ts variants from P. aeruginosa (pETPatsf) and 
EF-Ts from E. coli obtained from ASKA cloning. Cell pellets (approximately 10 g) were 
resuspended in 7 mL of buffer 3.2 (50 mM Tris-Cl pH 8.0 (4°C), 60 mM NH4Cl, 7 mM 
MgCl2, 300 mM KCl, 7 mM BME, 1 mM PMSF, 10 mM imidazole, 15% glycerol and 
50 µM GDP) per gram of cells and lysed with 1 mg/mL lysozyme. Cell debris were 
removed through centrifugation at 3000 x g for 30 min followed by 30 000 x g for 45 min 
using a JA-16 rotor (Beckman). The respective protein was purified from the cleared 
lysate (S30 extract) using affinity chromatography (7 mL Ni
2+
-Sepharose resin (GE 
Healthcare) equilibrated with buffer 3.2). The resin was washed 3 times with 50 mL of 
buffer 3.2 and 4 times with 50 mL of buffer 3.3 (buffer 3.2 with 20 mM imidazole). The 
protein was then eluted in 10 washes of 7 mL buffer 3.4 (buffer 3.2 with 250 mM 
imidazole). The obtained His6-tagged protein was then concentrated via ultrafiltration 
(Vivaspin 20, 30 000 MWCO for EF-Tu and Vivaspin 20, 10 000 MWCO for EF-Ts 
(Sartorius)) and further purified by SEC (XK26/100 column; Superdex 75 prep grade 
(GE Healthcare)) equilibrated in buffer 3.1. Fractions were analyzed by SDS-PAGE, and 
those containing protein that were >90% pure were pooled and concentrated via 
ultrafiltration (vide supra) and stored at -80C. The final protein concentration was 
determined spectrophotometrically at 280 nm using a molar extinction coefficient of 
32 900 M
-1
 cm
-1 
for all EF-Tu proteins (calculated using ProtParam (88)) and confirmed 
using the Bradford Protein Assay (BioRad). Due to the fact that EF-Ts does not contain 
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any tryptophan residues, protein concentration was determined using the Bradford 
Protein Assay. 
EF-Ts variants from E. coli (pHk1Ts) were purified using the following method. Cell 
pellets (approximately 10 g) were resuspended in 7 mL of buffer 3.5 (25 mM Tris-Cl pH 
7.5 (4°C), 50 mM NH4Cl, 10 mM MgCl2, 0.1% PMSF, and 50 µM GDP) per gram of 
cells and lysed with 1 mg/mL of lysozyme. Cell debris was removed through 
centrifugation as above to obtain a cleared lysate (S30 extract). The respective protein 
was purified from the cleared lysate using affinity chromatography (5 mL chitin beads 
(New England BioLabs)) equilibrated with buffer 3.5. The resin was washed 3 times with 
50 mL of buffer 3.5 and five times with 50 mL of buffer 3.6 (20 mM Tris-Cl pH 8.0 
(4°C), 50 mM NH4Cl, 0.1 mM EDTA and 50 µM GDP). Approximately 20 mL of buffer 
3.7 (20 mM Tris-Cl pH 8.0 (4°C), 50 mM NH4Cl, 0.1 mM EDTA, 60 mM DTT and 
400 mM KCl) was added to the column and was incubated for approximately 30 hrs at 
room temperature. The EF-Ts protein was eluted with 8 washes of 4.5 mL buffer 3.8 
(20 mM Tris-Cl pH 8.0 (4°C), 50 mM NH4Cl, 0.1 mM EDTA, 400 mM KCl and 50 μM 
GDP). Elutions containing EF-Ts were pooled and concentrated via ultrafiltration 
(Vivaspin 20, 10 000 MWCO (Sartorius)) and subsequently subjected to SEC (XK26/100 
column; Superdex 75 prep grade (GE Healthcare)) equilibrated in buffer 3.1 to further 
purify the protein. Fractions were analyzed by SDS-PAGE and those containing protein 
with a purity of >90% were pooled, concentrated via ultrafiltration (vide supra) and 
stored at -80C for further use. The final EF-Ts protein concentration was determined 
using the Bradford Protein Assay. The purities of the protein preparations used in this 
work are summarized on the SDS-PAGE in Appendix Figures A.4 and A.5.  
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To promote the dissociation of GDP, which is tightly bound to EF-Tu and co-elutes with 
the factor during purification, EF-Tu•GDP was incubated in buffer 3.9 (25 mM Tris-Cl, 
pH 7.5 (20°C), 50 mM NH4Cl, 10 mM EDTA) for 30 min at 37C. GDP and EF-Tu were 
separated using SEC (Acorn 10/300 GL column; Superdex 75 (GE healthcare)) 
equilibrated in buffer 3.10 (25 mM Tris-Cl pH 7.5 (4°C), 50 mM NH4Cl). To prepare the 
respective EF-Tu•EF-Ts complexes, EF-Tu•GDP was incubated with equimolar amount 
of EF-Ts in buffer 3.9 and subsequently purified using SEC as described above for 
purification of EF-TuGDP. 
 
3.2d Preparation of EF-Tu•mant-GDP, EF-Tu•mant-GTP 
EF-Tu•GDP was incubated with a 10-fold molar excess of mant-GDP or mant-GTP in 
buffer 3.1 for 30 min at 37C. When mant-GTP was used, the incubations were carried 
out in the presence of 3 mM PEP and 0.1 mg/mL PK (Roche Diagnostic) to convert any 
nucleotide di-phosphate present into the nucleotide tri-phosphate form (114). 
 
3.2e Rapid Kinetic Measurements 
Fluorescence stopped-flow measurements were performed using a KinTek SF-2004 
stopped-flow apparatus, as described in (90). Tryptophan fluorescence was excited at 
280 nm and measured after passing through LG-305-F cut-off filters (NewPort). 
Mant-nucleotides were excited via FRET from the single tryptophan (ex = 280 nm) 
present in EF-Tu and measured after passing through LG-400-F cut-off filters (NewPort).  
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The apparent rate for the bimolecular association of mant-nucleotides to nucleotide free 
EF-Tu was determined by rapidly mixing 25 μL of nucleotide free E. coli EF-TuE.c. 
(0.3 μM after mixing) or 25 μL of nucleotide free P. aeruginosa EF-TuP.a. (0.5 μM after 
mixing) with 25 μL of varying concentrations of mant-nucleotides (ranging from 1 to 
10 μM after mixing). Experiments were carried out at 20°C in buffer 3.1. Fluorescence 
time courses were evaluated by fitting with a single exponential equation (Equation 3.1). 
 
F = F + A  exp(-k  t)        (Equation 3.1) 
 
Where F is the fluorescence at time t, F is the fluorescence signal at equilibrium. k is the 
apparent rate constant of association (kapp) measured independently for each guanine 
nucleotide concentration. The apparent rate constants were then plotted as a function of 
nucleotide concentration. 
The apparent rate for the bimolecular association of nucleotides to nucleotide free 
EF-Tu•EF-Ts was determined by rapidly mixing 25 μL of nucleotide free EF-Tu•EF-Ts 
(0.5 μM after mixing) with 25 μL of varying concentrations of guanine nucleotides 
(ranging from 2.5 to 1000 μM after mixing) at 20°C in buffer 3.1. Fluorescence time 
courses of tryptophan emission were fit with equation 3.1 and kapp values obtained were 
plotted as a function of increasing guanine nucleotide concentration. Previous analysis of 
E. coli EF-Tu has demonstrated that at low concentrations of GTP the slope of the line is 
given by equation 3.2 (45). At low concentrations of GDP the slope of the line is given 
by equation 3.3. 
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Slope = k7 / (1 + k-7/k-6)       (Equation 3.2) 
 
Slope = k4/ (1 + k-4/k-3)       (Equation 3.3) 
 
Dissociation rate constants were determined by rapidly mixing 25 μL 
EF-Tu•mant-GTP/mant-GDP (0.3 μM after mixing) with 25 μL GTP/GDP (30 μM after 
mixing) at 20°C in buffer 3.1. Under these conditions only the dissociation of mant-
labelled nucleotide contributed to the observed fluorescence change as the presence of 
excess unlabelled nucleotide prevents the rebinding of mant-nucleotide. The observed 
fluorescence time courses were fit with Eq. 3.1, yielding k as the respective dissociation 
rate constant (k-1, k-5 for GDP and GTP, respectively). Using similar conditions, the 
dissociation of mant-GTP/mant-GDP from 25 μL EF-Tu•mant-GTP/GDP (0.3 μM after 
mixing) was stimulated with 25 μL of varying concentrations of EF-Ts (1 to 20 μM after 
mixing) at 20°C in buffer 3.1. The observed fluorescence time courses were fit with Eq. 
3.1, thus providing the apparent rates for nucleotide dissociation in the presence of 
different concentrations of EF-Ts. The apparent rates for nucleotide dissociation in the 
presence of the different EF-Ts concentrations were plotted as a function of increasing 
EF-Ts concentration. At low concentrations of EF-Ts, the initial slope of kapp for 
mant-GTP dissociation is given by equation 3.4 and mant-GDP dissociation is given by 
equation 3.5.   
 
Slope = k6 / (1 + k-6/k-7)       (Equation 3.4) 
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Slope = k3/ (1 + k-3/k-4)       (Equation 3.5) 
 
To determine the association rate constants (k2) for the EF-Tu-EF-Ts interaction, 
increasing concentrations of EF-Ts (1 to 5 µM final) were mixed with EF-Tu (1µM final) 
and the resulting decrease in tryptophan fluorescence was observed as a function of time. 
The resulting linearly concentration dependence of the observed association rates gave 
the respective k2 from the slope. Subsequently k-2 can be calculated based on the law of 
mass action from either the GTP or the GDP branch of the scheme in figure 3.5 using 
equations 3.6 and 3.7. 
 
k-2 = k-5k2k-6k7 / (k5k6k-7)       (Equation 3.6) 
 
k-2 = k-1k2k-3k4 / (k1k3k-4)       (Equation 3.7) 
 
Calculations were performed using TableCurve (Jandel Scientific) and Prism (GraphPad 
Software).  
 
3.2f Sequence alignment 
Protein primary sequences for EF-Ts and EF-Tu were obtained from the Swiss-Prot 
database (115). More than 40 bacterial sequences were aligned using ClustalW (116) to 
assess the conservation of EF-Tu and EF-Ts. Alignments were analyzed using GeneDoc 
(117). Percent identity for every amino acid was calculated based on the number of 
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identical residues present in the alignment and percent similarity was calculated based on 
conserved substitutions of residues observed in the alignment.   
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3.3 Results 
The interaction of EF-Tu with guanine nucleotides has been studied extensively in the 
model systems of E. coli (45) and yeast (104). However, no kinetic data is available for 
pathogenically relevant organisms such as P. aeruginosa. As E. coli and yeast are typical 
model systems, it is implied that findings in these model systems also translate to other 
organisms. In order to investigate if this holds true within bacteria, the kinetic mechanism 
of nucleotide exchange in P. aeruginosa has been determined here and compared to the 
rate constants in the E. coli system. These results will allow a better understanding of the 
similarities and differences between the P. aeruginosa and the E. coli nucleotide 
exchange mechanism. The kinetic mechanism of EF-Ts stimulated guanine nucleotide 
exchange in EF-Tu is depicted in Figure 3.5. In this mechanism, EF-Tu can bind to 
GDP (k1), GTP (k5) or EF-Ts (k2) and can subsequently dissociate. EF-Ts can interact 
with the EF-Tuguanine nucleotide complex and stimulate the dissociation of guanine 
nucleotide from EF-Tu.  
 
 
 
Figure 3.5. Kinetic mechanism of nucleotide exchange in EF-Tu catalyzed by EF-Ts. 
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3.3a Interaction of GDP/GTP with EF-Tu (k1, k-1, k5, k-5)  
The rate constants for guanine nucleotide association and dissociation in the absence of 
EF-Ts were determined using a stopped-flow apparatus by measuring FRET between a 
single tryptophan in EF-TuP.a. (Trp 40) or EF-TuE.c. (Trp 184) and the mant-group on 
mant-GTP/mant-GDP. Nucleotide dissociation rate constants for the EF-Tu•mant-GDP 
(k-1) and the EF-Tu•mant-GTP (k-5) complexes were determined by mixing with excess 
GDP or GTP. Mant-GTP or mant-GDP dissociation from EF-Tu occurs with an 
exponential fluorescence decrease (Figure 3.6). The dissociation rate constants k-1 and k-5 
for GDP and GTP were directly obtained by fitting the observed time courses with a 
single-exponential function (Eq. 3.1) and are summarized in Table 3.1. The values 
obtained for both GTP and GDP dissociation rate constants for EF-TuP.a. 
(k-1 = 0.0007 ± 0.0001 s
-1
, k-5 = 0.007 ± 0.001 s
-1
) are slightly lower than for EF-TuE.c. 
(k-1  0.0018 ± 0.0001 s
-1
, k-5 = 0.013 ± 0.001 s
-1
). The rates of dissociation from EF-TuE.c. 
is consistent with previous reports (45).  
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Figure 3.6. Dissociation of mant-GTP and mant-GDP from EF-Tu. (A) Time course of (1) 
EF-TuE.c.•mant-GDP complex (0.3 μM) dissociation in the presence of excess unlabelled GDP (30 μM) (2) 
EF-TuP.a.•mant-GDP complex (0.3 μM) dissociation in the presence of excess unlabelled GDP (30 μM). (3) 
Mant-GDP (3 μM) alone. (B) Time course of (1) EF-TuE.c.•mant-GTP complex (0.3 μM) dissociation in the 
presence of excess unlabelled GTP (30 μM) (2) EF-TuP.a.•mant-GTP complex (0.3 μM) dissociation in the 
presence of excess unlabelled GTP (30 μM). (3) Mant-GTP (3 μM). The fluorescence of the mant group 
was monitored following excitation through the intrinsic tryptophan residue in EF-Tu. 
 
Table 3.1. Kinetic Parameters Governing the Nucleotide Interaction with EF-Tu. 
Constant EF-TuP.a. EF-TuE.c.  
k-1 (s
-1
) 0.0007 ± 0.0001 0.0018 ± 0.0001 
k1 (M
-1
s
-1
) (1.5 ± 0.1) x 10
6
 (1.3 ± 0.1) x 10
6
 
k-5 (s
-1
) 0.007 ± 0.001 0.013 ± 0.001 
k5 (M
-1
s
-1
) (1.2 ± 0.1) x 10
6
 (0.4 ± 0.1) x 10
6
 
K1 (nM) 0.5 ± 0.1  1.4 ± 0.1  
K5 (nM) 6 ± 1  30 ± 10  
 
The rates of nucleotide association were measured at varying concentrations of 
mant-GTP or mant-GDP using a constant concentration of nucleotide-free EF-Tu (Figure 
3.7). The respective apparent rate constants (kapp) at different nucleotide concentrations 
were determined from the fluorescence time courses by fitting with a single-exponential 
function (Eq. 3.1). The linear dependence of kapp on the concentration of 
mant-GTP/mant-GDP (Figure 3.7) was used to determine the respective association rate 
constants (k1 and k5 for GDP and GTP, respectively). Values were determined for 
EF-TuE.c. (k1 = (1.3 ± 0.1) x 10
6 
M
-1
s
-
1, k5 = (0.4 ± 0.1) x 10
6 
M
-1
s
-1
) and EF-TuP.a. 
(k1 = (1.5 ± 0.1) x 10
6 
M
-1
s
-
1, k5 = (1.2 ± 0.1) x 10
6
 M
-1
s
-1
) (summarized in Table 3.1). 
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These results indicate a 2-fold increase in the rate of mant-GTP association observed for 
EF-TuP.a., but no difference was observed between the mant-GDP association rate 
constants for EF-TuP.a. and EF-TuE.c..  
 
 
Figure 3.7. Association of mant-GDP and mant-GTP to EF-Tu. The concentration dependence of the 
respective apparent rate constants are plotted against increasing concentrations of (A) mant-GDP or (B) 
mant-GTP. (A) mant-GDP association to EF-TuE.c. (0.3 μM) is shown as filled circles or to EF-TuP.a. 
(0.5 μM) is shown as open circles. (B) mant-GTP association to EF-TuE.c. (0.3 μM) is shown as filled 
squares or to EF-TuP.a. (0.5 μM) shown as open squares. 
 
Based on the above rate constants, the equilibrium dissociation constants (KD) can be 
calculated from k-1/k1 and k-5/k5 (summarized in Table 3.1) revealing a 5-fold (GTP) and a 
3-fold (GDP) higher affinity of EF-TuP.a. (KD(GTPTuP.a.) = 6 ± 1 nM, 
KD(GDPTuP.a.) = 0.5 ± 0.1 nM) for the respective nucleotides when compared to EF-TuE.c. 
(KD(GTPTuE.c.) = 30 ± 10 nM, KD(GDPTuE.c.) = 1.4 ± 0.1 nM).  
 
3.3b Interaction of EF-Tu with EF-Ts in the presence of GTP  
E. coli EF-Tu has a 10-fold higher affinity for GDP than for GTP (45). Although the 
concentration of GTP in the cell is 10-fold higher than that of GDP (48), GDP 
dissociation from EF-Tu is too slow (within minutes) to maintain the rates of protein 
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synthesis observed in vivo. EF-Ts stimulates the low intrinsic rate of guanine nucleotide 
dissociation from the EF-Tu•nucleotide complex by at least 5000-fold (45). The 
interaction of EF-Tu•GDP or EF-Tu•GTP with EF-Ts can be described by two 
consecutive steps (k3,k-3,k4,k-4 or k6,k-6,k7,k-7 in Figure 3.5). These two coupled equilibria 
represent the formation of the EF-Tu•nucleotide•EF-Ts ternary complex, followed by the 
release of the bound nucleotide (GDP or GTP). 
To study the EF-Ts-catalyzed dissociation of GTP from EF-Tu•GTP, experiments were 
carried out with mant-GTP (Materials and Methods). Upon mixing pre-formed 
EF-Tu•mant-GTP complex with EF-Ts, mant-GTP dissociates with an observed single-
exponential behavior. At low concentrations of EF-Ts, kapp increased linearly, indicating 
the formation of the ternary complex (EF-Tu•mant-GTP•EF-Ts). At high concentrations 
of EF-Ts, the rate of the reaction reaches saturation and equals the rate constant for GTP 
dissociation from the ternary complex, k-7 (Figure 3.8a). In order to assess the 
interchangeability of GEF EF-Ts from E. coli and P. aeruginosa, the experiment was 
performed with EF-TuE.c.•mant-GTP in the presence of EF-TsE.c. or EF-TsP.a. as well as 
with EF-TuP.a.•mant-GTP in the presence of EF-TsE.c. or EF-TsP.a. Analysis of the data 
gives values for k-7(TuE.c.•mantGTP•TsE.c.) = 125 ± 20 s
-1
; k-7(TuE.c.•mantGTP•TsP.a.) = 280 ± 90 s
-1
; 
k-7(TuP.a.•mantGTP•TsE.c.) = 5 ± 1 s
-1
; k-7(TuP.a.•mantGTP•TsP.a.) = 40 ± 2s
-1 
(summarized in Table 
3.2). It should be noted that at high concentrations of EF-TsP.a. (>4 M), dissociation of 
mant-GTP from EF-TuE.c. was two-exponential. Not surprisingly, mant-GTP dissociation 
from EF-TuP.a. was efficiently catalyzed 5000-fold by EF-TsP.a., similar to the E. coli 
system. Dissociation of mant-GTP from EF-TuP.a. is only catalyzed 500-fold by EF-TsE.c.. 
Interestingly, mant-GTP dissociation from EF-TuE.c. is increased by 5000-fold with 
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EF-TsE.c. and 10 000-fold with EF-TsP.a.. This indicates that EF-TsP.a. is able to stimulate 
GTP dissociation to a greater extent than EF-TsE.c. with either EF-Tu present.  
 
Figure 3.8. Interaction of EF-Tu with GTP and EF-Ts. (A) Concentration dependence of the rate of 
nucleotide dissociation (kapp) as a function of increasing EF-Ts concentrations. EF-TuE.c.•mant-GTP 
dissociated by EF-TsE.c., shown as filled circles. EF-TuE.c.•mant-GTP dissociated by increasing EF-TsP.a. is 
shown as open circles. EF-TuP.a.•mant-GTP dissociated by EF-TsP.a. shown as filled squares. 
EF-TuP.a.•mant-GTP dissociated by increasing EF-TsE.c. is shown as open squares. (B) Concentration 
dependence of the rate of EF-TuE.c.•TsP.a. (0.5 μM)  dissociation (kapp) calculated by single-exponential 
fitting from time courses of EF-TuE.c.•TsP.a. (0.5 μM) against increasing GTP concentrations (0 – 1000 μM). 
 
When stimulating EF-TuGTP dissociation at low concentrations of EF-Ts, the initial 
slope of the titration curve is equal to k6/(1 + k-6/k-7) (Eq. 3.4) allowing for the calculation 
of k6 when k-6 is known. In order to determine k-6, GTP was titrated against a fixed 
concentration of the purified EF-Tu•EF-Ts complex. The change in the intrinsic 
tryptophan fluorescence of EF-Tu reflects the dissociation of EF-Ts from the transiently 
formed EF-TuGTPEF-Ts complex. The rates of EF-Ts dissociation were determined 
from the time courses using single-exponential fits and plotted as a function of increasing 
GTP concentration (Figure 3.8b). At saturating concentrations of GTP, where rebinding 
of EF-Ts is negligible and EF-Ts dissociation is not limited by GTP binding, the value of 
k-6 is estimated to be 24 ± 5 s
-1
 for the EF-TuE.c.•EF-TsP.a. complex (Table 3.3). This is 
slower than the previously reported rate for the EF-TuE.c.•EF-TsE.c. complex (60 s
-1
 (45)). 
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The initial slope of the curve is equal to k7/(1 + k-7/k-6) (Eq. 3.2), giving a value for GTP 
association to the EF-TuEF-Ts complex, k7 equal to approximately 5 x 10
5 
M
-1
s
-1
 for the 
EF-TuE.c.•EF-TsP.a. complex which is 10-fold less than the EF-TuE.c.•EF-TsE.c. complex 
(6 x 10
6 
M
-1
s
-1
 (45)) (Table 3.3). The association rate constant for EF-Ts binding to 
EF-TuGTP (k6) is determined to be approximately 1.2 x 10
7 
M
-1
s
-1
 for the 
EF-TuE.c.•EF-TsP.a. complex, which is 3-fold less than the EF-TuE.c.•EF-TsE.c. complex 
(3 x 10
7 
M
-1
s
-1
 (45)) (Table 3.3). Therefore, the determined constant for EF-Ts interacting 
with the EF-TuGTP complex (K6) are comparable whether EF-TsE.c. or EF-TsP.a. is 
present. However, the constant describing the interaction of GTP with the EF-TuEF-Ts 
complex (K7) is significantly higher (more than 10-fold) in the presence of EF-TsP.a..  
Due to the location of the tryptophan residue within EF-TuP.a., no change in the 
tryptophan signal in EF-TuP.a. was observed for EF-TuEF-Ts induced dissociation upon 
GTP binding. Therefore, k-6, k6 and k7 could not be determined for the EF-TuP.a.•EF-TsP.a. 
or the EF-TuP.a.•EF-TsE.c. complex.  
 
3.3c Interaction of EF-Tu with EF-Ts in the presence of GDP  
The interactions of EF-Tu, EF-Ts, and GDP were studied in the same way as described 
above for GTP (Section 3.3b). Dissociation of GDP from EF-Tu in the presence of EF-Ts 
was monitored by the fluorescence of mant-GDP. Titrations were performed at constant 
concentrations of EF-Tu•mant-GDP and increasing concentrations of EF-Ts in the 
presence of excess unlabelled nucleotide (Figure 3.9a). k-4 was determined at saturating 
conditions of EF-Ts. Rates are summarized in Table 3.2; 
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(k-4(TuE.c.•mant-GDP•TsE.c.) = 220 ± 20 s
-1
; k-4(TuE.c.•mant-GDP•TsP.a.) = 450 ± 60 s
-1
; 
k-4(TuP.a.•mant-GDP•TsE.c.) = 10 ± 1 s
-1
; k-4(TuP.a.•mant-GDP•TsP.a.) = 40 ± 10 s
-1
. It should be noted 
that at high concentrations of EF-Tu (>4 M), dissociation of mant-GDP was two-
exponential. This indicates that similar to the GTP case, EF-TsP.a. stimulates the rate of 
GDP dissociation from EF-TuE.c. 2-fold faster than EF-TsE.c.. EF-TsP.a. enhances the rate 
of GDP dissociation from EF-TuP.a. by more than 50 000-fold. However, EF-TsE.c. is not 
able to stimulate the rate of GDP dissociation from EF-TuP.a. to a similar extent 
(approximately 15 000-fold). Therefore, EF-TsP.a. stimulates GDP dissociation from 
either EF-Tu more efficiently than EF-TsE.c..  
Similar to the GTP case, when stimulating dissociation of the EF-TuGDP complex by 
low concentrations of EF-Ts, the initial slope of the titration curve is equal to 
k3/(1 + k-3/k-4) (Eq. 3.5). In order to determine the EF-Ts association rate constant to the 
EF-TuGDP complex (k3) the stimulated GDP dissociation from EF-Tu by EF-Ts (k-4) 
and the dissociation of EF-Ts from the ternary complex, k-3 were determined. To 
determine k-3, GDP was titrated against a fixed concentration of the purified 
EF-Tu•EF-Ts complex and the change in the intrinsic tryptophan fluorescence of EF-Tu 
reporting the dissociation of EF-Ts was monitored. The rates of EF-Ts dissociation were 
determined from the resulting time courses by fitting with a single-exponential equation 
and subsequent analysis of the GDP concentration dependence of the respective apparent 
rates (Figure 3.9b). As determined at saturating concentrations of GDP, the value of k-3 is 
approximately 150 s
-1
 for the EF-TuE.c.•EF-TsP.a. complex (Table 3.3). This value is lower 
than the previously reported rate for the EF-TuE.c.•EF-TsE.c. complex (350 s
-1
 (45)). The 
initial slope of the curve is equal to k4/(1 + k-4/k-3) (Eq. 3.3), giving a value of k4 equal to 
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approximately 5 x 10
6 
M
-1
s
-1
 for the EF-TuE.c.•EF-TsP.a. complex which is one half that of 
the EF-TuE.c.•EF-TsE.c. complex (1.4 x 10
7 
M
-1
s
-1
 (45)) (Table 3.3). For the 
EF-TuE.c.•EF-TsP.a. complex, k3 is approximately 2 x 10
7
 M
-1
s
-1 
which is 3-fold less than 
for the EF-TuE.c.•EF-TsE.c. complex (6 x 10
7 
M
-1
s
-1
 (45)) (Table 3.3). These results give K3 
values which are similar whether EF-TsE.c. or EF-TsP.a. is present. However, K4 in the 
presence of EF-TsP.a. is higher than that with EF-TsE.c..  
Again, the location of the tryptophan residue within EF-TuP.a. did not allow for a 
detectable change in the tryptophan signal for EF-TuP.a. upon GDP induced dissociation 
of the EF-TuEF-Ts complex. Therefore, k-3, k3 and k4 could not be determined for the 
EF-TuP.a.•EF-TsP.a. or the EF-TuE.c.•EF-TsE.c. complex. 
 
Figure 3.9. Interaction of EF-Tu with GDP and EF-Ts. (A) Concentration dependence of the rate of 
nucleotide dissociation (kapp) as a function of increasing EF-Ts concentrations. EF-TuE.c.•mant-GDP 
dissociated by increasing EF-TsE.c. is shown as filled circles, while EF-TsP.a. is shown as open circles. 
EF-TuP.a.•mant-GDP dissociated by increasing EF-TsP.a. is shown as filled squares, while EF-TsE.c. is shown 
as open squares. (B) Concentration dependence of the rate of EF-TuE.c.•TsP.a. dissociation (kapp) as a 
function of increasing GDP concentrations (0 – 200 μM). 
 
3.3d Interaction of EF-Tu with EF-Ts (k2, k-2) 
The formation of the EF-Tu•EF-Ts complex was monitored through the change of the 
intrinsic tryptophan fluorescence of EF-TuE.c. upon EF-Ts binding, where a fluorescence 
96 
 
decrease is indicative of EF-Ts binding. Increasing concentrations of EF-Ts were used to 
determine the association constant (k2) from the linear dependence of kapp on the 
respective EF-Ts concentration (Figure 3.10). The value for k2 determined here between 
EF-TuE.c. and EF-TsE.c. is approximately 1.9 x 10
7
 M
-1
s
-1
, which is in agreement with 
previously published data (45). The value for k2 between EF-TuE.c. and EF-TsP.a. is 
approximately (0.5 ± 0.1) x 10
7
 M
-1
s
-1
, which is about a quarter of EF-TsE.c. 
(1.9 ± 0.5) x 10
7
 M
-1
s
-1
.  
The dissociation of the EF-Tu•EF-Ts complex is extremely slow and gives a poor signal 
such that this cannot be measured directly, however, it can be calculated from the other 
rate constants (Eq. 3.6 and 3.7). k-2 for EF-TuE.c.•EF-TsE.c. and EF-TuE.c.•EF-TsP.a. is equal 
to approximately 0.05 s
-1
 and 0.0006 s
-1
 respectively (Table 3.3). This results in K2 for 
EF-TuE.c.EF-TsP.a. (0.1 nM) which is 30-fold lower than that of EF-TuE.c.•EF-TsE.c. 
(3 nM).  
 
Figure 3.10. Interaction of EF-Tu with EF-Ts (k2). Dependence of kapp on increasing concentrations of 
EF-Ts. The values of kapp were calculated by single-exponential fitting of the respective time courses. 
EF-TuE.c. in the presence of increasing EF-TsE.c. is shown as filled circles, while EF-TuE.c. in the presence of 
increasing EF-TsP.a. is shown as filled squares. 
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Table 3.2. EF-Ts Induced Dissociation of GDP and GTP from EF-Tu.  
 GDP GTP 
 k-4 (s
-1
) k-7 (s
-1
) 
EF-TuP.a. vs. EF-TsP.a.   40 ± 10   40 ± 2 
EF-TuE.c. vs. EF-TsE.c. 220 ± 20 125 ± 20 
EF-TuP.a. vs. EF-TsE.c.   10 ± 1     5 ± 1 
EF-TuE.c. vs. EF-TsP.a. 450 ± 60 280 ± 90 
 
Table 3.3. Determined Rate Constants for the Kinetic Mechanism of Nucleotide 
Exchange in EF-TuE.c.. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Data previously published (45) 
Constant  EF-TuE.c. vs. EF-TsE.c. EF-TuE.c. vs. EF-TsP.a. 
k-2 (s
-1
) 
Dissociation of 
Ts from TuTs 
0.05 0.0006 
k2(M
-1
s
-1
) 
Association of 
Ts to Tu 
1.9 ± 0.5 x 10
7
 5 ± 1 x 10
6
 
k-3 (s
-1
) 
Dissociation of 
Ts from 
TuGDPTs 
350 * 150 ± 14 
k3(M
-1
s
-1
) 
Association of 
Ts to TuGDP 
6 x 10
7*
 2 ± 1 x 10
7
 
k-4 (s
-1
) 
Dissociation of 
GDP from 
TuGDPTs 
220 ± 20 450 ± 60 
k4(M
-1
s
-1
) 
Association of 
GDP to TuTs 
1.4 x 10
7*
 5 ± 3 x 10
6
 
k-6 (s
-1
) 
Dissociation of 
Ts from 
TuGTPTs 
60* 24 ± 5 
k6(M
-1
s
-1
) 
Association of 
Ts to TuGTP 
3 ± 1 x 10
7*
 1.2 ± 0.1 x 10
7
 
k-7 (s
-1
) 
Dissociation of 
GTP from 
TuGTPTs 
125 ± 20 280 ± 90 
k7(M
-1
s
-1
) 
Association of 
GTP to TuTs 
6 ± 1 x 10
6*
 5 ± 2 x 10
5
 
K2 (M)  3 x 10
-3
 1 x 10
-4
 
K3 (M)  6 8 
K4 (M)  30 170 
K6 (M)  2 2 
K7 (M)  20 550 
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3.3e Interaction of EF-Tu with EF-Ts Variants  
It was surprising that EF-TsP.a. is able to catalyze the dissociation of guanine nucleotides 
from EF-TuE.c. more efficiently than EF-TsE.c.. The primary sequence of EF-Ts from 
E. coli and P. aeruginosa share 55% identity and 69% similarity. The residues involved 
in the interaction surface between EF-Tu and EF-Ts are highly conserved between the 
species and the only variation in the interaction surface between EF-Tu and EF-Ts is in 
the C-terminal module (helix 13) of EF-Ts, pointing at a putative role of this helix in 
modulating nucleotide dissociation from the EF-TunucleotideEF-Ts complex.  
The difference in sequence is subtle and includes a two amino acid extension of helix 13 
(Appendix Figure A.6). The increased helix length and the variation in the sequence of 
the helix might enable additional interactions between domain I of EF-Tu and helix 13 of 
EF-TsP.a. that are not possible with the shorter EF-TsE.c.. These interactions could either 
stabilize the EF-Tu•EF-Ts interaction or stimulate guanine nucleotide dissociation from 
EF-Tu to a larger extent. In order to further dissect the role of helix 13 for the nucleotide 
exchange mechanism in EF-Tu, a C-terminal truncation variant of EF-TsP.a. as well as a 
C-terminal chimera replacing the last 6 amino acids in EF-TsE.c. with the C-terminal end 
of EF-TsP.a. (Figure 3.11) was constructed. 
Met 278 of EF-TsE.c. is located in helix 13 and makes hydrophobic contacts with residues 
in the guanine nucleotide binding pocket, Ala 29 and Thr 25 in EF-TuE.c. (47). Met 278 in 
E. coli EF-Ts is substituted with a glutamine in EF-TsP.a. (Q283), a residue of similar 
length but different chemical properties. To analyze whether this position influences the 
interaction made between the C-terminal module and domain I of EF-Tu, a substitution in 
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EF-TsP.a. replacing the Gln sidechain at position 283 with Met (Figure 3.11) was 
constructed.  
 
 
Figure 3.11. EF-Ts variants constructed. Domain alignment of EF-TsE.c., (N-terminal domain shown in 
orange, core domain in yellow and the C-terminal domain shown in black) with EF-TsP.a. (N-terminal 
domain shown in red, core domain in green and the C-terminal domain in blue). Residue numbers for each 
domain are shown below the respective domains. The end of the C-terminal module sequence is shown on 
the right and the name of each EF-Ts represented is shown on the left. The substitution of Q283M is shown 
in the sequence (EF-TsP.a.Q283M), highlighted in black. Residues corresponding to EF-TsP.a. are denoted in 
blue, and residues corresponding to EF-TsE.c. are denoted in black.  
 
The kinetic parameters describing interactions of EF-Tu, EF-Ts, and GDP as well as GTP 
were studied in a similar manner as described above. Dissociation of mant-GDP and 
mant-GTP from EF-Tu was observed at increasing concentrations of EF-Ts (Figure 3.12). 
At saturating concentrations of EF-Ts, k-4 and k-7 were determined. k-4 and k-7 for the 
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EF-TuE.c. and the EF-TsP.a. C-terminal truncation variant (EF-TsP.a.C.T.) is approximately 
10-fold slower (k-4(TuE.c.mant-GDPTsP.a.C.T.) = 30 ± 3 s
-1 
and 
k-7(TuE.c.mant-GTPTsP.a.C.T). = 6 ± 1
 
s
-1
) than for wild type EF-TsP.a. (Table 3.4). Similarly, 
stimulated dissociation of mant-GDP (k-4) and mant-GTP (k-7) from EF-TuP.a. in the 
presence of EF-TsP.a.C.T. is approximately 10-fold slower 
(k-4(TuP.a.mant-GDPTsP.a.C.T.) = 3 ± 1 s
-1 
and
 
k-7(TuP.a.mant-GTPTsP.a.C.T.) = 0.9 ± 0.1 s
-1
) than for 
wild type EF-TsP.a.. This indicates that the truncation of helix 13 in EF-TsP.a. affects 
nucleotide dissociation from either EF-TuE.c. and EF-TuP.a. to a similar extent, whether 
mant-GDP or mant-GTP is present. 
Substitution of Gln 283 with Met in EF-TsP.a. (EF-TsP.a.Q283M) yielded k-4 and k-7 values 
for EF-TuP.a. (k-4(TuP.a.mant-GDPTsP.a.Q283M) >50 s
-1 
and 
k-7(TuP.a.mant-GTPTsP.a.Q283M) = 190 ± 50 s
-1
) and EF-TuE.c. 
(k-4(TuE.c.mant-GDPTsP.a.Q283M) = 1000 ± 500 s
-1
 and 
k-7(TuE.c.mant-GTPTsP.a.Q283M) = 400 ± 100 s
-1
) (Table 3.4). The values obtained with 
EF-TuE.c. are similar to results with EF-TsP.a. (k-4(TuE.c.mant-GDPTsP.a.) = 450 ± 60 s
-1
 and 
k-7(TuE.c.mant-GTPTsP.a.) = 280 ± 90 s
-1
), indicating that substitution of Gln 283 does not 
significantly affect the ability of EF-TsP.a. to catalyze mant-GDP or mant-GTP 
dissociation from EF-TuE.c.. However, results obtained show an increased rate of 
mant-GDP and mant-GTP dissociation from EF-TuP.a. compared with wild type EF-TsP.a. 
(k-4(TuP.a.mant-GDPTsP.a.) = 40 ± 10 s
-1
 and k-7(TuP.a.mant-GTPTsP.a.) = 40 ± 2 s
-1
).  
The value obtained here for dissociation of GTP from EF-TuE.c. (k-7) catalyzed by the 
EF-TsE.c. chimera is equal to 120 ± 20 s
-1 
(Table 3.4) which is similar to EF-TsE.c.. The 
value for k-4 obtained for EF-TuE.c. with this chimera is 380 ± 80 s
-1 
(Table 3.4), which is 
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similar to EF-TsP.a.. The EF-TsE.c. chimera also seems to saturate at a lower concentration 
of EF-Ts and follows the trend of EF-TsP.a. despite the fact that 98% of this protein is 
identical to EF-TsE.c. (Figure 3.12). The EF-TsE.c. chimera is able to catalyze the rate of 
mant-GTP dissociation and mant-GDP dissociation from EF-TuP.a. (k-7 and k-4) more like 
EF-TsP.a. than EF-TsE.c. (Figure 3.12), giving values for k-7 of 25 ± 2 s
-1
 and k-4 of >40 s
-1
 
(Table 3.4).  
 
 
Figure 3.12. Catalyzed dissociation of guanine nucleotides from EF-Tu with EF-Ts variants. (A) 
Concentration dependence of kapp of EF-TuE.c.mant-GTP dissociated by increasing concentrations of 
EF-TsE.c. (filled circles), EF-TsP.a. (open circles), EF-TsP.a.C.T. (downward triangles), EF-TsP.a.Q283M 
(upwards triangles) and EF-TsE.c. chimera (diamonds). (B) Concentration dependence of kapp of 
EF-TuP.a.mant-GTP dissociated by increasing concentrations of EF-TsE.c. (open squares), EF-TsP.a. (filled 
squares), EF-TsP.a.C.T. (downward triangles), EF-TsP.a.Q283M (upwards triangles) and EF-TsE.c. chimera 
(diamonds). (C) Concentration dependence of kapp of EF-TuE.c.mant-GDP dissociated by increasing 
concentrations of EF-Ts, as in A. (D) Concentration dependence of kapp of EF-TuP.a.mant-GDP dissociated 
by increasing concentrations of EF-Ts, as in B. 
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Table 3.4 Determined Rate Constants for the Interaction between EF-Tu, EF-Ts 
Variants and Guanine Nucleotides 
 GDP GTP 
 k-4 (s
-1
) k-7 (s
-1
) 
EF-TuP.a.vs. EF-TsP.a. C.T..       3 ± 1  0.9 ± 0.1 
EF-TuE.c vs.EF-TsP.a. C.T..     30 ± 3     6 ± 1 
EF-TuP.a. vs. EF-TsP.a.Q283M   >50 190 ± 50 
EF-TuE.c. vs. EF-TsP.a. Q283M 1000 ± 500 400 ± 100 
EF-TuP.a. vs. EF-TsE.c. Chimera   >40   25 ± 2 
EF-TuE.c. vs. EF-TsE.c. Chimera   380 ± 80 120 ± 20 
EF-TuP.a. vs. EF-TsP.a.     40 ± 10   40 ± 2 
EF-TuE.c. vs. EF-TsE.c.   220 ± 20 125 ± 20 
EF-TuP.a. vs. EF-TsE.c.     10 ± 1     5 ± 1 
EF-TuE.c. vs. EF-TsP.a.   450 ± 60 280 ± 90 
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3.4 Discussion 
3.4a Guanine Nucleotide Exchange in E. coli and P. aeruginosa EF-Tu. 
The complete kinetic mechanism for the nucleotide exchange reaction in the human 
opportunistic pathogen P. aeruginosa has been determined and compared to the 
nucleotide exchange mechanism of E. coli to gain a better understanding of the 
evolutionary conservation of the kinetic parameters governing this central process during 
protein synthesis. The kinetic scheme describing the interaction of EF-Tu, EF-Ts and 
guanine nucleotides is shown in Figure 3.5. When comparing the obtained GTP and GDP 
dissociation rate constants it is observed that these are very similar between the two 
species of EF-Tu. However, a slight decrease in the rate of GTP dissociation from 
EF-TuP.a. and a 2-fold increase in the rate of GTP association for EF-TuP.a. when 
compared to EF-TuE.c. gives rise to a 10-fold increase in the affinity of EF-TuP.a. for GTP. 
This was surprising, given that the GDP binding properties are comparable between the 
two species and there is a high level of sequence conservation of both factors (84% 
identity and 90% similarity (Appendix Figure A.7)). The amino acid residues that are 
directly involved in binding to GTP are 100% conserved in identity between E. coli and 
P. aeruginosa EF-Tu. This then suggests that there is an altered contribution from other 
non-conserved residues towards the overall dynamics in the GTP-bound form of EF-Tu 
between organisms.  
Stimulation of guanine nucleotide dissociation from EF-TuP.a. is most efficient in the 
presence of EF-TsP.a. than EF-TsE.c.. Given that EF-TuP.a. has a slightly slower intrinsic 
guanine nucleotide dissociation rate than EF-TuE.c., EF-TsP.a. may have evolved 
additional structural features that increase its ability to stimulate the rate of guanine 
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nucleotide dissociation from EF-TuP.a. more than EF-TsE.c., thus overcoming the tighter 
binding of the respective nucleotide. It has been shown that mutations made in the 
nucleotide binding pocket of EF-Tu can accelerate the rate of GDP dissociation and can 
eliminate the need for EF-Ts (118). This is consistent with the kinetic constants 
determined here. The equilibrium binding constants for the interaction of EF-Ts with the 
respective nucleotide-bound complex of EF-TuE.c. (K3 and K6) are virtually identical 
whether P. aeruginosa or E. coli EF-Ts is present (Table 3.3). However, the interaction 
of guanine nucleotides with the EF-TuEF-Ts complex (K4 and K7) differ significantly 
depending on the identity of EF-Ts present. A closer investigation of the rate constants 
for these steps reveal that EF-TsP.a. can stimulate GTP and GDP dissociation from 
EF-TuE.c. 2-fold more efficiently than EF-TsE.c. regardless of the guanine nucleotide 
present. Interestingly, there was a second-phase observed in the dissociation of GDP/GTP 
from EF-TuE.c. in the presence of high EF-TsP.a. concentrations. Although this phase was 
not observed for lower concentrations of EF-TsP.a., the rate of the second phase did not 
dependent on the concentration of EF-TsP.a.. This is indicative of a further conformational 
change within EF-TuE.c. upon interaction with EF-TsP.a. in the presence of guanine 
nucleotides. Given that EF-TsP.a. has a C-terminal extension, it is likely that this 
extension interacts with or close to Trp 184 on helix F of EF-TuE.c. which excites 
mant-GDP/GTP through FRET (Figure 3.13).  
The values for GDP or GTP association to the TuTs complex (k4 and k7) determined for 
EF-TuE.c. in complex with EF-TsP.a. are significantly lower than with EF-TsE.c., suggesting 
that EF-TsP.a. has evolved the ability to further destabilize nucleotide binding in the 
ternary (EF-Tu•nucleotide•EF-Ts) complex. A sequence analysis between E. coli and 
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P. aeruginosa EF-Ts showed that they exhibit only 55% identity in sequence compared to 
84% identity between the respective EF-Tu proteins. Even though there are a large 
number of residues with low conservation in EF-Ts (Appendix Figure A.6), there are 
only a few differences in the amino acid residues participating in interactions with EF-Tu. 
Given the higher sequence variability observed in EF-Tss primary sequence compared to 
EF-Tu, the observed differences in the kinetic mechanism of nucleotide exchange 
between the two species likely arises mostly from structural differences in EF-Ts and not 
EF-Tu.  
 
3.4b Variation in the C-terminal module of EF-Ts  
The most prominent sequence variability in the contacts made between the EF-Tu•EF-Ts 
interaction is between domain I (G-domain) of EF-Tu and the C-terminal module (helix 
13) in EF-Ts. Helix 13 of EF-Ts is highly variable among bacteria in terms of length and 
sequence conservation (Appendix Figure A.6). EF-TsP.a. has a two amino acid extension 
compared to EF-TsE.c. and shows no sequence conservation in the last 7 amino acids. 
Previous work has revealed that deletion of helix 13 in E. coli EF-Ts decreases the 
EF-Tu•EF-Ts binding affinity by 2-fold (119). However, the kinetic effect of this deletion 
in terms of the ability of EF-Ts to act as a GEF was not analyzed. Given that EF-Ts in 
E. coli and P. aeruginosa both contain a C-terminal module but exhibit different rates of 
nucleotide dissociation, the length is likely important for the function of EF-Ts for 
catalysis. The C-terminal domain in EF-TsP.a. was truncated by only 6 amino acids to see 
if the length of this variable extension in the C-terminal module is important for EF-TsP.a. 
to catalyze the rate of facilitated guanine nucleotide dissociation. Interestingly, 
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independent of the nucleotide (mant-GTP or mant-GDP) bound to EF-Tu, the ability of 
EF-TsP.a.C.T. to catalyze dissociation of guanine nucleotides is reduced by an order of 
magnitude but is still 100-fold higher than the uncatalyzed dissociation of nucleotide. 
This effect of the EF-TsP.a.C.T. variant is observed in both EF-Tu from E. coli and 
P. aeruginosa. Therefore, even though the C-terminal module may not be essential for 
the function of EF-Ts, it is still important for fine-tuning the maximal rate of EF-Ts 
catalyzed dissociation of guanine nucleotides from EF-Tu.  
EF-TsE.c. has a shorter C-terminal module than EF-TsP.a. and it is therefore unknown how 
the additional C-terminal residues if EF-TsP.a. fold (47). However, it can be hypothesized 
that helix 13 in EF-TsP.a. protrudes further into domain I of EF-Tu than helix 13 from 
EF-TsE.c. forming additional interactions that are responsible for facilitating the 
acceleration of guanine nucleotide dissociation. This hypothesis is strongly supported by 
the results obtained with the EF-TsE.c. chimera, which is able to stimulate the dissociation 
of guanine nucleotides from EF-TuP.a. to a similar extent as wild type EF-TsP.a., even 
though 98% of this protein is identical to EF-TsE.c.. Based on the E. coli EF-TuEF-Ts 
X-ray crystal structure (47), the C-terminal module of EF-TsP.a. could contact helix A of 
EF-Tu, just before the switch I region, and/or make contacts with helix F in EF-Tu 
(Figure 3.12). These regions have low sequence conservation between EF-TuE.c. and 
EF-TuP.a. and may contribute to the interaction between the C-terminal extension of 
EF-TsP.a. and EF-Tu. Although these regions within EF-Tu have not been shown to be 
involved in coordinating the guanine nucleotide in the binding pocket, their flexibility is 
likely important for the structure of the G-domain as a whole and its ability to interact 
with guanine nucleotides.  
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Interestingly, this EF-TsE.c. chimera is able to stimulate the rate of GTP dissociation from 
EF-TuE.c. like wild type EF-TsE.c., however, GDP dissociation from EF-TuE.c. is more 
similar to wild type EF-TsP.a.. This indicates that the core of EF-Ts can work 
synergistically with the C-terminal module in catalyzing the dissociation of guanine 
nucleotides from EF-Tu. Furthermore, the interaction made between the C-terminal 
module and helices F and/or A in EF-Tu may influence the ability of EF-Ts to catalyze 
GTP or GDP dissociation from EF-Tu. Even though the majority of the residues that 
contact EF-Tu are conserved in EF-Ts, the primary sequence of EF-Ts is poorly 
conserved. The variability in the rest of EF-Ts could result in differences in the overall 
dynamics of EF-Ts. The highly conserved Phe 81 in subdomain N of EF-TsE.c. has been 
shown to intrude into helix B and C of EF-Tu (47), which leads to the disruption of the 
magnesium binding site in domain 1 of EF-Tu. The region following this conserved motif 
is highly variable in sequence (Figure 3.12) and may be one of the variable regions within 
EF-Ts that influences the dynamic movement of essential regions within EF-Ts that 
contact EF-Tu.  
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Figure 3.13. Variance in EF-Tu•EF-Ts contacts. EF-Tu (left) bound to EF-Ts (right) from E. coli (PDB 
ID 1EFU (47)) is represented in cartoon and coloured in black. Variable residues between E. coli and 
P. aeruginosa in helix A and F in EF-Tu are highlighted in red. Variable residues between E. coli and 
P. aeruginosa in the C-terminal extension in EF-Ts are highlighted in green. Phe 81 in EF-Ts is represented 
in licorice (coloured green) and residues following this that are variable between E. coli and P. aeruginosa 
are highlighted with a green circle. 
 
Given that EF-Tu has other interaction partners besides EF-Ts, mainly aa-tRNA and the 
ribosome, it is not feasible for this protein to substitute amino acids as this may interfere 
with essential contacts needed for the function of EF-Tu. Since EF-Ts does not have as 
many interaction partners as EF-Tu, it is likely that EF-Ts has evolved within each 
organism to fine-tune the rates of nucleotide exchange. The general strategy of GEFs is to 
destabilize the positive charges within the G-domain of the protein with that of the 
nucleotide phosphates. EF-TsE.c. contacts domain I of EF-Tu with its N-terminal domain, 
subdomain N and the C-terminal module (47). It has been previously shown that the 
N-terminal domain of EF-Ts is important for complex formation and catalysis of GDP 
dissociation from EF-Tu (103,119). Furthermore, EF-Ts in mitochondria as well as 
eEF1B do not contain a C-terminal module (107,110). However, the affinity between 
guanine nucleotides and mitochondrial EF-Tu and yeast eEF1A is an order of magnitude 
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less than bacterial EF-Tu (104). Furthermore, the spontaneous rate of GDP dissociation 
from eEF1A is 100-fold faster than from bacterial EF-Tu. These findings indicate that 
when EF-Tu has evolved to have a strong interaction with guanine nucleotides, an 
exchange factor develops strategies to overcome this tight binding and for EF-Ts may be 
in the evolution or divergence of the C-terminal module.  
Met 278 of EF-TsE.c. has previously been shown to make hydrophobic interactions with 
Ala 29 and Thr 25 in domain I of EF-Tu (47). Thr 25 has been shown to assist in 
coordinating Mg
2+
 within the G-domain of EF-Tu (44). The interaction between Met 278 
of EF-TsE.c. with Thr 25 of EF-TuE.c. may help disrupt the magnesium binding site in 
domain I of EF-Tu. Interestingly, only 12% of the 34 bacterial species aligned here that 
contain a C-terminal module, have a methionine in this position and 50% contain a 
glutamine (Appendix Figure A.6). Analysis of the substitution variant Gln 283 to Met in 
EF-TsP.a. gave similar rates of catalyzed guanine nucleotide dissociation from EF-TuE.c. 
as that of wild type EF-TsP.a.. However, this variant is able to catalyze the rate of guanine 
nucleotide dissociation from EF-TuP.a. more efficiently than wild type EF-TsP.a.. This 
suggests that position 283 is not critical for nucleotide exchange in EF-TuE.c. but has an 
impact in EF-TuP.a., supporting the idea that the core of EF-Ts works synergistically with 
the C-terminal module. In the E. coli system, EF-Ts has evolved in such a way that the 
core of EF-Ts mainly contributes to its ability to act as a GEF and the length of the 
C-terminal module is more important than the sequence. However, in the P. aeruginosa 
system the C-terminal module has evolved to have a stronger influence on the ability of 
EF-Ts to act as a GEF. This may be due to the variability in helices A and F of EF-Tu, 
which may have allowed for evolutionary changes within the C-terminal module of 
110 
 
EF-Ts. This reveals a molecular mechanism that can be used by some species to further 
maximize nucleotide dissociation rates and that the stimulation of guanine nucleotide 
dissociation from EF-Tu can be altered by the C-terminal module.  
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3.5 Future Directions 
P. aeruginosa is a gram-negative bacteria that can be found in water all over the world. It 
is not often found to infect healthy humans (120), however, it is a major cause of 
nosocomial infection in hospitals and in particular in patients with cystic fibrosis (121) 
and is becoming a major threat to public health. Infection can spread by patient-to-patient 
contacts or from a contaminated environment. Even though measures have been taken 
over the past few years to limit the spread of this pathogen in hospitals, such as 
separating infected patients from non-infected and decontaminate environments 
surrounding patients, the number of cystic fibrosis patients infected with this pathogen 
has not decreased (120).  
Most drugs that are currently in use either target the synthesis of the cell wall, protein 
synthesis or DNA replication and repair (122). However, prevalence of P. aeruginosa 
multidrug resistance has increased significantly over the past 20 years (123). 
Antibiotic resistance can arise from antibiotic modification, efflux of the antibiotics out 
of the cells or by altering the antibiotic binding site (122). One approach to overcome 
antibiotic resistance is to obtain knowledge on the mechanism of resistance such that a 
new compound that is active against the mechanism of resistance can be developed. 
Furthermore, the use of virtual screening is being used as a cost-effective method for 
rational drug design (124). However, the development of novel drugs/antibiotics, which 
would not harm the host, is hampered by the high level of conservation of the protein 
translation machinery among species.  
Here it is observed that EF-Ts is highly variable in sequence and can have altered 
function through modulation of the C-terminal domain. Virtual screening can be utilized 
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to identify antibiotics that may target the C-terminal module of EF-Ts to inhibit its 
function. In addition, the dissociation of nucleotides from EF-Tu can be targeted at 
various steps so that dissociation of guanine nucleotides from EF-Tu can be fine-tuned. In 
this way, EF-Ts might be a promising target for novel species-specific antibiotics, which 
would not harm the host. 
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Chapter 4 
Construction of a Fully Active Cys-less Elongation Factor Tu: Functional Role of 
Conserved Cysteine 81. 
*(Previously published in Biochimica et biophysica acta. 2011 May; 1814 (5): 684-692)  
 
4.1 Introduction 
EF-Tu and its eukaryotic counterpart eEF1 are essential proteins involved in gene 
expression. In rapidly growing bacterial cells, EF-Tu accounts for approximately 5% of 
the cellular proteins (85). As a GTP-dependent translation factor, EF-Tu participates in 
the cyclic process of mRNA-directed polypeptide synthesis through the delivery of 
aminoacyl-tRNA (aa-tRNA) to the A site of actively translating ribosomes. In its 
GTP-bound active state, EF-Tu binds to aa-tRNA with high affinity (KD ≈ 10
-8
 M) (100), 
forming an EF-Tu•GTP•aa-tRNA ternary complex (101). During aa-tRNA delivery this 
ternary complex first interacts with the ribosome in a codon independent initial binding 
step (42). Following codon recognition, a signal is transmitted, originating from the 
decoding site on the 30S ribosomal subunit, to domain I of EF-Tu, leading to GTPase 
activation and subsequent nucleotide hydrolysis (97). GTP hydrolysis is then followed by 
the release of inorganic phosphate (Pi) (43), causing a major conformational change in 
EF-Tu (44) and lowering the affinity of EF-Tu for aa-tRNA (100) significantly and 
allowing for the release of aa-tRNA into the ribosomal A site. The active GTP-bound 
state of EF-Tu (EF-Tu•GTP) is regenerated from the inactive GDP-bound state 
(EF-Tu•GDP) by the guanine nucleotide exchange factor EF-Ts (46) which enhances the 
rate of GDP dissociation from EF-Tu approximately 60 000-fold (45), enabling the rapid 
turnover of EF-Tu consistent with elongation rates found in vivo (102).  
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Crystal structures of EF-Tu have allowed the identification of amino acid residues in 
EF-Tu critical for the interactions between the ribosome (70), EF-Ts (47), aa-tRNA 
(101), and guanine nucleotides (44,69). However, little is known about the dynamic 
processes that lead up to and follow GTP hydrolysis and Pi release. Detailed knowledge 
of these processes is of great interest for understanding the design principles underlying 
the function of this cellular machine, in turn enabling the identification and 
characterization of, for example, novel antibiotics.  
Generally, little is known about the functional roles of residues that do not directly 
participate in the molecular interactions identified in crystal structures of the respective 
macromolecule. Nevertheless, these residues can be members of a critical 3-dimensional 
communication network regulating and fine-tuning the functional properties of a protein. 
Understanding the functional role of these often highly conserved secondary shell 
residues is pivotal for the rational design of novel biomolecular machines and tools. One 
important class of molecular tools consists of proteins covalently linked to 
non-fluorescent (e.g. crosslinking groups) or fluorescent reporter groups. These modified 
proteins are frequently used to study molecular dynamics by measuring distance changes 
using FRET between two dyes attached to the components of a molecular system such as 
the ribosome (125). Development of such molecular probes often requires the precise 
positioning of reporter groups on the molecular surface of the respective 
macromolecule(s). This problem is routinely addressed by introducing cysteine residues 
at positions of interest and subsequent labelling with a reporter group of choice. The 
power of this approach has been demonstrated in a number of studies (126,127). 
However, in order to allow for specific cysteine-directed labelling, naturally occurring 
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cysteine residues in the protein have to be removed first. The activity of the protein may 
be affected when functionally important cysteine residues are replaced. Functional 
importance is typically indicated by strict evolutionary conservation. EF-Tu from E. coli 
contains three cysteine residues (Figure 4.1) from which only one, cysteine 81 (Cys 81), 
exhibits significant evolutionary conservation (79% conserved, Appendix Figure A.7). 
This highly conserved cysteine is buried near the nucleotide binding pocket in domain I 
of EF-Tu. Although Cys 81 does not interact directly with the bound guanine nucleotide, 
it is involved in the formation of several hydrogen bonds with water molecules that 
participate in coordinating the bound magnesium ion and one of the nucleotide’s 
β-phosphate oxygen atoms (44). Previous studies revealed that Cys 81 can be modified 
with N-tosyl-L-phenylalanylchloromethane (TPCK) and that this modification essentially 
abolishes aa-tRNA binding (128). Further analysis on the functional role of Cys 81 used a 
glycine substitution, which significantly impaired GDP and aa-tRNA binding (129). 
These reports may have discouraged the development of a cysteine-free (Cys-less) 
version of EF-Tu, pivotal for further studies relying on the site-specific introduction of 
fluorescent and non-fluorescent labels. Availability of such a Cys-less version of EF-Tu 
will be of great value for the study of EF-Tus function on and off the ribosome. These 
processes are currently not accessible by techniques such as single molecule (sm) FRET, 
which have provided valuable information on a number of steps preceding and 
subsequent to accommodation (42,130). 
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Figure 4.1. Overview of cysteine residues present in the EF-Tu•GTP complex. The positions of the 
three cysteine residues present in EF-Tu from E. coli are indicated in black and represented in space fill. 
EF-Tu is represented in cartoon and coloured as in figure 3.1. (Figure was generated using coordinates 
from PDB ID 1EFT (44)) 
 
Previous attempts to construct a Cys-less version of EF-Tu were based on the structurally 
conservative substitution of cysteine with the isosteric serine (131). This approach 
resulted in a version of EF-Tu that was significantly impaired in aa-tRNA binding, 
significantly limiting its use for further kinetic studies. In this work, this problem is 
revisited and addressed from an evolutionary perspective based on the assumption that 
conservation of a particular amino acid reflects the constraints imposed by functional 
requirements in this position. Therefore naturally occurring substitutions in this position 
are likely to conserve the function of the protein. Based on the analysis of EF-Tu 
sequences available in the SwissProt Database (115), three Cys-less versions of EF-Tu 
were constructed containing serine, alanine or methione in position 81. The properties of 
these Cys-less variants were characterized with respect to the interaction with guanine 
nucleotides, EF-Ts, aa-tRNA and the ribosome. Here it is demonstrated that the Cys-less 
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variant of EF-Tu, based on an alanine substitution in position 81, does indeed exhibit 
wild-type activity as opposed to the respective methionine and serine variants. Therefore 
the introduction of cysteine residues into the Cys-less EF-Tu background for subsequent 
labelling should be based on the alanine rather than the serine or methionine variant. 
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4.2 Materials and Methods 
4.2a Cloning and Site-Directed Mutagenesis 
Amino acid substitutions were introduced into a derivative of pET21a (pKECAHIS 
(112)) containing the full-length sequence coding for an N-terminal His6-tagged EF-Tu 
and valine (GTC) substituting cysteine in positions 137 and 255 (introducing restriction 
sites for SgrAI and SalI, respectively) using the Quikchange
TM
 method. Primers were 
obtained from Invitrogen. Reactions were carried out in a TGradient (Biometra) 
thermocycler: 25 L of the reaction mixture contained 1000 ng of template plasmid 
DNA, 0.4 M primer pair, 400 M of each dNTP, and 3 units of DNA polymerase (Pfu, 
Fermentas).  
The reaction was carried out by heating the reaction mixture to 95C for 3 min followed 
by 18 cycles of 95C for 1 min, 64C for 1 min, 70C for 16 min and subsequent final 
elongation at 70C for 15 min. To remove the template DNA the reactions were treated 
with restriction enzyme DpnI (Fermentas) for 16 hrs at 37°C. 1.5 L aliquots of the 
resulting product were transformed into 15 μL E. coli DH5 competent cells (New 
England Biolabs), which were grown on LB media supplemented with 100 g/mL 
ampicillin. Plasmids were isolated from selected colonies using a mini-prep purification 
kit (EZ-10 Spin Column Plasmid DNA Kit, BioBasic). Positive mutants were identified 
by restriction digestion with SmaI (New England BioLabs Inc.). All mutants were 
confirmed by sequencing (Macrogen DNA Sequencing Services).  
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For all primers, the position of mutagenesis is denoted in bold; and the SmaI restriction 
site (CCCGGG) was removed through a silent mutation (underlined) to enable restriction 
screening.  
C81A-f  5’- CGCACACGTAGACGCACCGGGGCACGCC-3’ 
C81A-r 5’- GGCGTGCCCCGGTGCGTCTACGTGTGCG-3’ 
C81S-f  5’- CACTACGCACACGTAGACAGTCCGGGGCACG-3’ 
C81S-r  5’- AGTCGGCGTGCCCCGGACTGTCTACGTGTG-3’ 
C81M-f 5’ –CGCACACGTAGACATGCCGGGGCACGCC – 3’ 
C81M-r 5’ – GGCGTGCCCCGGCATGTCTACGTGTGCG – 3’ 
 
4.2b Protein Expression and Purification 
Wild-type and variant EF-Tu proteins were expressed in E. coli strain BL21-DE3 
(Novagen). Cells were grown at 37C in LB medium supplemented with 100 g/mL 
ampicillin to mid-log phase (OD600=0.6) and induced with 1 mM IPTG (Bio Basic) as in 
section 3.2c.  
Similar purification procedures were followed for wild-type EF-Tu and variant proteins 
from E. coli. This was performed as section 3.2c. The final protein concentration was 
determined spectrophotometrically at 280 nm using a molar extinction coefficient of 
32 900 M
-1
 cm
-1 
(calculated using ProtParam (88)) and confirmed using the Bradford 
Protein Assay (BioRad).  
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4.2c Preparation of Nucleotide-Free EF-Tu 
To promote the dissociation of GDP, which is tightly bound to EF-Tu and co-elutes with 
the factor during purification, nucleotide-free EF-Tu was prepared as in section 3.2d. 
 
4.2d Preparation of EF-Tu•mant-GDP, EF-Tu•mant-GTP 
EF-Tu•GDP was incubated with a 10-fold molar excess of mant-GDP or mant-GTP in 
buffer 4.1 (50 mM Tris-Cl pH 7.5 (20°C), 70 mM NH4Cl, 30 mM KCl and 7 mM MgCl2) 
for 30 min at 37C. These reactions were carried out in the presence of 3 mM PEP and 
0.1 mg/mL PK (Roche Diagnostic) to convert any nucleotide diphosphate present into 
their respective nucleotide triphosphate forms. 
 
4.2e Rapid Kinetic Measurements 
Fluorescence stopped-flow measurements were performed using a KinTek SF-2004 
stopped-flow apparatus similar to that previously described in reference (90) and in 
section 3.2e. Mant-nucleotides were excited via FRET from the single tryptophan 
(ex = 280 nm) present in EF-Tu and fluorescent emission was measured after passing 
through LG-400-F cut off filters (NewPort). The apparent rate for the bimolecular 
association of mant-nucleotides to nucleotide free EF-Tu was determined by rapidly 
mixing 25 μL of nucleotide free EF-Tu (0.3 μM after mixing) with 25 μL varying 
concentrations of mant-nucleotides (ranging from 0.3 to 10 μM after mixing) at 20°C in 
buffer 4.1. Fluorescence time courses were evaluated by fitting with a single exponential 
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equation, based on the one-step binding behavior (Equation 1) as only single exponential 
time courses were observed.  
 
F = F + A  exp(-k  t)        (Equation 4.1) 
 
Where F is the fluorescence at time t, F is the fluorescence at equilibrium, A is the 
amplitude and k is the apparent rate constant of association (kapp). The apparent rate 
constants were plot as a function of nucleotide concentration; the slope of this function 
yields the association rate constant (kon). 
Dissociation rate constants were determined by rapidly mixing 25 μL 
EF-Tu•mant-GTP/GDP (0.3 μM after mixing) with 25 μL GTP/GDP (30 μM after 
mixing) at 20°C in buffer 4.1. Due to the excess of unlabelled nucleotide present, only the 
dissociation of the mant-labelled nucleotide contributed to the observed fluorescence 
change and rebinding of the mant-nucleotide is negligible. Using similar conditions the 
dissociation of mant-GTP/GDP from 25 μL EF-Tu•mant-GTP/GDP (0.3 μM after 
mixing) was stimulated with 25 μL EF-Ts (1 μM after mixing) at 20°C in buffer 4.1. 
Fitting the observed fluorescence time courses with equation 4.1 yielded the rate of 
nucleotide dissociation in the presence of 1 μM EF-Ts. Calculations were performed 
using TableCurve (Jandel Scientific) and Prism (GraphPad Software).  
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4.2f Components of the Translation Machinery  
Ribosomes from E. coli were prepared as in section 2.2d and [
14
C]Phe-tRNA
Phe
 was 
prepared as described in Milon et. al., 2007 (89). [
14
C]Phe-tRNA
Phe 
was prepared through 
the aminoacylation of 10 µM E. coli tRNA
Phe
 (Sigma) with 40 µM [
14
C]Phe (MP 
Biomedical), 5% crude synthetase, 3 mM ATP (Sigma) in buffer 4.2 (25 mM Tris-acetate 
(OAc) pH 7.5 (20°C), 8 mM Mg(OAc)2, 3 mM ATP, 100 mM NH4OAc, 30 mM KOAc, 
1 mM DTT) to a final volume of 500 µL. [
14
C]Phe-tRNA
Phe
 was separated from tRNA
Phe
 
with a Jupiter 5 μm C18 300A reverse phase chromatography column (Phenomenex) on 
an HPLC (BioCad Sprint Perfusion Chromatography system) using a linear ethanol 
gradient from buffer 4.3 (20 mM NH4OAc pH 5, 10 mM Mg(OAc)2, 400 mM NaCl) to 
buffer 4.4 (buffer 4.3 with 30% ethanol).  
 
4.2g Hydrolysis Protection Assay 
To form the EF-Tu•GTP complex, 2.25 µM EF-Tu, 1.5 mM GTP, 3 mM PEP, 
0.1 mg/mL PK and 0.9 µM EF-Ts was incubated (total volume of 40 µL) in buffer 4.5 
(50 mM Tris-Cl pH 7.5 (4°C), 70 mM NH4Cl, 30 mM KCl, 10 mM MgCl2) for 20 min at 
37°C. Subsequently, 2 µM [
14
C]Phe-tRNA
Phe 
in 20 µL buffer 4.5 was added to the EF-Tu 
mixture to form the EF-Tu•GTP•[14C]Phe-tRNAPhe  ternary complex. The ternary 
complex was then incubated at 37°C and aliquots of 10 µL (~7 pmol ternary complex) of 
the reaction mixture were removed at various time points (from 0 to 100 min) and spotted 
onto pre-soaked 5% Trichloroacetic acid (TCA) Whatman paper (2.5 cm
2 
3MM CHR). 
Free [
14
C]Phe liberated by spontaneous hydrolysis was removed with three washes of 5% 
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TCA, excess TCA was subsequently removed by washing with 30% ethanol. Filter 
papers were dried at 80°C for 30 min and then added to 5 mL scintillation cocktail 
(EcoLite, MP Biomedical) in 20 mL liquid scintillation vials (Wheaton). Radioactivity 
was measured using a Tri-Carb 2800TR Perkin Elmer Liquid Scintillation Analyzer. Data 
was plotted as the natural logarithm of the ratio of the concentration of remaining 
[
14
C]Phe-tRNA
Phe 
at time t (ct) relative to the concentration at time 0 (c0).  
 
4.2h Dipeptide formation 
Ribosomes (0.5 μM) were programmed with poly(U) (1 mg/mL) by incubation at 37C 
for 15 min in a total of 10 μL buffer 4.6 (buffer 4.5 with 1 mM DTT) followed by the 
addition of an equal volume (10 μL) of EF-Tu•GTP (1 μM EF-Tu, 1mM GTP, 3 mM 
PEP and 0.1 mg/mL PK in buffer 4.6). Dipeptide formation was initiated by adding 5 μL 
of 1 μM [14C]Phe-tRNAPhe to the above mixture and further incubated at 37C for 30 s. 
The reaction was quenched with one volume (30 μL) of 2 M KOH and incubated at 37C 
for 15 min. An equal volume (60 μL) of glacial acetic acid was added and the solution 
was centrifuged at 15 000 x g for 10 min using a Hermle Z180M (Labnet International, 
Inc.) centrifuge. 60 μL of the supernatant was removed and added to 125 μL of buffer 4.7 
(0.1% Trifluoroacetic acid (TFA) in H2O). The dipeptide content was subsequently 
analyzed on an EC 250/4 NUCLEOSIL 100-5 C18 column (Macherey-Nagel) using a 
linear acetonitrile gradient from buffer 4.7 to buffer 4.8 (0.1% TFA, 65% Acetonitrile in 
H2O) on a Breeze HPLC system (Waters). 
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4.3 Results 
4.3a Evolution-Based Construction of a Cysteine-Free Variant of EF-Tu 
Based on the assumption that evolutionary conservation can provide important clues on 
the functional conservation of specific positions within a protein, a multiple sequence 
alignment was performed on bacterial EF-Tu sequences (Appendix Figure A.7) available 
in the SwissProt Database (115) using ClustalW (116). Analysis of the conservation 
levels, as well as specific substitutions found in a particular position can provide critical 
information regarding the identity of residues tolerated in the respective position. The 
conservation levels and substitutions of the three cysteine residues present in EF-Tu (Cys 
81, Cys 136, and Cys 255) from E. coli were analyzed using GeneDoc software version 
2.7 (117). This analysis revealed that the cysteine residue in position 81 is present in 79% 
of the aligned bacterial sequences whereas alanine was found in 19% and methionine in 
one (2%) of the sequences (Appendix Figure A.7). The sequence alignment also showed 
Cys 136 and Cys 255 to be 31% and 25% conserved, respectively (Appendix Figure A.7). 
Based on this observation, three different variants were constructed for a cysteine-free 
EF-Tu, alanine (EF-TuAVV), methionine (EF-TuMVV), as well as the structurally 
conservative serine (isosteric to cysteine) variant (EF-TuSVV), in which the non-conserved 
cysteine residues (position 136 and 255) were replaced with the most frequent 
substitution, valine (25%, 35% respectively), found in the multiple sequence alignment. 
Subsequently, the activity of the three cysteine-free variants of EF-Tu were assessed 
through a comparative analysis with respect to the four key catalytic activities of EF-Tu: 
GDP/GTP binding, EF-Ts interaction, aa-tRNA binding, and aa-tRNA delivery to the 
translating ribosome (peptide-bond formation). 
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4.3b Interaction with Guanine Nucleotides (GDP/GTP) 
The kinetic parameters governing the interaction of EF-Tu with the respective guanine 
nucleotides have previously been successfully determined using a FRET-based rapid-
kinetics approach (45). Based on this approach, rate constants of nucleotide binding and 
dissociation for the three constructed EF-Tu variants have been determined, as well as for 
the wild type enzyme using the stopped-flow technique, measuring FRET between the 
single tryptophan (Trp 184) in EF-Tu to mant-GDP and mant-GTP.  
The apparent rate of nucleotide association was measured at varying concentrations of 
mant-GDP/mant-GTP using a constant concentration of nucleotide-free EF-Tu (Figure 
4.2a, 4.2b). Only a single binding step was observed and the respective apparent rate 
constants (kapp) were determined from the collected fluorescence time courses by fitting 
with an exponential function at each titration point (Eq. 4.1). The linear dependence of 
kapp on the concentration of mant-GDP/GTP (Figure 4.2c, 4.2d) was used to determine 
the GTP and GDP association rate constants. Values were determined for all variant and 
wild type proteins (summarized in Table 4.1): EF-Tu wt 
(kon(TuwtGTP) = (3.7 ± 0.2) x 10
5 
M
-1
s
-1
, kon(TuwtGDP) = (1.6 ± 0.2) x 10
6 
M
-1
s
-1
); EF-TuAVV 
(kon(TuAVVGTP) = (1.7 ± 0.1) x 10
5
 M
-1
s
-1
, kon(TuAVVGDP) = (1.6 ± 0.2) x 10
6 
M
-1
s
-1
); EF-TuMVV
 
(kon(TuMVVGTP) = (3.9 ± 0.1) x 10
5 
M
-1
s
-
1, kon(TuMVVGDP) = (4.3 ± 0.2) x 10
6
 M
-1
s
-1
);
 
EF-TuSVV 
(kon(TuSVVGTP) = (2.2 ± 0.1) x 10
5 
M
-1
s
-1
, kon(TuSVVGDP) = (1.2 ± 0.1) x 10
6 
M
-1
s
-1
). These 
results indicate that EF-TuAVV, EF-TuMVV, and EF-TuSVV have similar association rate 
constants for both guanine nucleotides when compared to wild-type EF-Tu. 
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Figure 4.2. Determination of nucleotide association rate constants. (A) Time course of 3 μM mant-GTP 
association to (1) EF-Tu wt (0.3 μM) measured via FRET excitation of mant fluorescence; (2) control 
without EF-Tu. (B) Time course of 3 μM mant-GDP association to (1) EF-Tu wt (0.3 μM), (2) control 
without EF-Tu. (C, D) Concentration dependence of kapp determined by fitting time courses similar to (A, 
B) at various nucleotide concentrations with a single-exponential function. Filled circles, EF-Tu wt; open 
circles, EF-TuAVV; open squares, EF-TuMVV; open triangles, EF-TuSVV. 
 
Table 4.1. Kinetic Constants Governing the Interactions Between EF-Tu and  
Guanine Nucleotides. 
 
Constant EF-Tu wt EF-TuAVV EF-TuMVV EF-TuSVV 
konGTP M
-1
s
-1
 3.7 ± 0.2 x 10
5
 1.7 ± 0.1 x 10
5
 3.9 ± 0.1 x 10
5
 2.2 ± 0.1 x 10
5
 
konGDP M
-1
s
-1
 1.6 ± 0.2 x 10
6
 1.6 ± 0.2 x 10
6
 4.3 ± 0.2x 10
6
 1.2 ± 0.1 x 10
6
 
koffGTP s
-1
 0.04 ± 0.01 0.06 ± 0.01 0.04 ± 0.01 0.06 ± 0.01 
koffGDP s
-1
 0.002 ± 0.001 0.004 ± 0.001 0.002 ± 0.001 0.003 ± 0.001 
KD (GTP) nM 110 ± 30 350 ± 80 100 ± 30 270 ± 60 
KD (GDP) nM 1.3 ± 0.8 3 ± 1 0.5 ± 0.3 3 ± 1 
 
Nucleotide dissociation rate constants for the EF-Tu•mant-GTP and EF-Tu•mant-GDP 
complexes were determined by mixing with excess GDP/GTP using FRET between the 
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single tryptophan present in EF-Tu and the bound mant-GDP/GTP (Figure 4.3a, 4.3b). 
The presence of excess unlabelled nucleotide inhibits the rebinding of free 
mant-GDP/mant-GTP, resulting in fluorescence time courses reflecting a single 
dissociation step. Consequently, the dissociation rate constants were obtained by fitting 
the observed time courses in Figures 4.3a and 4.3b with a single-exponential function 
(Eq. 4.1). Values obtained for the respective koff are summarized in Table 4.1: EF-Tu wt 
(koff(TuwtGTP) = 0.04 ± 0.01s
-1
, koff(TuwtGDP) = 0.002 ± 0.001s
-1
); EF-TuAVV 
(koff(TuAVVGTP) = 0.06 ± 0.01 s
-1
, koff(TuAVVGDP) = 0.004 ± 0.001 s
-1
); EF-TuMVV
 
(koff(TuMVVGTP) = 0.04 ± 0.01 s
-1
, koff(TuMVVGDP) = 0.002 ± 0.001 s
-1
);
 
EF-TuSVV 
(koff(TuSVVGTP) = 0.06 ± 0.01 s
-1
, koff(TuSVVGDP) = 0.003 ± 0.001 s
-1
). The values obtained for 
both GDP and GTP dissociation rate constants are similar for all three variants of EF-Tu 
as well as wild type EF-Tu and are consistent with those reported previously (45). Based 
on these results, equilibrium binding constants (KD) for the variants and the wild type 
protein can be calculated from KD = koff/kon (summarized in Table 4.1) revealing only 
slight effects (3-fold) of the substitutions on the respective binding constants. 
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Figure 4.3. Determination of nucleotide dissociation rate constants. (A) Time course of mant-GTP 
dissociation from (1) EF-Tu wt (0.3 μM) measured via FRET excitation of mant fluorescence; (2) control 
without EF-Tu. (B) Time course of mant-GDP dissociation from (1) EF-Tu wt (0.3 μM); (2) control 
without EF-Tu. (C) Time course of mant-GTP dissociation from EF-Tu wt (0.3 μM) stimulated by EF-Ts 
(1 μM). (D) Time course of mant-GDP dissociation from EF-Tu wt (0.3 μM) stimulated by EF-Ts (1 μM). 
 
4.3c EF-Ts Stimulated Guanine Nucleotide Dissociation 
In order to assess the effect of replacing cysteine residues present in EF-Tu on 
interactions with its nucleotide exchange factor EF-Ts, stopped-flow measurements of the 
nucleotide dissociation rates in the presence of a fixed concentration of EF-Ts were 
performed. Under these conditions, effects on the affinity of the variant EF-Tus to EF-Ts 
and on the mechanism of nucleotide dissociation was assayed. 
EF-Tu•mant-GDP/EF-Tu•mant-GTP was rapidly mixed with EF-Ts in the presence of 
excess unlabelled nucleotide, and a decrease in the fluorescence of the mant reporter 
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group due to the dissociation of the nucleotide was recorded (Figure 4.3c, 4.3d). As for 
the intrinsic dissociation reaction, the observed time courses were fit with a single-
exponential function (Eq. 4.1). The obtained values (summarized in Table 4.2) indicate 
that nucleotide dissociation from variant EF-Tu is stimulated by EF-Ts similar to rates 
obtained with wild type EF-Tu under these conditions. This suggests that the introduced 
substitutions do not affect the EF-Ts stimulated nucleotide exchange reaction, nor the 
interaction between the two proteins. 
Table 4.2. EF-Ts Induced Dissociation of mant-Nucleotides from EF-Tu. 
EF-Tu kapp s
-1
 (GTP + Ts) kapp s
-1
 (GDP + Ts) 
EF-Tu wt 6.9 ± 0.1 2.6 ± 0.1 
EF-TuAVV 6.3 ± 0.2 4.4 ± 0.1 
EF-TuMVV 7.1 ± 0.1 2.5 ± 0.1 
EF-TuSVV 4.9 ± 0.2 1.7 ± 0.1 
 
 
4.3d Interaction of aa-tRNA with EF-Tu 
Results here confirm that nucleotide binding properties are not significantly affected by 
the introduced amino acid residue substitutions. The effect of these substitutions on the 
interaction with another main cellular interaction partner of EF-Tu, aa-tRNA, was also 
analyzed. To this end, the ability of wild-type EF-Tu and the three variants to protect the 
aminoacyl-ester bond between [
14
C]-labelled phenylalanine and the tRNA
Phe
 body against 
spontaneous hydrolysis was examined. A fixed amount of [
14
C]Phe-tRNA
Phe
 was 
incubated in the presence of EF-TuGTP and the amount of [14C]Phe-tRNAPhe remaining 
intact was measured as function of time (Figure 4.4). The half-life (t1/2) of 
[
14
C]Phe-tRNA
Phe 
in the presence of each variant was calculated and compared to wild 
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type EF-Tu (Table 4.3). The calculated t1/2
 
in the presence of EF-Tu wt and EF-TuAVV 
were comparable (90 ± 5 min and 80 ± 20 min, respectively), whereas the t1/2
 
in the 
presence of EF-TuMVV and EF-TuSVV was significantly affected (40 ± 4 min and 
30 ± 8 min, respectively) indicating an altered mode of interaction with aa-tRNA for the 
latter two variants. However, both variants are still capable of protecting the aminoacyl-
ester bond against spontaneous hydrolysis to some extent, when compared to the 
hydrolysis in the absence of EF-Tu (Figure 4.4, Table 4.3) which has a half-life of 
10 ± 7 min. This suggests that a ternary complex also forms in the presence of the 
EF-TuMVV and EF-TuSVV variants, but the interaction might be weaker and thus more 
dynamic with the aa-tRNA dissociating more frequently from EF-Tu. Furthermore, the 
observation showing EF-TuAVV exhibiting wild type-like behavior in this assay suggests 
that the substitutions at position 255 and 136 do not effect aa-tRNA interaction. 
 
Figure 4.4. EF-Tu•GTP•aa-tRNA ternary complex stability. Time dependence of 0.5 μM 
[
14
C]Phe-tRNA
Phe
 hydrolysis, incubated in the presence of EF-Tu wt (filled circles) EF-TuAVV (open 
circles) EF-TuMVV (open squares) EF-TuSVV (open triangles) and absence of factor (filled triangles). 
ln(cn/c0) is plotted over time, where the slope indicates the rate of aminoacyl-ester bond cleavage. cn is the 
concentration of [
14
C]Phe-tRNA
Phe 
at a given time point and c0 is the concentration of
 
[
14
C]Phe-tRNA
Phe 
at 
time 0. 
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Table 4.3. EF-Tu Mediated Protection of Phe-tRNA
Phe
 against  
Spontaneous Hydrolysis. 
 
EF-Tu t1/2 Phe-tRNA
Phe
 (min) 
EF-Tu wt 90 ± 5 
EF-TuAVV 80 ± 20 
EF-TuMVV 40 ± 4 
EF-TuSVV 30 ± 8 
No EF-Tu 10 ± 7 
 
 
 
4.3e EF-Tu Dependent Dipeptide Formation 
During the elongation phase of protein synthesis, EF-Tu interacts with the ribosome as a 
ternary complex EF-Tu•GTP•aa-tRNA in a codon-dependent manner. Productive 
interaction results in peptide-bond formation between the ribosome-bound growing 
peptide chain and the amino acid of the incoming aa-tRNA. To assess the ability of the 
three variants to sustain ribosome-dependent protein synthesis, the ability to promote 
dipeptide formation was measured using a poly(U)-dependent in vitro translation assay 
(Figure 4.5). The amount of dipeptide formed was analyzed using HPLC and quantified 
using scintillation counting (Material and Methods). When compared to the dipeptide 
formation promoted by wild-type EF-Tu (100 ± 20%), all three variants (EF-TuAVV, 
EF-TuMVV and EF-TuSVV) showed a similar dipeptide formation activity (84 ± 8 %, 
72 ± 11 %, and 85 ± 12%, respectively) under these conditions. This is significantly 
higher than in the absence of EF-Tu (8 ± 3%). These findings indicated that all three 
variants of EF-Tu are not significantly affected in their interactions with the translating 
ribosomes comprising all the different steps of A site binding up to dipeptide formation. 
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Figure 4.5. Peptide-bond formation. Percent dipeptide formation of [
14
C]Phe-[
14
C]Phe dipeptide within 
30 s at 10 mM Mg
2+
 in the presence of EF-Tu wt, EF-TuAVV EF-TuMVV, EF-TuSVV or no EF-Tu as indicated 
on the x-axis. Purified 70S ribosomes were programmed with poly(U) and dipeptide formation was 
initiated by the addition of [
14
C]Phe-tRNA
Phe
 in the presence of the respective EF-Tu•GTP. Dipeptides 
formed were separated using HPLC and subsequently quantified using scintillation counting. 
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4.4 Discussion 
Over recent years, fluorescence-based rapid kinetic approaches have provided valuable 
information regarding the structural dynamics and functional mechanism of translation in 
bacteria (41,132). A detailed understanding of the underlying principles of this last step 
in gene expression is of great importance for a large number of applications, ranging 
from the rational design of biomolecular machines to the development of novel 
antibiotics. With the advent of sophisticated single-molecule fluorescence techniques, 
further detail about structural dynamics of involved macromolecules has been added to 
the existing knowledge (125). However, the picture generated by these combined 
techniques still has several blind spots, including a detailed description of the structural 
dynamics of EF-Tu during aa-tRNA release into the ribosomal A site following GTP 
hydrolysis and Pi release. This is mainly due to a lack of appropriate molecular tools to 
address this step, such as an EF-Tu allowing for the specific incorporation of fluorescent 
dyes optimal for both ensemble and single molecule measurements. Therefore, the focus 
of this study was to develop a cysteine-free variant of EF-Tu, which retains wild type 
properties and can serve as a starting point for the development of novel fluorescence-
based assays to study the structural dynamics of EF-Tu during protein synthesis. 
 
4.4a Evolution-Based Design and Previous Studies  
The need to maintain the structural and functional integrity of an evolving protein 
severely restricts the repertoire of acceptable amino acid substitutions. The selective 
constraint imposed on evolving proteins can be very strong, therefore amino acid 
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conservation provides critical information on the functional importance of particular 
amino acids. Based on the evolutionary analysis performed here, it was confirmed that 
only one (Cys 81) of the three cysteine residues present in EF-Tu from E. coli (Cys 81, 
Cys 136, and Cys 255) is highly conserved. Furthermore, the cysteine residues in position 
136 and 255 can be substituted with valine, the most abundant amino acid substitution 
occurring in these positions. The high degree of evolutionary conservation of Cys 81, as 
well as evidence from previous studies (129), suggests that a cysteine side chain in this 
position is important for the function of EF-Tu. The fact that Cys 81 displays reactivity 
against TPCK and that this modification strongly affects EF-Tu dependent poly(Phe) 
synthesis (128), demonstrates the necessity to replace the cysteine side chain in this 
position with a side chain that will not be reactive in subsequent labelling reactions. One 
of these potential substitutions replacing cysteine with glycine has previously been 
reported (129). Although this variant was originally constructed to study the role of Cys 
81 during aa-tRNA binding, it also demonstrated that the reduction of the side chain to a 
hydrogen atom in this position cannot be tolerated by EF-Tu. This substitution resulted in 
an overall slower rate of poly(Phe) synthesis, decreased protection of the aminoacyl-ester 
bond against spontaneous hydrolysis (40%), as well as altered nucleotide binding 
properties (i.e. a 13-fold higher KD for GDP) (129). This phenotype is consistent with the 
multiple sequence alignment performed here in which no glycine residue was found at 
this position. 
Interestingly, although highly conserved, it was found that the cysteine is replaced in a 
small number of bacterial sequences with only two other amino acids, alanine and 
methionine, suggesting that these mutations may be tolerated. Variants of EF-Tu were 
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therefore constructed based on this evolutionary clue. As expected, these variants did not 
have the strong phenotype associated with the glycine substitution as they exhibited wild 
type-like behavior with respect to a number of key functions of EF-Tu, including 
nucleotide binding and poly(Phe) synthesis. However, the respective methionine and 
serine, but not the alanine, substitutions were significantly impaired in protecting the 
labile aa-ester bond against spontaneous hydrolysis. This might be the reason why this 
substitution was only found in one of the bacterial sequences. The fact that the protein 
containing methionine at position 81 is from Streptomyces coelicolor can be explained by 
the presence of several copies of genes coding for EF-Tu in its genome. In addition to the 
gene giving rise to the nonessential methionine variant, it also contains a version of 
EF-Tu containing cysteine in this position, enabling S. coelicolor to overcome any 
negative effect that might be associated with the methionine substitution in vivo. 
Furthermore, S. coelicolor produces several antibiotics, such as actinorhodin, 
methylenomycin, undecylprodigiosin, and perimycin (133). It is believed that the 
alternate versions of EF-Tu in this organism are necessary for cellular resistance 
strategies against the produced antibiotics. 
In order to further test these hypothesis that maintaining the function of EF-Tu is the 
reason for the observed limited sequence variability (Ala and Met) at this position, a 
Cys-less variant of EF-Tu containing serine at position 81 was also constructed. Although 
the serine variant was not as strongly affected as the previously reported glycine variant, 
it also displayed decreased protection activity against the spontaneous hydrolysis of the 
aa-ester bond between the phenylalanine and the tRNA
Phe
. 
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4.4b Functional Role of Cysteine 81  
No direct interactions of the cysteine side chain with either the aa-tRNA or the nucleotide 
have been identified in the available crystal structures and it is not clear what the 
mechanistic/structural reason for the observed limited sequence variability in position 81 
is. Findings reported here suggest that the main functional constraint is imposed by the 
ability of EF-Tu to form a stable ternary complex with aa-tRNA rather than the general 
effects observed in the previously reported glycine variant (129). Substitution with 
glycine affects aa-tRNA binding, nucleotide binding properties of EF-Tu as well as its 
thermal stability, which is most likely due to the increased backbone flexibility and 
decreased side chain packing around this position. This is further supported by the 
observation that replacing cysteine with either serine or methionine restores nucleotide 
binding properties, as well as the interaction with EF-Ts to promote nucleotide 
dissociation, but not the protection of the aa-ester bond. This is surprising since the 
cysteine, and therefore also the methionine and serine side chain, are more than 15 Å 
away from the aa-ester bond in the ternary complex (101) and should not have any direct 
influence on the stability of this bond. Mutational studies to identify the 
thermodynamically relevant interactions between EF-Tu and aa-tRNA revealed a cluster 
of amino acids (Tyr 87, Lys 89, Asn 90) in helix B of EF-Tu (six amino acids 
downstream of Cys 81) that are involved in aa-tRNA binding by forming a molecular 
clamp recognizing the phosphate backbone of the bound aa-tRNA acceptor arm (134).  
Selective mutations of these invariant amino acids lead to the disruption of the specific 
interactions and a 10-fold decrease in the affinity for aa-tRNA (134), which is within the 
same order of magnitude as the reduction of protection found in these experiments. Helix 
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B is of particular interest since it participates in the drastic conformational change 
occurring during the transition from the active GTP-bound state to the inactive GDP-
bound form of EF-Tu. In the GTP-bound form, residues 54-59 in the switch I region of 
the G-domain fold into helix A, whereas the same residues are part of -strand b’ in the 
GDP conformation (44). All this occurs in close proximity to helix B, which in the GTP-
bound form of EF-Tu is shifted by 42 compared to the GDP-bound form. In the GTP 
conformation, side chain packing around Cys 81 is high and its side chain is in close 
proximity (4.1 Å) to the invariant Gly 94 on the other side (downstream) of helix B, 
aiding in its positioning. In the GDP-bound state of EF-Tu, helix B reorients and this 
distance increases to 10.2 Å, moving Tyr 87 into the spatial position previously occupied 
by Cys 81. Based on the participation of helix B in binding of the aa-tRNA, slight 
differences in the positioning of the molecular clamp formed by helix B (residues Tyr 87, 
Lys 89, Asn 90) are likely to have consequences on the aa-tRNA binding affinity. The 
consideration of the complex structural arrangements leading to the formation of the 
EF-Tu•GTP•aa-tRNA ternary complex, as well as the high density of side chain packing 
around Cys 81 would suggest that only alanine can be tolerated in this position, as 
indicated by its evolutionary conservation. Based on this it is possible to speculate on the 
effects of methionine at this position. Due to its larger size it can interfere with this 
packing and ultimately alter the positioning of helix B, in turn affecting the binding mode 
of the aa-tRNA. Whereas the interpretation of the methionine effect is straightforward, 
the reason why serine cannot be tolerated in this position is more complicated. As serine 
and cysteine are isosteric, the steric properties of the side chain are most likely not 
responsible for the observed effect on aa-tRNA binding. It is more likely that the 
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physicochemical properties of the OH-versus the SH-group, and therefore the altered 
protonation and hydrogen bonding properties give rise to the observed effects. This 
would point towards altered dynamics based on, for example, different hydrogen bonding 
interactions available during the transition between the GTP and GDP-bound forms of 
EF-Tu or a different positioning of helix B and the respective amino acids. However, in 
either case (methionine or serine), altered interactions around position 81 are likely to 
affect the dynamics observed during conformational change from the GTP to the GDP-
bound state and vice versa, as well as during aa-tRNA binding and dissociation, making 
these two substitutions a poor choice for the construction of a Cys-less version of EF-Tu 
for subsequent studies on the dynamics of this protein during protein synthesis.  
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4.5 Future Directions 
Based on the results reported here, it is demonstrated that a Cys-less variant of EF-Tu 
retaining wild type dynamic and biochemical properties can be constructed by replacing 
the highly conserved cysteine in position 81 with alanine, but not with methionine or 
serine. This Cys-less EF-Tu will be the background of choice for future studies on the 
function of EF-Tu using site-specific introduction of fluorescent and non-fluorescent 
reporter groups. These modified proteins will provide powerful tools for the identification 
and characterization of novel antibiotics targeting the translational machinery, as well as 
provide important insights into the highly dynamic process of aa-tRNA delivery. 
The Cys-less EF-TuAVV has been used as a background for the construction of a series of 
EF-Tu variants with either a single or two cysteines introduced at positions on the protein 
surface that are non-conserved and ideal for chemical modification with thiol specific, 
fluorescent reporter groups.  
Singly fluorescently labelled EF-Tu will allow for studies on the interaction between 
EF-Tu and the ribosome. This can shed light on whether EF-Tu dissociates from the 
ribosome before or after tRNA accommodation in the A site. Intramolecular hetero-
labelled EF-Tu will allow monitoring of the dynamics of the conformational change 
within EF-Tu. This data will be a beneficial screening tool for potential inhibitors of 
EF-Tu function. Labelling strategy and efficiency is provided in the appendix section 
A.3. 
140 
 
Chapter 5 Conclusion 
Protein synthesis is one of the most fundamental processes in all living cells. As such it is 
an effective current target for antibiotics (57) as inhibiting this process stops cellular 
growth. However, antibiotic resistance continues to increase and is a major public health 
concern.  
The cyclic process of peptide elongation during protein synthesis is a highly conserved 
process and is the target of many currently utilized antibiotics (135). Not only do 
antibiotics interfere with protein synthesis by binding to the ribosome, but some target 
translation elongation factors. EF-Tu and EF-G are the targets for some antibiotics 
currently in use. Pulvomycin and GE2270A inhibit EF-Tu function by preventing 
aa-tRNA from binding to EF-Tu, and kirromycin and enacyloxin IIa prevent the release 
of EF-Tu from the ribosome (136). Fusidic acid targets EF-G and prevents the release of 
EF-G from the ribosome (136). Inhibiting the function of these translation factors 
efficiently inhibits protein synthesis.  
Beyond the canonical translation factors, LepA has been identified to function as a 
translational GTPase, and its functional mechanism is only poorly understood. Here it is 
demonstrated that, similar to EF-Tu, LepA contains a catalytic histidine that is needed for 
efficient GTPase activity of LepA on and off the ribosome. Furthermore, the unique CTD 
of LepA is required for tight binding of LepA to the ribosome and efficient ribosome-
stimulated GTPase activity, making the CTD of LepA a possible unique future target for 
antibiotics.  
The comparison of the kinetics of EF-Ts mediated nucleotide exchange between E. coli 
and P. aeruginosa revealed that the catalytic ability of EF-Ts to stimulate guanine 
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nucleotide dissociation from the highly conserved EF-Tu can be modulated though the 
C-terminal module of EF-Ts. In most organisms, EF-Ts is necessary to sustain in vivo 
rates of protein synthesis, however, it is currently not a target for antibiotics. Given the 
importance of EF-Ts for maintaining protein synthesis rates in bacteria, it is surprising 
that it is currently not an antibiotic target. Findings here demonstrate that the length of the 
C-terminal module is important for the function of EF-Ts. Furthermore, the sequence of 
the C-terminal extension can influence the ability of EF-Ts to act as a GEF, depending on 
what system is being analyzed. The variability in the sequence and length of the 
C-terminal module can be utilized in virtual screening methods to specifically target an 
organism without affecting another.  
Little is known about the dynamics of the conformational change EF-Tu undergoes. A 
Cys-less EF-Tu that is functional has been developed here and can be utilized in future 
dynamic analysis. Identification of new potential intermediates may serve as a new target 
for antibiotics. As EF-Tu is a current effective target for antibiotics, identification of new 
functional states will allow for the development of new effective drugs which can target 
this essential protein.  
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Appendix 
A.1 LepA 
 
 
 
 
 
Figure A.1. LepA Protein Preparations. 10% SDS-PAGE of LepA protein preparations where LepA 
H81A (67 kDa) is shown in lane 1, LepA ΔA494 (55 kDa) is in lane 2, LepA ΔP520 (58 kDa) is in lane 3, 
LepA ΔG555 (61 kDa) is in lane 4 and wild type LepA (67 kDa) is represented in lane 5. 
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A.1a Cysteine residues in LepA 
 
Figure A.2. Overview of cysteine residues in E. coli LepA. Structure of E. coli LepA represented in 
cartoon and coloured as figure 2.1. Cysteine residues are represented in spacefill and coloured in black. 
Coordinates used for this representation are from PDB ID 3CB4 (58). 
Table A.1. Identity of Cysteine Composition within Bacterial LepA.  
Position of cysteines in E. coli LepA and percent identity within bacterial organisms 
aligned is outlined. The substitution of each cysteine is also shown. 
Cysteine Position in E. coli Percent Identity  Substitution 
Constructed 
  28 31 Thr 
  95 97 Ser 
116 27 Val 
161 21 Val 
252 10 Ala 
260 12 Ala 
340 90 Val 
406 12 Ala 
422 83 Ala 
553 93 Leu 
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A.1b Alignment of LepA Primary Sequence within Bacteria 
 
Table A.2. Accession Numbers and Organisms used to Align LepA Primary 
Sequence.  
Accession numbers were obtained from the SwissProt Database (115). Percent of 
cysteine residues within the LepA primary sequence is represented. 
Accession 
Number 
Organism Percent Cysteine 
Composition 
Percent Identity 
to E. coli 
P60785 Escherichia coli 17  
Q9X1V8 Thermotoga maritima   6 50 
Q72KV2 Thermus thermophilus   3 55 
A0RIT7 Bacillus thuringiensis 10 56 
C3P8M5 Bacillus anthracis 10 55 
P37949 Bacillus subtilis   8 56 
Q65H50 Bacillus licheniformis   8 56 
A6QHC7 Staphylococcus aureus   8 54 
C1CKU6 Streptococcus pneumoniae   9 54 
Q5M4M2 Streptococcus thermophilus   9 56 
Q831Z0 Enterococcus faecalis   9 56 
Q03QU8 Lactobacillus brevis 10 53 
Q03FQ4 Pediococcus pentosaceus   3 53 
Q14NN1 Spiroplasma citri 10 53 
A7FXL9 Clostridium botulinum   8 55 
A6L744 Bacteroides vulgatus 15 53 
A6LC18 Parabacteroides distasonis 15 52 
Q2S5I1 Salinibacter ruber   7 53 
A5U598 Mycobacterium tuberculosis 12 52 
I7G5I5 Mycobacterium smegmatis 11 48 
Q82BZ3 Streptomyces avermitilis   8 48 
Q9Z8I4 Chlamydia pneumoniae 13 50 
Q823H7 Chlaymydophila caviae 13 49 
Q9PKX6 Chlamydia muridarum 13 49 
P60788 Shigella flexneri 17 100 
P0A1W5 Salmonella typhi 17 96 
A4TKY0 Yersinia pestis 17 92 
Q6LMS0 Photobacterium profundum 15 83 
Q3IDL4 Pseudoalteromonas haloplanktis 12 75 
Q0VP16 Alcanivorax borkumensis 13 74 
A9KF98 Coxiella burnetii 12 71 
Q87C09 Xylella fastidiosa 12 67 
A9III9 Bordetella petrii 12 66 
B9J716 Agrobacterium radiobacter 10 57 
B9JYH0 Agrobacterium vitis 10 55 
Q8UIQ2 Agrobacterium tumefaciens 10 57 
Q6G1F5 Bartonella quintana 12 56 
Q0C5X0 Hyphomonas neptunium 17 56 
Q5NLP5 Zymomonas mobilis 12 59 
Q5FHQ1 Ehrlichia ruminantium 17 51 
A8F140 Rickettsia massiliae 17 56 
C4XND4 Desulfovibrio magneticus 12 60 
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Figure A.3. Primary sequence alignment of LepA within bacteria. Black shows 100% conservation, grey shows 80-100% conservation and 
white is less than 80% conservation. Conserved catalytic histidine is highlighted in panel 1 a box. 
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Figure A.4. Phylogenetic Tree of bacterial LepA aligned above. Phylogenetic tree generated by the ClustalW2 program using the LepA 
bacterial sequences aligned above. The sequence accession code along with the abbreviated species name is shown. 
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A.2 EF-Tu and EF-Ts 
 
 
 
 
 
 
 
Figure A.5. EF-Tu preparations. 12% SDS-PAGE of EF-Tu protein preparations where EF-Tu from 
P. aeruginosa (43 kDa) is shown in lane 1 and EF-Tu from E. coli (43 kDa) is in lane 2. 
 
 
 
 
 
 
Figure A.6. EF-Ts preparations. 12% SDS-PAGE of EF-Ts protein preparations where EF-Ts from 
E. coli (30 kDa) is shown in lane 1 and 2 and EF-Ts from P. aeruginosa (32 kDa) is in lane 3. EF-TsE.c. 
Chimera (30 kDa) is shown in lane 4, EF-TsP.a. C-terminal truncation (31 kDa) is shown in lane 5 and 
EF-TsP.a.Q283M (32 kDa) is shown in lane 6. 
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A.2a Alignment of EF-Ts Primary Sequence within Bacteria 
Table A.3. Accession Numbers and Organisms used to Align EF-Ts Primary 
Sequence.  
Accession numbers were obtained from SwissProt Database (115). The presence of a 
C-terminal module is indicated.  
Accession 
Number 
Organism Contains  
C-terminal 
module? 
Residue at 
E. coli Met 
278 
Percent 
Identity 
with  
E. coli 
Classification 
P0A6P1 Escherichia  
coli 
Yes Met  Gram Negative 
O82851 Pseudomonas 
aeruginosa  
Yes Gln 54 Gram Negative 
P43895 Thermus 
Thermophilus 
No  29 Gram Negative 
O31213 Streptomyces 
coelicolor  
No  33 Gram Positive 
P0A6P4 Shigella flexneri Yes Met 98 Gram Negative  
P80700 Bacillus subtilis  Yes Gln 46 Gram Positive 
P0A3B7 Streptococcus 
pneumoniae  
Yes Met 34 Gram Positive 
Q65JJ8 Bacillus licheniformis  Yes Gln 44 Gram Positive 
Q9X5U9 Coxiella burnetii  Yes Gln 48 Gram Negative 
A0QVB9 Mycobacterium 
smegmatis  
No  35 Gram Positive 
Q10788 Mycobacterium 
tuberculosis 
No  33 Gram Positive 
P64053 Salmonella typhi Yes Met 90 Gram Negative 
Q8ZH65 Yersinia pestis Yes Met 69 Gram Negative 
A5I4L2 Clostridium botulinum  Yes Gln 36 Gram Positive 
Q81WK9 Bacillus anthracis Yes Gln 45 Gram Positive 
P71146 Chlamydia muridarum  No  27 Gram Negative 
P61330 Pseudoalteromonas 
haloplanktis  
Yes Gln 62 Gram Negative 
Q6LN25 Photobacterium 
profundum  
Yes Gln 61 Gram Negative 
A0RHJ9 Bacillus thuringiensis  Yes Gln 45 Gram Positive 
Q9XCM5 Bartonella quintana  Yes Ala 42 Gram Negative 
P99171 Staphylococcus aureus  Yes Gln 41 Gram Negative 
Q5M1X4 Streptococcus 
thermophilus  
Yes Met 35 Gram Positive 
Q9PAD9 Xylella fastidiosa  Yes Gln 48 Gram Negative 
Q8UFM2 Agrobacterium 
tumefaciens  
Yes Val 43 Gram Negative 
Q0VQF6 Alcanivorax 
borkumensis  
Yes Ala 50 Gram Negative 
P19216 Spiroplasma citri Yes Gln 39 No Cell Wall 
Q82JX8 Streptomyces 
avermitilis  
No  33 Gram Positive 
Q9X5E8 Zymomonas mobilis  Yes Ala 42 Gram Negative 
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Q9X5Z9 Streptomyces 
ramocissimus 
No  31 Gram Positive 
Q0C1C0 Hyphomonas 
neptunium  
Yes Leu 44 Gram Negative 
Q03QS2 Lactobacillus brevis  Yes Gln 38 Gram Positive 
Q038L3 Lactobacillus casei  Yes Gln 40 Gram Positive 
Q044C9 Lactobacillus gasseri  Yes Gln 33 Gram Positive 
Q04F87 Oenococcus oeni  Yes Gln 38 Gram Positive 
Q03FT5 Pediococcus 
pentosaceus  
Yes Met 39 Gram Positive 
Q2S6J1 Salinibacter ruber  No  35 Gram Negative 
Q9X1U1 Thermotoga maritima  No  30 Gram Negative 
A6L0V2 Bacteroides vulgatus  No  27 Gram Negative 
A9INV9 Bordetella petrii  Yes  47 Gram Negative 
C4XMY1 Desulfovibrio 
magneticus  
No  29 Gram Negative 
A6LHM8 Parabacteroides 
distasonis  
No  27 Gram Negative 
A8F0J0 Rickettsia massiliae  Yes Ile 41 Gram Negative 
B9JEX1 Agrobacterium 
radiobacter  
Yes Val 43 Gram Negative 
B9JX32 Agrobacterium vitis  Yes Val 41 Gram Negative 
Q824U4 Chlamydophila caviae  No  27 Gram Negative 
Q831V0 Enterococcus faecalis  Yes Gln 39 Gram Positive 
E1B278 Geobacillus anatolicus Yes Gln 41 Gram Negative 
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Figure A.7. Primary sequence alignment of EF-Ts within bacteria. Black shows 100% conservation, grey shows 80-100% conservation and 
white is less than 80% conservation. The conservation of Met 278 from E. coli is highlighted in panel 3 by a box. 
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Figure A.8. Phylogenetic Tree of bacterial EF-Ts species aligned above. Phylogenetic tree generated by the ClustalW2 program using the 
EF-Ts bacterial sequences aligned above. The sequence accession code along with the abbreviated species name is shown. 
 
165 
 
A.2b Alignment of EF-Tu Primary Sequence within Bacteria 
Table A.4. Accession Numbers and Organisms used to Align EF-Tu Primary 
Sequence.  
Accession numbers were obtained from the SwissProt Database (115). The identity with 
E. coli EF-Tu is outlined. 
Accession 
Number 
Organism Identity to E. coli  
EF-Tu 
A0QS98 Mycobacterium smegmatis  74 
A0R8H8 Bacillus thuringiensis  74 
A5I7K8 Clostridium botulinum  73 
A6LE88 Parabacteroides distasonis  72 
A9IJ05 Bordetella petrii  81 
B9JDR0 Agrobacterium radiobacter  73 
C4XIP7 Desulfovibrio magneticus  73 
C7LCI5 Brucella microti  74 
P09591 Pseudomonas aeruginosa  84 
P0A1H6 Salmonella typhi 99 
P0A558 Mycobacterium tuberculosis 74 
P0CE47 Escherichia coli   
P13537 Thermotoga maritima  69 
P29542 Streptomyces ramocissimus 74 
P33166 Bacillus subtilis  76 
P40174 Streptomyces coelicolor  77 
P40175 Streptomyces coelicolor  57 
P64030 Streptococcus pneumoniae  72 
P99152 Staphylococcus aureus  74 
Q039K9 Lactobacillus casei  71 
Q03F25 Pediococcus pentosaceus  71 
Q03QN5 Lactobacillus brevis  69 
Q042T5 Lactobacillus gasseri  70 
Q04FQ4 Oenococcus oeni  69 
Q0C1F4 Hyphomonas neptunium  76 
Q0PHN9 Geobacillus anatolicus 75 
Q0VSL7 Alcanivorax borkumensis  82 
Q14QA4 Spiroplasma citri 72 
Q2S1P8 Salinibacter ruber  70 
Q3ILP4 Pseudoalteromonas 
haloplanktis  
84 
Q5HAS0 Ehrlichia ruminantium  66 
Q5M101 Streptococcus thermophilus  72 
Q5NQ65 Zymomonas mobilis  75 
Q5SHN6 Thermus thermophilus  70 
Q65PA9 Bacillus licheniformis  75 
Q6FZC0 Bartonella quintana  74 
Q6LVC0 Photobacterium profundum  85 
Q81VT2 Bacillus anthracis 74 
Q822I4 Chlamydophila caviae  68 
Q82DQ0 Streptomyces avermitilis  74 
Q839G8 Enterococcus faecalis  76 
Q83ES6 Coxiella burnetii  78 
Q83JC4 Shigella flexneri 100 
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Q8UE16 Agrobacterium tumefaciens  73 
Q8ZJB2 Yersinia pestis 95 
Q9P9Q9 Xylella fastidiosa  77 
Q9PK73 Chlamydia muridarum  68 
Q9Z9A7 Chlamydia pneumoniae  68 
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Figure A.9. Primary sequence alignment of EF-Tu within bacteria. Black shows 100% conservation, grey shows 80-100% conservation 
and white is less than 80% conervation. The conservation of Cys 81 from E. coli is highlighted in panel 1 by a box. 
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Figure A.10. Phylogenetic Tree of bacterial EF-Tu species aligned above. Phylogenetic tree generated by the ClustalW2 program using the 
EF-Tu bacterial sequences aligned above. The sequence accession code along with the abbreviated species name is shown. 
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A.3 Fluorescent labelling of EF-Tu  
5-((((2-iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid (1,5-IAEDANS 
(Invitrogen)), 7-diethylamino-3-(4-maleimidylphenyl)4-Methylcoumarin (CPM 
(Biotium)), Fluorescein-5-maleimide (F5M (Biotium)) or Rhodamine Red Maleimide 
(RRM (Invitrogen)) were used as thiol specific fluorescent dyes (Figure A.11).  
 
Figure A.11. Structures of thiol reactive fluorescent dyes. (A) 1,5-IAEDANS: Peak excitation 336 nm, 
peak emission 490 nm. (B) CPM: Peak excitation 384 nm, peak emission 470 nm. (C) F5M: Peak 
excitation 494 nm, peak emission 515 nm. (D) RRM: Peak excitation 560 nm, peak emission 580 nm. R 
represents (CH2CH3)2. 
 
A.3a Fluorescently Labelling EF-Tu Containing a Single Cysteine (L264C) 
15 000 pmol of highly purified EF-Tu was diluted 5-fold in buffer A.1 (25 mM Tris-Cl 
pH 7.5 (4 °C), 7 mM MgCl2, 30 mM KCl, 20% glycerol). A 20-fold molar excess of 
1,5-IAEDANS , CPM or F5M was added to the solution and incubated at 4°C in the dark 
for 3 hrs with periodic mixing. After incubation, the solution was centrifuged at 
13 000 x g for 5 min. Labelled protein was purified away from excess free dye using a 
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26 mL size exclusion column (Sephadex G25, GE Healthcare) (set to a 1 mL/min flow 
rate) equilibrated in buffer A.2 (25 mM Tris-Cl pH 7.5 (4 °C), 7 mM MgCl2, 30 mM 
KCl). Fractions (500 μL) were collected and analyzed via 12% SDS-PAGE. Fractions 
containing EF-Tu were pooled and concentrated using ultrafiltration (MWCO 30 000 
(Sartorious)). Aliquots were stored at -80°C. Efficiency of labelling EF-Tu using the 
above method is represented in Table A.5, where yields for each step were determined 
based on the amount of EF-Tu present as observed by SDS-PAGE and absorbance values 
at 280 nm. Quantification of the protein concentration was achieved using silver stained 
SDS-PAGE and analysis using Image J software. 
 
Table A.5. Protein Yield Following Fluorescent Labelling of a Single Cysteine 
Containing EF-Tu.  
 
Step Protein 
Recovered with  
1,5-IAEDANS 
Protein 
Recovered with 
F5M 
Protein 
Recovered with  
CPM 
Post incubation with 
fluorescent dye  
75% 75% 60% 
Final Labelled Protein 30% 30% 30% 
 
 
A.3b Intramolecular Hetero-Fluorescent Labelling of EF-Tu Containing Two Cysteine 
Residues 
Purified EF-Tu (70 000 pmol) was diluted 5-fold in buffer A.1 supplemented with 20 M 
GDP. A 20-fold molar excess of CPM was added dropwise and the reaction was 
quenched after 30-50 sec with 10 mM BME. The sample was centrifuged at 13 000 x g 
for 5 min. CPM labelled EF-Tu was separated from excess dye using SEC 
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chromatography (Sephadex G25 (GE Healthcare)) equilibrated in buffer A.1. Fractions 
(500 µL) were analyzed by 12% SDS-PAGE and those containing EF-Tu were pooled 
and incubated on a 5 mL activated thiol sepharose 4B resin (GE Healthcare) for 9 hrs. 
Any unbound protein was collected by centrifugation at 500 x g for 2 min. All following 
washes and elutions were collected in this manner. The thiol sepharose resin was washed 
with 20 mL of buffer A.1 until absorbance values after washes were close to zero at 
280 nm (protein) and 384 nm (CPM). Protein covalently linked to the thiol sepharose 
resin was eluted with 5 mL of buffer A.3 (buffer A.1 supplemented with 100 mM DTT 
(Biobasic)). All washes and elutions were analyzed for EF-Tu content by 12% SDS-
PAGE, and the elutions containing EF-Tu were pooled and concentrated using 
ultrafiltration as above. Excess DTT was removed using dialysis (10 000 MWCO tubing 
(Sigma-Aldrich)) against buffer A.1 so that DTT was diluted at least 500-fold. The 
sample was incubated with a 35-fold molar excess of F5M at 4°C with periodic mixing 
for 2 hrs. The sample was centrifuged at 13 000 x g for 5 min. Excess free dye was 
removed by SEC chromatography (Sephadex G25) equilibrated in buffer A.2 as 
described above. Fractions were analyzed by 12% SDS-PAGE and those containing 
EF-Tu were pooled and concentrated using ultrafiltration as above. Efficiency of 
labelling using the above method is represented in Table A.6 and was determined based 
on the amount of EF-Tu present as observed by SDS-PAGE and absorbance values at 
280 nm as described above in section A.3a.  
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Table A.6. Protein Yield Following Intramolecular Double-Labelling an EF-Tu 
Containing Two Cysteine Residues.  
 
Step Overall Protein Recovered 
Post CPM incubation 80-90% 
Post affinity chromatography  
(thiol column) 
40-50% 
Removal of DTT by dialysis 20-30% 
Post F5M incubation 15-20% 
Final labelled proteins 10% 
 
 
A.3c Intramolecular Hetero-Fluorescent Labelling of EF-Tu Containing Two Cysteine 
Residues using a “Shotgun” Method 
Purified EF-Tu (100 000 pmol) was diluted 5-fold in buffer A.1 supplemented with 
7 mM BME. Excess BME was diluted at least 1000-fold by dialyzing against buffer A.1 
at 4°C overnight. The retained solution was centrifuged at 5000 x g for 2 min. 10-fold 
molar excess of dyes (F5M and RRM) was added simultaneously. The mixture was 
incubated at 4°C for 3 hrs with mixing. To separate excess free dye away from labelled 
EF-Tu the mixture was purified using SEC chromatography (Sephadex G25), 
equilibrated in buffer A.2, at 1 mL/min. Fractions (500 µL) were analyzed via absorbance 
at 280 nm (protein), 493 nm (F5M) and 560 nm (RRM) to determine which fractions 
contained all three components. The fractions containing both dyes and EF-Tu were 
pooled and concentrated before being flash frozen and stored at -80°C. Efficiency of 
labelling using the above method is represented in Table A.7 and was determined based 
on the amount of EF-Tu present as observed by absorbance measurements at 280 nm. 
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Table A.7. Protein Yield Following Intramolecular Double-Labelling an EF-Tu 
Containing Two Cysteine Residues via “Shotgun” Method.  
 
Step Overall Protein Recovered 
Post Dialysis 40% 
Post incubate with dyes 30% 
Final labelled proteins 15% 
 
A.3d Absorbance and Fluorescence Emission Analysis 
Samples of identical concentration were prepared by dilution in buffer A.2.  
Absorbance scans were performed on a UV/Visible Spectrophotometer (Varian Eclipse). 
Fluorescence emission scans were performed on a fluorescence spectrometer (PTI) set to 
3 nm slit widths. EF-Tu fluorescently labelled with either 1,5-IAEDANS, CPM or F5M 
was examined by direct excitation of tryptophan at 280 nm (Figure A.12). EF-Tu labelled 
with two different fluorescent dyes (CPM and F5M or F5M and RRM) was analyzed by 
excitation of the tryptophan (280 nm) (Figure A.13a) or excitation of F5M (493 nm) 
(Figure A.13b).  
Trypsin digestion of F5M and RRM labelled EF-Tu was performed to ensure 
fluorescence emission observed was indeed FRET and not direct excitation of the 
acceptor dye RRM. Trypsin (BioBasic) was added to a final concentration of 40 mg/mL 
to labelled EF-Tu and incubated for 1 hr. This was then analyzed and compared to 
labelled EF-Tu not treated with trypsin (Figure A.13b).  
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Figure A.12. Fluorescence emission scans of single labelled EF-Tu. Samples were excited at 280 nm and 
fluorescence emission was scanned from 300 – 550 nm. EF-Tu labelled with 1,5-IAEDANS (red), or CPM 
(blue), or F5M (purple) is shown. Fluorescence emission of (1) EF-Tu at 325 nm, (2) blue shifted 
fluorescence emission of 1,5-IAEDANS at 450 nm, (3) CPM at 470 nm and (4) F5M at 515 nm can be 
observed. Unlabelled EF-Tu is also shown in black with one emission peak at 325 nm. 
 
 
 
Figure A.13. Emission scans of EF-Tu fluorescently labelled with two different dyes. (A) Samples 
were excited at 280 nm and fluorescence emission was scanned from 300 – 550 nm. EF-Tu labelled with 
CPM and F5M (green) is shown. Fluorescence emission of (1) EF-Tu at 325 nm, (2) blue shifted 
fluorescence emission of CPM at 430 nm and (3) F5M at 515 nm can be observed. Unlabelled EF-Tu is 
also shown in black with one emission peak at 325 nm. (B) Samples were excited at 493 nm and 
fluorescence emission was scanned from 500 – 700 nm. EF-Tu labelled with F5M and RRM (green) is 
shown. Fluorescence emission of (1) red shifted F5M at 530 nm and (2) RRM at 580 nm can be observed. 
Unlabelled EF-Tu is also shown in black and trypsin digested fluorescently labelled EF-Tu is shown (grey) 
with one emission for F5M at 515 nm. 
 
Fluorescence emission analyses of F5M-RRM labelled samples were analyzed on SDS-
PAGE and imaged on a Typhoon 9400 Variable Mode Imager (GE). F5M was imaged 
using a blue 488 nm laser and RRM was imaged with a Green 532 nm laser (Figure 
A.14). 
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Figure A.14. EF-Tu labelled with F5M and RRM. Fluorescent imaging was performed on a Typhoon 
9400 scanner to confirm labelling. (1) Protein was imaged using coomassie brilliant blue. (2) F5M was 
imaged using a blue 488 nm laser. (3) RRM was imaged using a green 532 nm laser. 
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